_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,baseline-decision,orig_e1,orig_e2,relation,sent_id,orig_sentence,term1,term2
725343038,5/24/2015 14:38:07,1642638086,5/24/2015 14:37:44,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,149,48,,,164,51,LYMPHADENOPATHY,CLL,Symptoms Signs Onset insidious; CLL evaluation of asymptomatic LYMPHADENOPATHY.,0-13-20-37-122-133-136-149-48,26-29-37-48-52-55-61-71-122-133-136-149,is usually insidious; CLL is often diagnosed incidentally evaluation of asymptomatic lymphadenopathy.,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 14:44:20,1642639654,5/24/2015 14:43:59,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,149,48,,,164,51,LYMPHADENOPATHY,CLL,asymptomatic LYMPHADENOPATHY.,136-149,48,CLL,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 14:50:29,1642641008,5/24/2015 14:50:07,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,149,48,,,164,51,LYMPHADENOPATHY,CLL,asymptomatic LYMPHADENOPATHY.,136-149,48,CLL,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 15:01:06,1642643110,5/24/2015 14:58:38,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,149,48,,,164,51,LYMPHADENOPATHY,CLL,asymptomatic LYMPHADENOPATHY.,136-149,48,CLL,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 15:20:10,1642646924,5/24/2015 15:19:56,false,neodev,1,32087449,USA,DE,,108.59.10.153,149,48,,,164,51,LYMPHADENOPATHY,CLL,asymptomatic LYMPHADENOPATHY.,136-149,37-48,insidious; CLL,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 15:22:52,1642647532,5/24/2015 15:22:06,false,points4rewards,1,28703583,USA,,,97.73.85.209,149,48,,,164,51,LYMPHADENOPATHY,CLL,CLL asymptomatic LYMPHADENOPATHY.,48-136-149,48-136-149,CLL asymptomatic lymphadenopathy.,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 15:26:00,1642648313,5/24/2015 15:25:34,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,149,48,,,164,51,LYMPHADENOPATHY,CLL,asymptomatic LYMPHADENOPATHY.,136-149,48,CLL,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 15:31:38,1642649404,5/24/2015 15:31:26,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,149,48,,,164,51,LYMPHADENOPATHY,CLL,LYMPHADENOPATHY.,149,48,CLL,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 15:32:32,1642649634,5/24/2015 15:32:18,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,149,48,,,164,51,LYMPHADENOPATHY,CLL,asymptomatic LYMPHADENOPATHY.,136-149,48,CLL,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343038,5/24/2015 15:46:53,1642653337,5/24/2015 15:46:36,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,149,48,,,164,51,LYMPHADENOPATHY,CLL,LYMPHADENOPATHY.,149,48,CLL,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy.,149,48,149,48,1,164,51,TWrex-cause,813148,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of asymptomatic lymphadenopathy,lymphadenopathy,CLL
725343039,5/24/2015 11:33:14,1642604797,5/24/2015 11:33:01,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,117,99,,,125,106,DIABETES,INSULIN,insulin dependent DIABETES mellitus.,99-107-117-126,99-107-117-126,INSULIN dependent diabetes mellitus.,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 11:34:51,1642604985,5/24/2015 11:34:33,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,117,99,,,125,106,DIABETES,INSULIN,insulin therapy DIABETES,64-117-72,99-117,INSULIN diabetes,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 11:49:18,1642607244,5/24/2015 11:48:31,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,117,99,,,125,106,DIABETES,INSULIN,insulin dependent DIABETES mellitus.,99-107-117-126,99-107-117-126,INSULIN dependent diabetes mellitus.,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 11:54:43,1642608239,5/24/2015 11:54:25,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,117,99,,,125,106,DIABETES,INSULIN,insulin dependent DIABETES mellitus.,99-107-117-126,99-107-117-126,INSULIN dependent diabetes mellitus.,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 12:09:09,1642610625,5/24/2015 12:08:39,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,117,99,,,125,106,DIABETES,INSULIN,insulin - dependent DIABETES mellitus.,99-107-117-126-106,99,INSULIN,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 12:13:19,1642611264,5/24/2015 12:12:48,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,117,99,,,125,106,DIABETES,INSULIN,insulin dependent DIABETES mellitus.,99-117-126-107,99-107-117-126,INSULIN dependent diabetes mellitus.,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 12:17:04,1642611865,5/24/2015 12:16:50,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,117,99,,,125,106,DIABETES,INSULIN,insulin dependent DIABETES mellitus.,99-107-117-126,99-107-117-126,INSULIN dependent diabetes mellitus.,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 12:18:11,1642612093,5/24/2015 12:17:51,false,clixsense,1,31482589,NLD,,,31.201.11.16,117,99,,,125,106,DIABETES,INSULIN,insulin dependent DIABETES mellitus.,99-107-117-126,99-107-117-126,INSULIN dependent diabetes mellitus.,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 12:18:16,1642612101,5/24/2015 12:17:41,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,117,99,,,125,106,DIABETES,INSULIN,intensive insulin therapy in newly diagnosed insulin dependent DIABETES mellitus.,54-64-72-80-83-89-99-107-117-126,54-64-80-83-89-99-107-117-126-72,intensive insulin therapy in newly diagnosed INSULIN dependent diabetes mellitus.,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343039,5/24/2015 12:23:28,1642612871,5/24/2015 12:22:48,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,117,99,,,125,106,DIABETES,INSULIN,insulin dependent DIABETES mellitus.,99-107-117-126,99-107-117-126,INSULIN dependent diabetes mellitus.,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.",117,99,117,99,-1,125,106,TWrex-cause,800601,"Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus",diabetes,insulin
725343040,5/24/2015 14:34:15,1642637145,5/24/2015 14:33:56,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,75,30,,,84,35,INFECTION,VIRUS,"influenza virus INFECTION,",59-69-75,16-30-36,"parainfluenza VIRUS infections,","Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 14:36:35,1642637688,5/24/2015 14:36:17,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,75,30,,,84,35,INFECTION,VIRUS,"parainfluenza virus infections, as influenza virus INFECTION, most often present winter,",16-36-56-59-69-75-86-91-97-112-30,6-10-30-36-48-51-59-69-0,"Mumps and other VIRUS infections, as well influenza virus","Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 14:42:45,1642639322,5/24/2015 14:42:13,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,75,30,,,84,35,INFECTION,VIRUS,"influenza virus INFECTION,",59-69-75,16-30-36,"parainfluenza VIRUS infections,","Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 14:47:50,1642640331,5/24/2015 14:47:28,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,75,30,,,84,35,INFECTION,VIRUS,"influenza virus INFECTION,",59-69-75,16-30-36,"parainfluenza VIRUS infections,","Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 14:52:07,1642641282,5/24/2015 14:51:47,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,75,30,,,84,35,INFECTION,VIRUS,"virus INFECTION,",75-69,30-36,"VIRUS infections,","Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 14:55:52,1642642061,5/24/2015 14:54:16,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,75,30,,,84,35,INFECTION,VIRUS,"influenza virus INFECTION,",59-69-75,16-30-36,"parainfluenza VIRUS infections,","Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 15:18:49,1642646697,5/24/2015 15:18:32,false,neodev,1,32087449,USA,DE,,108.59.10.153,75,30,,,84,35,INFECTION,VIRUS,"INFECTION,",75,30,VIRUS,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 15:19:23,1642646772,5/24/2015 15:18:44,false,points4rewards,1,28703583,USA,,,97.73.85.209,75,30,,,84,35,INFECTION,VIRUS,"influenza virus INFECTION,",59-69-75,16-30-36,"parainfluenza VIRUS infections,","Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 15:24:41,1642647970,5/24/2015 15:24:28,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,75,30,,,84,35,INFECTION,VIRUS,"influenza virus INFECTION,",59-69-75,16-30-36,"parainfluenza VIRUS infections,","Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343040,5/24/2015 15:30:40,1642649131,5/24/2015 15:30:12,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,75,30,,,84,35,INFECTION,VIRUS,"influenza virus INFECTION,",59-69-75,16-30,parainfluenza VIRUS,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year.",75,30,75,30,1,84,35,TWrex-cause,810309,"Mumps and other parainfluenza virus infections, as well as influenza virus infection, most often present in the winter, although they may occur at any time of year",infection,virus
725343041,5/24/2015 11:36:19,1642605153,5/24/2015 11:36:01,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,333,10,,,338,19,JOINT,ARTHRITIS,"Charcot's JOINT),",323-333,10,ARTHRITIS,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 11:37:47,1642605421,5/24/2015 11:37:32,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,333,10,,,338,19,JOINT,ARTHRITIS,"Arthritis JOINT),",333-10,10-341-347,"ARTHRITIS joint trauma,","ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 11:53:39,1642608013,5/24/2015 11:53:17,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,333,10,,,338,19,JOINT,ARTHRITIS,"Charcot's JOINT),",323-333,10,ARTHRITIS,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 11:57:43,1642608605,5/24/2015 11:57:19,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,333,10,,,338,19,JOINT,ARTHRITIS,"Charcot's JOINT),",323-333,10,ARTHRITIS,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 12:11:51,1642611063,5/24/2015 12:11:31,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,333,10,,,338,19,JOINT,ARTHRITIS,"Charcot's JOINT),",323-333,10,ARTHRITIS,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 12:19:46,1642612275,5/24/2015 12:19:28,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,333,10,,,338,19,JOINT,ARTHRITIS,"Charcot's JOINT),",323-333,10,ARTHRITIS,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 12:20:23,1642612400,5/24/2015 12:20:08,false,clixsense,1,31482589,NLD,,,31.201.11.16,333,10,,,338,19,JOINT,ARTHRITIS,"Charcot's JOINT),",323-333,10,ARTHRITIS,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 12:26:00,1642613299,5/24/2015 12:25:20,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,333,10,,,338,19,JOINT,ARTHRITIS,"metabolic disturbances neuropathies (e.g., Charcot's JOINT), joint trauma, endocrine",124-303-316-323-333-341-347-355-134,0-10-20-24-31-36,ETIOLOGY: ARTHRITIS may result from infections,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 12:27:05,1642613506,5/24/2015 12:26:07,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,333,10,,,338,19,JOINT,ARTHRITIS,"Charcot's JOINT),",323-333,10,ARTHRITIS,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343041,5/24/2015 12:27:52,1642613671,5/24/2015 12:26:26,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,333,10,,,338,19,JOINT,ARTHRITIS,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's JOINT), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",0-10-20-24-31-36-47-54-64-71-86-98-109-124-134-147-154-160-168-182-190-200-212-223-232-239-250-261-272-281-287-303-316-323-333-341-347-355-365-374-381-394-398-404,0-10-20-24-31-36-47-54-64-71-86-98-109-124-134-147-154-160-168-182-190-200-212-223-232-239-250-261-272-281-287-303-316-323-333-341-347-355-365-374-381-394-398-404,"ETIOLOGY: ARTHRITIS may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.","ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",333,10,333,10,-1,338,19,TWrex-cause,802172,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, systemic lupus erythematosus), neuropathies (e.g., Charcot's joint), joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses",joint,arthritis
725343042,5/24/2015 11:32:26,1642604643,5/24/2015 11:31:55,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER,3-11,110,LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 11:34:04,1642604892,5/24/2015 11:33:41,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER lamotrigine,3-11-110,3-110-11,Bipolar Disorder LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 11:43:55,1642606406,5/24/2015 11:43:44,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER,3-11,110,LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 11:46:15,1642606691,5/24/2015 11:45:57,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER,3-11,110,LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 11:53:49,1642608042,5/24/2015 11:53:29,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER,3-11,110,LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 11:56:05,1642608423,5/24/2015 11:55:52,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER,3-11,110,LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 12:08:07,1642610462,5/24/2015 12:07:53,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER,3-11,110,LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 12:10:18,1642610775,5/24/2015 12:10:09,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER,3-11,110,LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 12:11:49,1642611057,5/24/2015 12:11:25,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,BIPOLAR DISORDER lamotrigine,3-11-110,3-110-11,Bipolar Disorder LAMOTRIGINE,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343042,5/24/2015 12:13:34,1642611315,5/24/2015 12:12:24,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,3,110,,,19,121,BIPOLAR DISORDER,LAMOTRIGINE,"a BIPOLAR DISORDER Maintenance Therapy Oral: Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",0-3-11-27-39-48-55-67-75-83-87-94-106-110-122-125-134-144-153-158-161-171-186-201-212-223-226-235-244-253-259-263-274-277-283,0-3-11-21-27-39-48-55-67-75-83-87-94-106-110-122-125-134-144-153-158-161-171-186-201-212-223-226-235-244-253-259-263-274-277-283,"a Bipolar Disorder &gt; Maintenance Therapy Oral: Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.","a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",3 11,110,3,110,-1,19,121,TWrex-cause,803794,"a  Bipolar Disorder  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for lamotrigine in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5",bipolar disorder,lamotrigine
725343043,5/24/2015 11:37:19,1642605305,5/24/2015 11:36:57,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS,0-10,141,METHACHOLINE,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 11:38:41,1642605560,5/24/2015 11:38:26,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS methacholine,0-10-141,0-141-10,Bronchial hyperresponsiveness METHACHOLINE,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 11:55:25,1642608340,5/24/2015 11:55:06,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS,0-10,141,METHACHOLINE,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 11:58:44,1642608775,5/24/2015 11:58:27,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS,0-10,141,METHACHOLINE,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 12:20:37,1642612421,5/24/2015 12:20:22,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS,0-10,141,METHACHOLINE,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 12:21:18,1642612543,5/24/2015 12:21:04,false,clixsense,1,31482589,NLD,,,31.201.11.16,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS,0-10,141,METHACHOLINE,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 12:28:57,1642613824,5/24/2015 12:27:59,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS,0-10,141,METHACHOLINE,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 12:33:35,1642614587,5/24/2015 12:32:49,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test The PC20 is defined as the provocative methacholine inducing a 20% drop in FEV1.,0-10-30-34-39-42-52-57-59-69-79-85-89-94-97-105-108-112-141-154-163-165-169-174-177,0-10-30-34-39-42-52-57-59-69-79-85-89-94-97-105-108-112-124-138-141-154-163-165-169-174-177,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 12:37:59,1642615479,5/24/2015 12:37:49,false,elite,1,31913360,GBR,,,5.152.201.148,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS can also be,0-10-30-34-39,112-124-138-141-154-163-165,provocative concentration of METHACHOLINE inducing a 20%,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343043,5/24/2015 12:55:20,1642618562,5/24/2015 12:55:06,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,0,141,,,29,153,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE,BRONCHIAL HYPERRESPONSIVENESS,0-10,141,METHACHOLINE,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1.,0 10,141,0,141,-1,29,153,TWrex-cause,803019,Bronchial hyperresponsiveness can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of methacholine inducing a 20% drop in FEV1,bronchial hyperresponsiveness,methacholine
725343044,5/24/2015 12:23:18,1642612850,5/24/2015 12:22:46,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,36,78-89-94,TUBERCULIN skin test,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 12:24:20,1642613092,5/24/2015 12:24:05,false,clixsense,1,31482589,NLD,,,31.201.11.16,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,36,78-89-94,TUBERCULIN skin test,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 12:40:42,1642616014,5/24/2015 12:40:08,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,"illus: TUBERCULOSIS ; illus: TUBERCULOSIS ; immunological therapy tuberculin skin test ; vaccine, BCG; Nursing Diagnoses Appendix.",6-13-26-29-36-49-53-67-78-89-94-99-102-111-118-126-136,6-13-26-29-36-49-53-67-75-78-89-94-102-111-118-126-136,"illus: TUBERCULOSIS ; illus: TUBERCULOSIS ; immunological therapy ; TUBERCULIN skin test vaccine, BCG; Nursing Diagnoses Appendix.","SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 12:58:45,1642619181,5/24/2015 12:58:35,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS ; illus: TUBERCULOSIS immunological therapy tuberculin Nursing Diagnoses Appendix.,13-26-29-36-53-67-78-118-126-136,53-67-75-78-89-94-102-118-126-136,"immunological therapy ; TUBERCULIN skin test vaccine, Nursing Diagnoses Appendix.","SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 13:01:42,1642619683,5/24/2015 13:00:01,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,36,78,TUBERCULIN,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 13:15:11,1642622394,5/24/2015 13:15:01,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,36,78,TUBERCULIN,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 13:19:16,1642623231,5/24/2015 13:17:21,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,"TUBERCULOSIS ; illus: TUBERCULOSIS immunological therapy tuberculin skin test vaccine, Nursing Diagnoses",13-26-29-36-53-67-78-89-94-102-118-126,13-29-36-53-67-75-78-89-94-102-118-126,"TUBERCULOSIS illus: TUBERCULOSIS immunological therapy ; TUBERCULIN skin test vaccine, Nursing Diagnoses","SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 13:26:17,1642624550,5/24/2015 13:25:45,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS ; illus: TUBERCULOSIS immunological therapy,13-26-29-36-53-67,53-67-75-78-89-94-102,"immunological therapy ; TUBERCULIN skin test vaccine,","SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 13:28:14,1642624857,5/24/2015 13:28:04,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.35,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,; TUBERCULOSIS,26-36,75-78-89-94,; TUBERCULIN skin test,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343044,5/24/2015 13:31:40,1642625485,5/24/2015 13:30:51,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,36,78,,,48,88,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,36,78-89-94,TUBERCULIN skin test,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix.",36,78,36,78,-1,48,88,TWrex-cause,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  tuberculin skin test ;  vaccine, BCG;   Nursing Diagnoses Appendix",tuberculosis,tuberculin
725343045,5/24/2015 11:34:43,1642604965,5/24/2015 11:34:24,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,ULCERATIVE COLITIS,213-224,251-263,Transdermal NICOTINE,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 11:36:09,1642605130,5/24/2015 11:35:46,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,ULCERATIVE COLITIS Transdermal nicotine,213-224-251-263,213-263-224,ulcerative colitis NICOTINE,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 11:51:12,1642607543,5/24/2015 11:50:46,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,ULCERATIVE COLITIS,213-224,251-263,Transdermal NICOTINE,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 11:56:02,1642608413,5/24/2015 11:55:40,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,ULCERATIVE COLITIS,213-224,263,NICOTINE,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 12:10:35,1642610818,5/24/2015 12:10:18,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,ULCERATIVE COLITIS,213-224,251-263,Transdermal NICOTINE,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 12:18:29,1642612141,5/24/2015 12:18:10,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,ULCERATIVE COLITIS,213-224,251-263,Transdermal NICOTINE,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 12:19:18,1642612199,5/24/2015 12:18:58,false,clixsense,1,31482589,NLD,,,31.201.11.16,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,ULCERATIVE COLITIS,213-224,263,NICOTINE,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 12:22:37,1642612754,5/24/2015 12:20:38,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,Probiotics for induction of remission in ulcerative colitis Azathioprine and 6 mercaptopurine for maintenance of remission in ULCERATIVE COLITIS Transdermal nicotine for induction of remission in ulcerative colitis Colorectal Disease Laparoscopic surgery for ulcerative colitis  a meta - analysis.,68-79-83-93-96-106-109-120-147-160-164-166-181-185-197-200-210-213-224-251-263-272-276-286-289-299-302-313-340-351-360-373-381-385-396-404-406-408-412-413,68-79-83-93-96-106-109-120-147-160-164-166-181-185-197-200-210-213-224-251-263-272-276-286-289-299-302-313-340-351-360-373-381-385-396-404-406-408-412-413,Probiotics for induction of remission in ulcerative colitis Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis Transdermal NICOTINE for induction of remission in ulcerative colitis Colorectal Disease Laparoscopic surgery for ulcerative colitis  a meta - analysis.,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 12:24:29,1642613109,5/24/2015 12:24:19,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,of remission in ULCERATIVE COLITIS Review) Transdermal nicotine,197-200-210-213-224-242-251-263,224-232-242-251-263-272-276-286-213,ulcerative colitis (Cochrane Review) Transdermal NICOTINE for induction of,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343045,5/24/2015 12:24:48,1642613157,5/24/2015 12:24:14,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,213,263,,,231,271,ULCERATIVE COLITIS,NICOTINE,ULCERATIVE COLITIS,213-224,251-263,Transdermal NICOTINE,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis.,213 224,263,213,263,-1,231,271,TWrex-cause,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  Transdermal nicotine for induction of remission in ulcerative colitis (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis - a meta-analysis,ulcerative colitis,nicotine
725343046,5/24/2015 13:37:11,1642626620,5/24/2015 13:36:42,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,55,35,,,59,42,LUNG,FAILURE,"hypoxemic patients, failure affects LUNG component gas exchange.",3-13-35-55-60-99-103-43,3-13-35-43-55-60-99-103,"hypoxemic patients, FAILURE affects lung component gas exchange.","In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 13:48:08,1642628562,5/24/2015 13:47:47,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,55,35,,,59,42,LUNG,FAILURE,LUNG,55,23-35,respiratory FAILURE,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 14:08:05,1642631965,5/24/2015 14:07:29,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,55,35,,,59,42,LUNG,FAILURE,LUNG component,55-60,23-35,respiratory FAILURE,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 14:09:08,1642632218,5/24/2015 14:08:30,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,55,35,,,59,42,LUNG,FAILURE,LUNG component,55-60,23-35,respiratory FAILURE,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 14:09:27,1642632238,5/24/2015 14:08:49,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,55,35,,,59,42,LUNG,FAILURE,hypoxemic respiratory LUNG,3-23-55,3-23-35-55,hypoxemic respiratory FAILURE lung,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 14:14:48,1642633208,5/24/2015 14:14:23,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,55,35,,,59,42,LUNG,FAILURE,respiratory failure affects the LUNG component,23-35-43-51-55-60,23-35,respiratory FAILURE,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 14:25:24,1642635414,5/24/2015 14:24:29,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,55,35,,,59,42,LUNG,FAILURE,LUNG component,55-60,35,FAILURE,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 14:25:36,1642635455,5/24/2015 14:25:10,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,55,35,,,59,42,LUNG,FAILURE,LUNG,55,23-35,respiratory FAILURE,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 14:26:24,1642635575,5/24/2015 14:25:23,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,55,35,,,59,42,LUNG,FAILURE,failure affects the LUNG component and arises from failure of gas,35-43-51-55-60-70-74-81-88-96-99,35-43-51-55-60-70-74-81-88-99-103,FAILURE affects the lung component and arises from failure gas exchange.,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343046,5/24/2015 14:26:49,1642635681,5/24/2015 14:25:38,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,55,35,,,59,42,LUNG,FAILURE,failure affects the LUNG component,35-43-51-55-60,3-13-23-35,"hypoxemic patients, respiratory FAILURE","In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange.",55,35,55,35,-1,59,42,TWrex-cause,802358,"In hypoxemic patients, respiratory failure affects the lung component and arises from a failure of gas exchange",lung,failure
725343047,5/24/2015 12:27:57,1642613676,5/24/2015 12:27:41,false,clixsense,1,31482589,NLD,,,31.201.11.16,18,100,,,27,113,INFECTION,HERPES ZOSTER,Primary VZV INFECTION,6-14-18,100-107,HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 13:27:25,1642624712,5/24/2015 13:26:53,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,18,100,,,27,113,INFECTION,HERPES ZOSTER,VZV INFECTION varicella (chickenpox); infection herpes zoster.,14-18-39-49-79-100-107,14-18-39-49-79-100-107,VZV infection varicella (chickenpox); infection HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 13:35:55,1642626372,5/24/2015 13:34:28,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,18,100,,,27,113,INFECTION,HERPES ZOSTER,Primary INFECTION results in varicella,6-18-28-36-39,63-76-79-89-97-100-107-18,infection reactivation of infection results in HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 13:37:03,1642626617,5/24/2015 13:36:42,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,18,100,,,27,113,INFECTION,HERPES ZOSTER,Primary VZV INFECTION,6-14-18,100-107,HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 13:41:10,1642627325,5/24/2015 13:40:48,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,18,100,,,27,113,INFECTION,HERPES ZOSTER,Primary VZV INFECTION,6-14-18,100-107,HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 13:55:01,1642629808,5/24/2015 13:54:25,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,18,100,,,27,113,INFECTION,HERPES ZOSTER,Primary VZV INFECTION,6-14-18,100-107,HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 13:57:04,1642630095,5/24/2015 13:56:29,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,18,100,,,27,113,INFECTION,HERPES ZOSTER,VZV INFECTION varicella (chickenpox); herpes zoster.,14-18-39-49-100-107,14-39-49-79-100-107,VZV varicella (chickenpox); infection HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 13:59:03,1642630500,5/24/2015 13:57:00,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,18,100,,,27,113,INFECTION,HERPES ZOSTER,Primary VZV INFECTION,6-14-18,100-107,HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 14:01:18,1642630822,5/24/2015 14:00:57,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,18,100,,,27,113,INFECTION,HERPES ZOSTER,INFECTION varicella (chickenpox);,18-39-49,39-100-107-49,varicella (chickenpox); HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343047,5/24/2015 14:11:15,1642632493,5/24/2015 14:09:42,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,18,100,,,27,113,INFECTION,HERPES ZOSTER,Primary VZV INFECTION,6-14-18,100-107,HERPES ZOSTER.,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster.,18,100 107,18,100,1,27,113,TWrex-cause,810161,49 •  Primary VZV infection results in varicella (chickenpox); reactivation of infection results in herpes zoster,infection,herpes zoster
725343048,5/24/2015 13:32:53,1642625761,5/24/2015 13:32:10,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,291,146,,,294,155,IBS,TEGASEROD,"treatment, patients IBS.",173-245-291,123-132-137-146-173-245-291,"language that compared TEGASEROD treatment, patients IBS.","Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 13:42:51,1642627595,5/24/2015 13:42:37,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,291,146,,,294,155,IBS,TEGASEROD,objectively documented IBS.,268-280-291,146,TEGASEROD,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 13:44:57,1642627976,5/24/2015 13:44:41,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,291,146,,,294,155,IBS,TEGASEROD,IBS.,291,146,TEGASEROD,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 14:02:14,1642630979,5/24/2015 14:01:10,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,291,146,,,294,155,IBS,TEGASEROD,objectively documented IBS.,280-291-268,146,TEGASEROD,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 14:02:57,1642631107,5/24/2015 14:01:36,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,291,146,,,294,155,IBS,TEGASEROD,"quasirandomized tegaserod placebo, IBS.",72-146-161-291,72-146-161-291,"quasirandomized TEGASEROD placebo, IBS.","Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 14:04:49,1642631459,5/24/2015 14:03:05,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,291,146,,,294,155,IBS,TEGASEROD,objectively documented IBS.,268-280-291,146,TEGASEROD,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 14:10:55,1642632440,5/24/2015 14:10:40,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,291,146,,,294,155,IBS,TEGASEROD,with objectively documented IBS.,263-268-280-291,146-156-161,"TEGASEROD with placebo,","Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 14:19:25,1642634159,5/24/2015 14:18:43,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,291,146,,,294,155,IBS,TEGASEROD,IBS.,291,146,TEGASEROD,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 14:22:11,1642634703,5/24/2015 14:21:41,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,291,146,,,294,155,IBS,TEGASEROD,IBS.,291,146-170,TEGASEROD no,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343048,5/24/2015 14:22:16,1642634729,5/24/2015 14:21:48,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,291,146,,,294,155,IBS,TEGASEROD,with objectively documented IBS.,263-268-280-291,123-132-137-146-156-161,"language that compared TEGASEROD with placebo,","Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS.",291,146,291,146,-1,294,155,TWrex-cause,800581,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared tegaserod with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with objectively documented IBS",IBS,tegaserod
725343049,5/24/2015 11:31:07,1642604410,5/24/2015 11:30:51,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,166,98,,,173,109,OBESITY,PHENTERMINE,OBESITY,166,98,PHENTERMINE,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 11:32:59,1642604778,5/24/2015 11:32:35,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,166,98,,,173,109,OBESITY,PHENTERMINE,"Benzphetamine, OBESITY",166-36,98-153-163-166,PHENTERMINE treatment of obesity,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 11:35:57,1642605114,5/24/2015 11:35:47,false,elite,1,26544151,GBR,,,213.205.252.203,166,98,,,173,109,OBESITY,PHENTERMINE,OBESITY,166,98,PHENTERMINE,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 11:43:06,1642606241,5/24/2015 11:42:56,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,166,98,,,173,109,OBESITY,PHENTERMINE,OBESITY,166,98,PHENTERMINE,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 11:43:34,1642606331,5/24/2015 11:42:52,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,166,98,,,173,109,OBESITY,PHENTERMINE,OBESITY,166,98,PHENTERMINE,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 11:52:42,1642607830,5/24/2015 11:52:21,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,166,98,,,173,109,OBESITY,PHENTERMINE,OBESITY,166,98,PHENTERMINE,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 11:55:16,1642608336,5/24/2015 11:55:03,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,166,98,,,173,109,OBESITY,PHENTERMINE,OBESITY,166,98,PHENTERMINE,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 12:07:22,1642610262,5/24/2015 12:07:09,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,166,98,,,173,109,OBESITY,PHENTERMINE,OBESITY,166,98,PHENTERMINE,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 12:09:40,1642610712,5/24/2015 12:09:29,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,166,98,,,173,109,OBESITY,PHENTERMINE,OBESITY,166,98,PHENTERMINE,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343049,5/24/2015 12:11:20,1642610936,5/24/2015 12:09:48,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,166,98,,,173,109,OBESITY,PHENTERMINE,"Agents Approved for Short Term Use Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short term treatment of OBESITY",0-7-16-20-26-31-36-51-68-84-94-98-110-114-123-126-130-134-138-148-153-163-166-142,0-7-16-20-26-31-36-51-68-84-94-98-110-114-123-126-130-134-138-142-148-153-163-166,"Agents Approved for Short Term Use Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of obesity","Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks.",166,98,166,98,-1,173,109,TWrex-cause,800759,"Agents Approved for Short-Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine are approved by the FDA for the short-term treatment of obesity (weeks",obesity,phentermine
725343050,5/24/2015 13:36:15,1642626470,5/24/2015 13:35:19,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,diltiazem treatment patients ATRIAL FIBRILLATION congestive heart failure.,72-85-99-106-153-164-170-53,53-72-85-99-106-164-170-153,DILTIAZEM treatment patients atrial fibrillation congestive heart failure.,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 13:47:31,1642628375,5/24/2015 13:47:05,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,ATRIAL FIBRILLATION,99-106,40-53,Intravenous DILTIAZEM,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 13:48:55,1642628702,5/24/2015 13:48:07,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,ATRIAL FIBRILLATION,99-106,40-53,Intravenous DILTIAZEM,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 14:06:31,1642631776,5/24/2015 14:05:45,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,ATRIAL FIBRILLATION,99-106,40-53,Intravenous DILTIAZEM,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 14:08:09,1642631990,5/24/2015 14:07:38,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,ATRIAL FIBRILLATION,99-106,40-53,Intravenous DILTIAZEM,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 14:08:12,1642632028,5/24/2015 14:07:32,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,Intravenous diltiazem ATRIAL FIBRILLATION congestive heart failure.,40-53-99-106-153-164-170,40-53-99-106-153-164-170,Intravenous DILTIAZEM atrial fibrillation congestive heart failure.,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 14:13:51,1642633048,5/24/2015 14:13:11,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,ATRIAL FIBRILLATION or flutter,99-106-119-122,40-53,Intravenous DILTIAZEM,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 14:23:47,1642635057,5/24/2015 14:23:04,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,ATRIAL FIBRILLATION,99-106,40-53,Intravenous DILTIAZEM,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 14:24:45,1642635223,5/24/2015 14:24:26,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,of patients with ATRIAL FIBRILLATION,82-85-94-99-106,40-53-64-68-72-82-85,Intravenous DILTIAZEM for the treatment of patients,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343050,5/24/2015 14:24:52,1642635272,5/24/2015 14:24:31,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,99,53,,,118,62,ATRIAL FIBRILLATION,DILTIAZEM,ATRIAL FIBRILLATION,99-106,40-53,Intravenous DILTIAZEM,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.",99 106,53,99,53,-1,118,62,TWrex-cause,804168,"Goldenberg IF, Lewis WR, Dias VC et al. Intravenous  diltiazem  for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure",atrial fibrillation,diltiazem
725343051,5/24/2015 14:13:10,1642632882,5/24/2015 14:12:17,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,165,72,,,172,84,PUBERTY,GONADOTROPIN,central precocious PUBERTY.,146-154-165,66-72-85-95-103,depot GONADOTROPIN releasing hormone analogue,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:14:39,1642633160,5/24/2015 14:13:58,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,165,72,,,172,84,PUBERTY,GONADOTROPIN,precocious PUBERTY.,154-165,66-72,depot GONADOTROPIN,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:16:59,1642633715,5/24/2015 14:16:37,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,165,72,,,172,84,PUBERTY,GONADOTROPIN,central precocious PUBERTY.,146-154-165,66-72-85-95-103,depot GONADOTROPIN releasing hormone analogue,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:28:01,1642635890,5/24/2015 14:27:40,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,165,72,,,172,84,PUBERTY,GONADOTROPIN,central precocious PUBERTY.,146-154-165,66-72-85-95-103,depot GONADOTROPIN releasing hormone analogue,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:29:29,1642636121,5/24/2015 14:28:56,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,165,72,,,172,84,PUBERTY,GONADOTROPIN,central precocious PUBERTY.,146-154-165,66-72-85-95,depot GONADOTROPIN releasing hormone,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:30:00,1642636215,5/24/2015 14:28:53,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,165,72,,,172,84,PUBERTY,GONADOTROPIN,gonadotropin releasing hormone central precocious PUBERTY.,72-85-95-146-154-165,49-63-66-72-85-95-103-119-129-132-141-146-154-165,effectiveness of depot GONADOTROPIN releasing hormone analogue treatment of children with central precocious puberty.,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:31:14,1642636458,5/24/2015 14:30:14,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,165,72,,,172,84,PUBERTY,GONADOTROPIN,with central precocious PUBERTY.,141-146-154-165,72-85-95-103,GONADOTROPIN releasing hormone analogue,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:31:48,1642636551,5/24/2015 14:30:36,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,165,72,,,172,84,PUBERTY,GONADOTROPIN,central precocious PUBERTY.,154-165-146,66-72-85-95-103,depot GONADOTROPIN releasing hormone analogue,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:35:36,1642637487,5/24/2015 14:34:51,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,165,72,,,172,84,PUBERTY,GONADOTROPIN,central precocious PUBERTY.,146-154-165,72-85-95,GONADOTROPIN releasing hormone,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343051,5/24/2015 14:37:19,1642637879,5/24/2015 14:35:38,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,165,72,,,172,84,PUBERTY,GONADOTROPIN,precocious PUBERTY.,154-165,66-72-85-95-103,depot GONADOTROPIN releasing hormone analogue,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.",165,72,165,72,-1,172,84,TWrex-cause,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty",puberty,gonadotropin
725343052,5/24/2015 14:38:50,1642638279,5/24/2015 14:38:37,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,36,84,,,39,92,ACD,REACTION,contact dermatitis (ACD): ACD is a type IV cell mediated hypersensitivity reaction,9-17-28-36-40-43-45-50-58-67-84-53,0-9-17-53-58-67-84-93-98-102-28,Allergic contact dermatitis (ACD): cell mediated hypersensitivity REACTION that has 2,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 14:45:47,1642639975,5/24/2015 14:45:07,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,36,84,,,39,92,ACD,REACTION,Allergic contact dermatitis (ACD): ACD a,0-9-17-28-36-43,53-58-67-84,cell mediated hypersensitivity REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 14:52:52,1642641456,5/24/2015 14:52:07,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,36,84,,,39,92,ACD,REACTION,contact dermatitis (ACD): ACD,9-17-28-36,53-58-67-84,cell mediated hypersensitivity REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 15:03:59,1642643693,5/24/2015 15:03:39,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,36,84,,,39,92,ACD,REACTION,ACD,36,53-58-67-84,cell mediated hypersensitivity REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 15:21:16,1642647160,5/24/2015 15:21:00,false,neodev,1,32087449,USA,DE,,108.59.10.153,36,84,,,39,92,ACD,REACTION,(ACD): ACD,28-36,53-58-67-84,cell mediated hypersensitivity REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 15:25:52,1642648292,5/24/2015 15:25:04,false,points4rewards,1,28703583,USA,,,97.73.85.209,36,84,,,39,92,ACD,REACTION,Allergic contact dermatitis ACD,0-9-17-36,0-9-17-28-84,Allergic contact dermatitis (ACD): REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 15:26:44,1642648385,5/24/2015 15:26:30,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,36,84,,,39,92,ACD,REACTION,ACD,36,53-58-67-84,cell mediated hypersensitivity REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 15:32:32,1642649633,5/24/2015 15:32:06,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,36,84,,,39,92,ACD,REACTION,ACD,36,45-50-53-58-67-84,type IV cell mediated hypersensitivity REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 15:47:57,1642653600,5/24/2015 15:47:38,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,36,84,,,39,92,ACD,REACTION,ACD,36,67-84,hypersensitivity REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343052,5/24/2015 15:48:56,1642653820,5/24/2015 15:48:35,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,36,84,,,39,92,ACD,REACTION,ACD,36,53-58-67-84,cell mediated hypersensitivity REACTION,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure.,36,84,36,84,1,39,92,TWrex-cause,811264,Allergic contact dermatitis (ACD):  ACD is a type IV cell-mediated hypersensitivity reaction that has 2 phases: sensitization to an antigen and response on reexposure,ACD,reaction
725343053,5/24/2015 13:38:48,1642626938,5/24/2015 13:38:22,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,68,84,,,72,93,YAW,TREPONEMA,penicillin G treatment YAWS Treponema pertenue.,38-49-55-68-84-94,38-49-55-68-84-94,penicillin G treatment yaws TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 13:49:38,1642628820,5/24/2015 13:49:13,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,68,84,,,72,93,YAW,TREPONEMA,YAWS,68,84-94,TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 14:09:55,1642632324,5/24/2015 14:09:21,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,68,84,,,72,93,YAW,TREPONEMA,YAWS,68,84-94,TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 14:10:42,1642632411,5/24/2015 14:10:25,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,68,84,,,72,93,YAW,TREPONEMA,YAWS,68,84-94,TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 14:15:42,1642633343,5/24/2015 14:15:26,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,68,84,,,72,93,YAW,TREPONEMA,YAWS caused by Treponema pertenue.,68-73-80-84-94,68-73-80-84-94,yaws caused by TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 14:26:21,1642635566,5/24/2015 14:26:01,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,68,84,,,72,93,YAW,TREPONEMA,YAWS,68,84-94,TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 14:27:06,1642635730,5/24/2015 14:26:30,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,68,84,,,72,93,YAW,TREPONEMA,YAWS,68,84-94,TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 14:27:26,1642635774,5/24/2015 14:26:51,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,68,84,,,72,93,YAW,TREPONEMA,for treatment of YAWS,51-55-65-68,68-73-80-84-94,yaws caused by TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 14:27:28,1642635780,5/24/2015 14:27:07,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,68,84,,,72,93,YAW,TREPONEMA,YAWS caused by Treponema pertenue.,68-73-80-84-94,73-80-84-94,caused by TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343053,5/24/2015 14:27:43,1642635803,5/24/2015 14:26:49,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,68,84,,,72,93,YAW,TREPONEMA,YAWS,68,84-94,TREPONEMA pertenue.,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue.",68,84,68,84,1,72,93,TWrex-cause,810886,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of yaws caused by  Treponema pertenue",yaw,treponema
725343054,5/24/2015 14:18:58,1642634057,5/24/2015 14:18:44,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM BOTULISM is neuromuscular poisoning,0-10-19-22-36,52-64-74-75,CLOSTRIDIUM BOTULINUM  TOXIN.,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 14:30:52,1642636388,5/24/2015 14:30:36,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM,10,52-64-74-75,CLOSTRIDIUM BOTULINUM  TOXIN.,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 14:32:57,1642636819,5/24/2015 14:32:46,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM BOTULISM is neuromuscular poisoning Clostridium botulinum toxin.,0-10-19-22-36-52-64-75,10-22-36-46-52-64-74-75-0,BOTULISM Botulism neuromuscular poisoning from CLOSTRIDIUM BOTULINUM  TOXIN.,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 14:35:26,1642637422,5/24/2015 14:35:09,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM BOTULISM is neuromuscular poisoning,0-10-19-22-36,22-36-46-52-64-74,neuromuscular poisoning from CLOSTRIDIUM BOTULINUM,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 14:38:34,1642638206,5/24/2015 14:37:56,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM,10,52-64-74,CLOSTRIDIUM BOTULINUM,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 14:39:26,1642638465,5/24/2015 14:38:36,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM,10,52-64-74-75,CLOSTRIDIUM BOTULINUM  TOXIN.,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 14:39:35,1642638499,5/24/2015 14:38:53,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM,10,52-64-74-75,CLOSTRIDIUM BOTULINUM  TOXIN.,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 14:41:26,1642638969,5/24/2015 14:40:18,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM,10,52-64-74-75,CLOSTRIDIUM BOTULINUM  TOXIN.,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 14:49:46,1642640809,5/24/2015 14:49:24,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM,10,52-64-74,CLOSTRIDIUM BOTULINUM,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343054,5/24/2015 15:11:35,1642645219,5/24/2015 15:10:57,false,points4rewards,1,28703583,USA,,,97.73.85.209,10,52,,,18,80,BOTULISM,CLOSTRIDIUM BOTULINUM TOXIN,BOTULISM neuromuscular poisoning,10-22-36,22-36-52-64-74,neuromuscular poisoning CLOSTRIDIUM BOTULINUM,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin.,10,52 64 74,10,52,1,18,80,TWrex-cause,810958,BOTULISM  Botulism is neuromuscular poisoning from  Clostridium botulinum  toxin,botulism,clostridium botulinum toxin
725343055,5/24/2015 11:29:38,1642604233,5/24/2015 11:29:22,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,28,0,,,32,3,PAIN,PHN,PAIN:,28,0,PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 11:31:07,1642604408,5/24/2015 11:30:37,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,28,0,,,32,3,PAIN,PHN,PAIN: deep aching;,28-56-61,0-19-28-25,PHN types of pain:,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 11:34:59,1642605000,5/24/2015 11:34:46,false,elite,1,26544151,GBR,,,213.205.252.203,28,0,,,32,3,PAIN,PHN,PAIN:,28,0,PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 11:40:14,1642605845,5/24/2015 11:38:32,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,28,0,,,32,3,PAIN,PHN,PAIN:,28,0,PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 11:42:14,1642606113,5/24/2015 11:42:00,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,28,0,,,32,3,PAIN,PHN,PAIN:,28,0,PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 11:51:19,1642607551,5/24/2015 11:51:01,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,28,0,,,32,3,PAIN,PHN,PAIN:,28,0,PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 11:54:17,1642608111,5/24/2015 11:54:04,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,28,0,,,32,3,PAIN,PHN,PAIN:,28,0,PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 11:54:32,1642608153,5/24/2015 11:54:23,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,28,0,,,32,3,PAIN,PHN,three types of PAIN: a constant burning PHN,13-19-25-28-34-36-45-273,0-4-13-19-273,PHN involves three types PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 12:06:01,1642610002,5/24/2015 12:05:48,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,28,0,,,32,3,PAIN,PHN,PAIN:,28,0,PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343055,5/24/2015 12:08:52,1642610571,5/24/2015 12:08:41,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,28,0,,,32,3,PAIN,PHN,PAIN:,28,0,PHN,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",28,0,28,0,1,32,3,TWrex-cause,812932,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous pain with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep",pain,PHN
725343056,5/24/2015 14:20:43,1642634433,5/24/2015 14:19:55,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,139,156,,,145,160,VAGINA,BODY,VAGINA,139,148-156-161-172-183-193-201-206,foreign BODY reaction Fournier's gangrene foreign body reaction,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 14:31:57,1642636585,5/24/2015 14:31:32,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,139,156,,,145,160,VAGINA,BODY,VAGINA,139,148-156,foreign BODY,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 14:33:54,1642637005,5/24/2015 14:33:33,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,139,156,,,145,160,VAGINA,BODY,foreign bodies in the skin foreign bodies in VAGINA foreign body reaction,91-99-106-109-121-129-136-139-148-156-161-113,136-139-148-156-161-172-183-193-201-206,in vagina foreign BODY reaction Fournier's gangrene foreign body reaction,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 14:37:11,1642637832,5/24/2015 14:36:40,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,139,156,,,145,160,VAGINA,BODY,foreign bodies in VAGINA,121-129-136-139,136-139-148-156-161-172-183,in vagina foreign BODY reaction Fournier's gangrene,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 14:39:55,1642638556,5/24/2015 14:39:18,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,139,156,,,145,160,VAGINA,BODY,VAGINA,139,156,BODY,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 14:41:33,1642639038,5/24/2015 14:40:50,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,139,156,,,145,160,VAGINA,BODY,VAGINA,139,139-148-156-161-172-183,vagina foreign BODY reaction Fournier's gangrene,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 14:42:47,1642639341,5/24/2015 14:41:25,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,139,156,,,145,160,VAGINA,BODY,VAGINA,139,139-148-156-161-172-183,vagina foreign BODY reaction Fournier's gangrene,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 14:46:43,1642640146,5/24/2015 14:45:12,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,139,156,,,145,160,VAGINA,BODY,VAGINA,139,148-156-161,foreign BODY reaction,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 14:50:36,1642641033,5/24/2015 14:50:17,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,139,156,,,145,160,VAGINA,BODY,VAGINA,139,136-148-156-161,in foreign BODY reaction,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343056,5/24/2015 15:14:19,1642645690,5/24/2015 15:13:29,false,points4rewards,1,28703583,USA,,,97.73.85.209,139,156,,,145,160,VAGINA,BODY,VAGINA Fournier's gangrene,139-172-183,139-148-156-172-183,vagina foreign BODY Fournier's gangrene,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body.",139,156,139,156,-1,145,160,TWrex-cause,801997,"SEE:   foreign bodies in ear ;  foreign bodies in the esophagus ;  foreign body in nose ;  foreign bodies in the skin ;  foreign bodies in vagina   foreign body reaction — Fournier's gangrene  foreign body reaction    A localized inflammatory response elicited by any material (e.g., a splinter or a suture) that would not normally be found within the body",vagina,body
725343057,5/24/2015 11:39:32,1642605707,5/24/2015 11:39:14,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,ANXIETY.,109,23-35-43,GENERALIZED ANXIETY DISORDER,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 11:40:39,1642605880,5/24/2015 11:40:22,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,anxiety disorder ANXIETY.,35-109-43,23-35-43-94,GENERALIZED ANXIETY DISORDER Depression,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 11:58:51,1642608781,5/24/2015 11:58:27,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,ANXIETY.,109,23-35-43,GENERALIZED ANXIETY DISORDER,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 12:01:38,1642609247,5/24/2015 12:00:45,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,ANXIETY.,109,23-35-43,GENERALIZED ANXIETY DISORDER,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 12:22:29,1642612734,5/24/2015 12:22:15,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,ANXIETY.,109,23-35-43,GENERALIZED ANXIETY DISORDER,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 12:23:39,1642612915,5/24/2015 12:23:26,false,clixsense,1,31482589,NLD,,,31.201.11.16,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,ANXIETY.,109,23-35-43,GENERALIZED ANXIETY DISORDER,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 12:39:13,1642615687,5/24/2015 12:38:54,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and ANXIETY.,0-10-20-23-35-43-52-57-61-75-91-94-105-109-85,0-10-20-23-35-43-52-57-61-75-85-91-94-105-109,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and Anxiety.,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 12:58:13,1642619030,5/24/2015 12:57:53,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,anxiety disorder Consensus on Depression and ANXIETY.,35-43-91-94-105-109-75,0-10-20-23-35-43-52-57-61-94-109,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Depression Anxiety.,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 12:58:38,1642619171,5/24/2015 12:57:16,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,ANXIETY.,109,23-35-43,GENERALIZED ANXIETY DISORDER,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343057,5/24/2015 13:14:47,1642622350,5/24/2015 13:14:39,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,109,23,,,116,51,ANXIETY,GENERALIZED ANXIETY DISORDER,ANXIETY.,109,23-35-43,GENERALIZED ANXIETY DISORDER,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.,109,23 35 43,109,23,1,116,51,TWrex-cause,814777,Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety,anxiety,generalized anxiety disorder
725343058,5/24/2015 11:38:52,1642605577,5/24/2015 11:38:33,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,272,206,,,275,210,APL,ACID,APL.,272,185-190-197-206,"all trans retinoic ACID,","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 11:39:58,1642605788,5/24/2015 11:39:40,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,272,206,,,275,210,APL,ACID,leukemia APL.,272-158,206-158,"leukemia ACID,","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 11:57:53,1642608619,5/24/2015 11:57:23,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,272,206,,,275,210,APL,ACID,APL.,272,185-188-190-197-206,"all - trans retinoic ACID,","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 12:00:21,1642609025,5/24/2015 12:00:06,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,272,206,,,275,210,APL,ACID,APL.,272,185-190-197-206,"all trans retinoic ACID,","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 12:21:58,1642612681,5/24/2015 12:21:40,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,272,206,,,275,210,APL,ACID,APL.,272,190-197-206,"trans retinoic ACID,","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 12:22:57,1642612800,5/24/2015 12:22:45,false,clixsense,1,31482589,NLD,,,31.201.11.16,272,206,,,275,210,APL,ACID,APL.,272,185-190-197-206,"all trans retinoic ACID,","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 12:37:27,1642615340,5/24/2015 12:35:55,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,272,206,,,275,210,APL,ACID,"Although the precise functional properties of the chimeric molecule, PML - RAR - α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all - trans  retinoic acid, which has revolutionized the clinical care of patients with APL.",0-9-13-21-32-43-46-50-59-69-73-76-77-80-84-93-98-112-122-126-135-150-153-158-167-170-180-185-188-190-196-197-206-212-218-222-237-241-250-255-258-267-272-72,0-9-13-21-32-43-46-50-59-69-72-73-76-77-80-84-93-98-112-122-126-135-150-153-158-167-170-180-185-188-190-196-197-206-212-218-222-237-241-250-255-258-267-272,"Although the precise functional properties of the chimeric molecule, PML - RAR - α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all - trans  retinoic ACID, which has revolutionized the clinical care of patients with APL.","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 12:57:01,1642618838,5/24/2015 12:56:40,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,272,206,,,275,210,APL,ACID,APL.,272,206,"ACID,","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 12:57:21,1642618869,5/24/2015 12:56:45,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,272,206,,,275,210,APL,ACID,"chimeric molecule, PML RAR trans retinoic acid, of patients with APL.",50-59-69-73-197-206-255-258-267-272-190,59-185-190-197-206-212-218-222-50,"chimeric molecule, all trans retinoic ACID, which has revolutionized","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343058,5/24/2015 13:14:34,1642622286,5/24/2015 13:14:15,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,272,206,,,275,210,APL,ACID,APL.,272,185-190-197-206,"all trans retinoic ACID,","Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL.",272,206,272,206,-1,275,210,TWrex-cause,804246,"Although the precise functional properties of the chimeric molecule, PML-RAR-α, are unknown, this translocation underlies the dramatic responsiveness of this leukemia to treatment with all- trans -retinoic acid, which has revolutionized the clinical care of patients with APL",APL,acid
725343059,5/24/2015 14:37:41,1642637952,5/24/2015 14:37:24,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,16,94,,,20,111,TIC,TOURETTE SYNDROME,Vocal and motor TICS that begin early in life prominent features of Tourette syndrome (TS.,0-6-10-16-21-26-32-38-41-72-82-91-94-103-112,72-82-91-94-103,prominent features of TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 14:43:57,1642639595,5/24/2015 14:43:37,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,16,94,,,20,111,TIC,TOURETTE SYNDROME,Vocal and motor TICS,0-6-10-16,94-103,TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 14:50:03,1642640871,5/24/2015 14:49:15,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,16,94,,,20,111,TIC,TOURETTE SYNDROME,Vocal and motor TICS,0-6-10-16,94-103,TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 14:58:37,1642642622,5/24/2015 14:58:13,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,16,94,,,20,111,TIC,TOURETTE SYNDROME,Vocal and motor TICS,0-6-16-10,94-103,TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 15:19:51,1642646848,5/24/2015 15:19:36,false,neodev,1,32087449,USA,DE,,108.59.10.153,16,94,,,20,111,TIC,TOURETTE SYNDROME,TICS,16,94-103,TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 15:22:01,1642647317,5/24/2015 15:21:03,false,points4rewards,1,28703583,USA,,,97.73.85.209,16,94,,,20,111,TIC,TOURETTE SYNDROME,TICS Tourette syndrome (TS.,16-94-103-112,16-94-103-112,tics TOURETTE SYNDROME (TS.,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 15:25:33,1642648205,5/24/2015 15:25:19,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,16,94,,,20,111,TIC,TOURETTE SYNDROME,Vocal and motor TICS,0-6-10-16,94-103,TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 15:31:25,1642649329,5/24/2015 15:31:11,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,16,94,,,20,111,TIC,TOURETTE SYNDROME,TICS,16,94-103,TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 15:32:17,1642649543,5/24/2015 15:32:06,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,16,94,,,20,111,TIC,TOURETTE SYNDROME,Vocal and motor TICS,0-6-10-16,94-103,TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343059,5/24/2015 15:46:36,1642653240,5/24/2015 15:46:08,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,16,94,,,20,111,TIC,TOURETTE SYNDROME,TICS,16,94-103,TOURETTE SYNDROME,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS.,16,94 103,16,94,1,20,111,TWrex-cause,814691,Vocal and motor tics that begin early in life and then wax and wane are prominent features of Tourette syndrome (TS,tic,tourette syndrome
725343060,5/24/2015 13:30:33,1642625275,5/24/2015 13:29:45,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,sulfasalazine JUVENILE RHEUMATOID ARTHRITIS rheumatoid arthritis.,52-84-93-104-169-180,52-84-93-104-169-180,SULFASALAZINE juvenile rheumatoid arthritis rheumatoid arthritis.,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 13:41:23,1642627358,5/24/2015 13:39:39,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,JUVENILE RHEUMATOID ARTHRITIS,84-93-104,52,SULFASALAZINE,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 13:42:09,1642627487,5/24/2015 13:41:51,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,JUVENILE RHEUMATOID ARTHRITIS,84-93-104,52,SULFASALAZINE,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 13:58:52,1642630428,5/24/2015 13:58:03,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,JUVENILE RHEUMATOID ARTHRITIS,84-93-104,52,SULFASALAZINE,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 14:00:22,1642630673,5/24/2015 13:59:38,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,sulfasalazine JUVENILE RHEUMATOID ARTHRITIS rheumatoid arthritis.,52-84-93-104-169-180,52-84-93-104-169-180,SULFASALAZINE juvenile rheumatoid arthritis rheumatoid arthritis.,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 14:01:21,1642630825,5/24/2015 14:00:43,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,JUVENILE RHEUMATOID ARTHRITIS,84-93-104,52,SULFASALAZINE,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 14:02:54,1642631076,5/24/2015 14:02:37,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,JUVENILE RHEUMATOID ARTHRITIS,84-93-104,52-84-93-104,SULFASALAZINE juvenile rheumatoid arthritis,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 14:09:45,1642632280,5/24/2015 14:09:16,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,JUVENILE RHEUMATOID ARTHRITIS,84-93-104,52,SULFASALAZINE,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 14:16:45,1642633646,5/24/2015 14:15:23,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,JUVENILE RHEUMATOID ARTHRITIS,84-93-104,52,SULFASALAZINE,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343060,5/24/2015 14:19:20,1642634150,5/24/2015 14:18:31,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,84,52,,,113,65,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,for management of JUVENILE RHEUMATOID ARTHRITIS,66-70-81-84-93-104,33-42-52-66-70-81-84-93,children receiving SULFASALAZINE for management of juvenile rheumatoid,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis.,84 93 104,52,84,52,-1,113,65,TWrex-cause,804872,146  Adverse effects observed in children receiving sulfasalazine for management of juvenile rheumatoid arthritis generally are similar to those observed in adults with rheumatoid arthritis,juvenile rheumatoid arthritis,sulfasalazine
725343061,5/24/2015 13:35:17,1642626225,5/24/2015 13:34:45,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,14,77,,,23,80,VARICELLA,VZV,VARICELla immunized VZV fever cutaneous lesions.,16-44-79-120-134-144,16-44-79-120-134-144,varicella immunized VZV fever cutaneous lesions.,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 13:47:04,1642628307,5/24/2015 13:46:48,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,14,77,,,23,80,VARICELLA,VZV,VARICELla,16,79,VZV,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 13:48:06,1642628552,5/24/2015 13:47:51,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,14,77,,,23,80,VARICELLA,VZV,VARICELla,16,79,VZV,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 14:05:35,1642631532,5/24/2015 14:04:47,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,14,77,,,23,80,VARICELLA,VZV,VARICELla,16,76-79,tO VZV,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 14:07:31,1642631863,5/24/2015 14:05:54,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,14,77,,,23,80,VARICELLA,VZV,VARICELla immunized VZV cutaneous lesions.,16-44-79-134-144,16-44-79-134-144,varicella immunized VZV cutaneous lesions.,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 14:07:37,1642631874,5/24/2015 14:07:21,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,14,77,,,23,80,VARICELLA,VZV,Breakthrough' VARICELla,0-16,79,VZV,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 14:13:10,1642632878,5/24/2015 14:12:42,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,14,77,,,23,80,VARICELLA,VZV,VARICELla,16,79,VZV,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 14:23:03,1642634890,5/24/2015 14:21:58,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,14,77,,,23,80,VARICELLA,VZV,VARICELla,16,79,VZV,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 14:24:25,1642635132,5/24/2015 14:24:00,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,14,77,,,23,80,VARICELLA,VZV,Breakthrough' VARICELla that occurs in an immunized person,0-16-26-31-38-41-44-54,61-67-76-79,after exposure tO VZV,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343061,5/24/2015 14:24:30,1642635169,5/24/2015 14:23:56,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,14,77,,,23,80,VARICELLA,VZV,Breakthrough' VARICELla,0-16,79,VZV,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,,,14,77,-1,23,80,TWrex-cause,803170,'Breakthrough' varicella that occurs in an immunized person after exposure to VZV is almost always mild with low-grade fever and few cutaneous lesions,varicella,VZV
725343062,5/24/2015 14:38:24,1642638156,5/24/2015 14:38:08,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,113,182,,,123,187,INFECTION,VIRUS,"acquired respiratory viral INFECTIONS, such as respiratory syncytial virus (RSV), parainfluenza virus,",86-95-107-113-125-130-133-145-155-161-168-182,155-161-168-182-189-199-208-212-254-259-270,"virus (RSV), parainfluenza VIRUS, influenza viruses, and metapneumovirus late developing BOS.","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 14:44:45,1642639736,5/24/2015 14:44:22,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,113,182,,,123,187,INFECTION,VIRUS,"respiratory viral INFECTIONS,",95-107-113,168-182-189-199,"parainfluenza VIRUS, influenza viruses,","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 14:51:39,1642641197,5/24/2015 14:50:32,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,113,182,,,123,187,INFECTION,VIRUS,"acquired respiratory viral INFECTIONS,",86-95-107-113,168-182,"parainfluenza VIRUS,","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 15:02:34,1642643457,5/24/2015 15:01:07,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,113,182,,,123,187,INFECTION,VIRUS,"community acquired respiratory viral INFECTIONS,",76-95-107-113-86,168-182,"parainfluenza VIRUS,","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 15:20:36,1642647019,5/24/2015 15:20:13,false,neodev,1,32087449,USA,DE,,108.59.10.153,113,182,,,123,187,INFECTION,VIRUS,"respiratory viral INFECTIONS,",95-107-113,155-161-168-182-189-199,"virus (RSV), parainfluenza VIRUS, influenza viruses,","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 15:23:51,1642647776,5/24/2015 15:22:58,false,points4rewards,1,28703583,USA,,,97.73.85.209,113,182,,,123,187,INFECTION,VIRUS,"acquired respiratory viral INFECTIONS, BOS.",86-95-107-113-270,182-270,"VIRUS, BOS.","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 15:26:14,1642648328,5/24/2015 15:26:01,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,113,182,,,123,187,INFECTION,VIRUS,"respiratory viral INFECTIONS,",95-107-113,168-182,"parainfluenza VIRUS,","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 15:31:52,1642649456,5/24/2015 15:31:39,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,113,182,,,123,187,INFECTION,VIRUS,"respiratory INFECTIONS,",95-113,182,"VIRUS,","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 15:32:49,1642649679,5/24/2015 15:32:34,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,113,182,,,123,187,INFECTION,VIRUS,"community acquired respiratory viral INFECTIONS,",76-86-95-107-113,168-182,"parainfluenza VIRUS,","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343062,5/24/2015 15:47:15,1642653435,5/24/2015 15:46:54,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,113,182,,,123,187,INFECTION,VIRUS,"respiratory viral INFECTIONS,",95-107-113,155-168-182,"virus parainfluenza VIRUS,","The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS.",113,182,113,182,1,123,187,TWrex-cause,810377,"The relationship between CMV infection and BOS has been inconsistent; other community-acquired respiratory viral infections, such as respiratory syncytial virus (RSV), parainfluenza virus, influenza viruses, and metapneumovirus have been associated with late-developing BOS",infection,virus
725343063,5/24/2015 13:38:17,1642626845,5/24/2015 13:37:13,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"weight loss, diet, exercise, patients risk developing NAFLD, metabolic syndrome (diabetes impaired fasting glucose; OBESITY, abdominal obesity; dyslipidemia; hypertension.",69-76-82-92-105-117-125-136-171-181-190-203-212-220-229-249-259-268-286,69-76-82-92-105-117-125-136-171-181-190-203-212-220-229-249-259-268-286,"weight loss, diet, exercise, patients risk developing NAFLD, metabolic syndrome (diabetes impaired fasting glucose; obesity, ABDOMINAL OBESITY; dyslipidemia; hypertension.","C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 13:49:11,1642628740,5/24/2015 13:48:18,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"OBESITY,",229,249-259,ABDOMINAL OBESITY;,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 14:09:18,1642632229,5/24/2015 14:08:08,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"OBESITY,",229,249-259,ABDOMINAL OBESITY;,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 14:10:24,1642632374,5/24/2015 14:09:10,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"OBESITY,",229,249-259,ABDOMINAL OBESITY;,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 14:10:57,1642632461,5/24/2015 14:09:29,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"NAFLD, metabolic syndrome (diabetes glucose; OBESITY, dyslipidemia; hypertension.",136-171-181-190-220-229-268-286,136-171-181-190-220-229-249-259-268-286,"NAFLD, metabolic syndrome (diabetes glucose; obesity, ABDOMINAL OBESITY; dyslipidemia; hypertension.","C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 14:15:25,1642633306,5/24/2015 14:14:49,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"OBESITY, especially abdominal obesity; dyslipidemia; hypertension.",229-238-249-259-268-286,229-238-249-259-268-282-286,"obesity, especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.","C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 14:25:59,1642635512,5/24/2015 14:25:37,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"OBESITY,",229,249-259,ABDOMINAL OBESITY;,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 14:26:29,1642635581,5/24/2015 14:25:56,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"OBESITY,",229,249-259,ABDOMINAL OBESITY;,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 14:26:48,1642635670,5/24/2015 14:25:25,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"OBESITY,",229,249-259,ABDOMINAL OBESITY;,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343063,5/24/2015 14:27:04,1642635735,5/24/2015 14:26:25,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,229,249,,,236,266,OBESITY,ABDOMINAL OBESITY,"OBESITY, especially abdominal obesity; dyslipidemia; and hypertension.",229-238-249-259-268-286-282,249-259-268-282-286,ABDOMINAL OBESITY; dyslipidemia; and hypertension.,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension.",229,249 259,229,249,1,236,266,TWrex-cause,814182,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; obesity, especially abdominal obesity; dyslipidemia; and hypertension",obesity,abdominal obesity
725343064,5/24/2015 14:46:41,1642640128,5/24/2015 14:46:10,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,193,79-90-107,THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 14:54:39,1642641761,5/24/2015 14:53:27,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,193,56-63-72-79-90-107,UREMIC SYNDROME (HUS) THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 15:07:09,1642644453,5/24/2015 15:04:38,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,193,79-90-107,THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 15:21:58,1642647304,5/24/2015 15:21:41,false,neodev,1,32087449,USA,DE,,108.59.10.153,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic,166-176-190-193-210-214-231,56-63-72-79-90-107-115-119-129,UREMIC SYNDROME (HUS) THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 15:27:36,1642648556,5/24/2015 15:27:02,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,193,79-90-107,THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 15:27:35,1642648557,5/24/2015 15:26:37,false,points4rewards,1,28703583,USA,,,97.73.85.209,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,(TTP) (HUS) THROMBOCYTOPENIA,36-72-193,36-72-79-90-107,(TTP) (HUS) THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 15:33:49,1642649849,5/24/2015 15:33:34,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,193,79-90-107,THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 15:48:48,1642653783,5/24/2015 15:48:14,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,193,79-90-107,THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 15:49:28,1642653929,5/24/2015 15:49:09,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,193,79-90-107,THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343064,5/24/2015 15:58:04,1642655722,5/24/2015 15:57:50,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,193,79,,,209,114,THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA,THROMBOCYTOPENIA,193,79-90-107,THROMBOTIC THROMBOCYTOPENIC PURPURA,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia.",193,79 90 107,193,79,1,209,114,TWrex-cause,814544,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC-UREMIC SYNDROME (HUS)  Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome are acute, fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia",thrombocytopenia,thrombotic thrombocytopenic purpura
725343065,5/24/2015 11:31:23,1642604449,5/24/2015 11:31:08,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,NEUROCYSTICERCOSIS:,24,0-12,ALBENDAZOLE therapy,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 11:33:19,1642604804,5/24/2015 11:33:01,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,Albendazole therapy NEUROCYSTICERCOSIS:,0-24-12,0-12-20-24,ALBENDAZOLE therapy for neurocysticercosis:,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 11:43:19,1642606279,5/24/2015 11:43:08,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,NEUROCYSTICERCOSIS:,24,0-12,ALBENDAZOLE therapy,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 11:44:39,1642606488,5/24/2015 11:43:37,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,NEUROCYSTICERCOSIS:,24,0-12,ALBENDAZOLE therapy,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 11:53:02,1642607920,5/24/2015 11:52:43,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,NEUROCYSTICERCOSIS:,24,0,ALBENDAZOLE,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 11:55:32,1642608356,5/24/2015 11:55:18,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,NEUROCYSTICERCOSIS:,24,0,ALBENDAZOLE,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 12:07:34,1642610341,5/24/2015 12:07:23,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,NEUROCYSTICERCOSIS:,24,0-12,ALBENDAZOLE therapy,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 12:09:51,1642610739,5/24/2015 12:09:41,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,NEUROCYSTICERCOSIS:,24,0,ALBENDAZOLE,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 12:10:26,1642610792,5/24/2015 12:10:05,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,Albendazole NEUROCYSTICERCOSIS:,24-0,0-24,ALBENDAZOLE neurocysticercosis:,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343065,5/24/2015 12:11:58,1642611100,5/24/2015 12:11:21,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,24,0,,,42,11,NEUROCYSTICERCOSIS,ALBENDAZOLE,Albendazole therapy for NEUROCYSTICERCOSIS:,0-12-20-24,0-12-20-24,ALBENDAZOLE therapy for neurocysticercosis:,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment.,24,0,24,0,-1,42,11,TWrex-cause,803503,Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment,neurocysticercosis,albendazole
725343066,5/24/2015 11:39:13,1642605647,5/24/2015 11:38:53,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,Lyme DISEASE,95-100,59-68,BORRELIA BURGDORFERI,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 11:40:21,1642605851,5/24/2015 11:39:58,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,DISEASE Ehrlichia,100-172,59-68-125,BORRELIA BURGDORFERI Disease,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 11:58:18,1642608714,5/24/2015 11:57:57,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,Lyme DISEASE,95-100,59-68,BORRELIA BURGDORFERI,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 12:00:43,1642609072,5/24/2015 12:00:23,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,Lyme DISEASE,95-100,59-68,BORRELIA BURGDORFERI,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 12:22:14,1642612711,5/24/2015 12:21:59,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,Lyme DISEASE,95-100,59-68,BORRELIA BURGDORFERI,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 12:23:26,1642612868,5/24/2015 12:22:59,false,clixsense,1,31482589,NLD,,,31.201.11.16,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,Lyme DISEASE,95-100,59-68,BORRELIA BURGDORFERI,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 12:38:52,1642615597,5/24/2015 12:37:28,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,"The tick vector of babesiosis may simultaneously transmit Borrelia burgdorferi the agent of Lyme DISEASE see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and Ehrlichia ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",0-4-9-16-19-30-34-49-59-68-82-86-92-95-100-110-114-120-125-133-137-143-155-164-167-172-183-185-195-197-206-210-217-220-233-235-239-246-257-261-264-276-287-291,0-4-9-16-19-30-34-49-59-68-82-86-92-95-100-108-110-114-120-125-133-137-143-155-164-167-172-183-185-195-197-206-210-217-220-233-235-239-246-257-261-264-276-287-291,"The tick vector of babesiosis may simultaneously transmit BORRELIA BURGDORFERI the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and Ehrlichia ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.","The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 12:57:16,1642618866,5/24/2015 12:57:01,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,DISEASE,100,59-68,BORRELIA BURGDORFERI,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 12:57:52,1642618950,5/24/2015 12:57:21,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,tick vector of babesiosis agent of Lyme DISEASE see 7:VII Lyme Spirochetal Zoonoses Ehrlichia Anaplasma,4-9-16-19-86-92-95-100-110-114-120-143-155-172-185,19-30-34-49-59-68-82-86-92-143-276-291-264,"babesiosis may simultaneously transmit BORRELIA BURGDORFERI the agent of Spirochetal Rickettsia, Ehrlichia, Coxiella.","The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343066,5/24/2015 13:20:43,1642623528,5/24/2015 13:19:18,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,100,59,,,107,79,DISEASE,BORRELIA BURGDORFERI,"vector babesiosis Borrelia burgdorferi agent Lyme DISEASE Lyme Disease Spirochetal Zoonoses Ehrlichia Anaplasma species, ehrlichiosis Rickettsia, Ehrlichia, Coxiella.",9-19-59-68-86-95-100-120-125-143-155-172-185-197-220-264-276-291,9-19-59-68-95-100-120-125-143-155-172-185-197-220-246-264-276-291,"vector babesiosis BORRELIA BURGDORFERI Lyme disease Lyme Disease Spirochetal Zoonoses Ehrlichia Anaplasma species, ehrlichiosis Infections Rickettsia, Ehrlichia, Coxiella.","The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella.",100,59 68,100,59,1,107,79,TWrex-cause,810531,"The tick vector of babesiosis may simultaneously transmit  Borrelia burgdorferi , the agent of Lyme disease [ see 7:VII Lyme Disease and Other Spirochetal Zoonoses ], and  Ehrlichia  ( Anaplasma ) species, the agents of ehrlichiosis [ see 7:XVII Infections Due to Rickettsia, Ehrlichia, and Coxiella",disease,borrelia burgdorferi
725343067,5/24/2015 12:26:37,1642613448,5/24/2015 12:25:57,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,151,87,,,155,97,AID,ZIDOVUDINE,immunodeficiency syndrome (AIDS) advanced AIDS,124-141-150-161-170,87,ZIDOVUDINE,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 12:27:40,1642613607,5/24/2015 12:27:16,false,clixsense,1,31482589,NLD,,,31.201.11.16,151,87,,,155,97,AID,ZIDOVUDINE,immunodeficiency syndrome (AIDS) and advanced AIDS,124-141-150-157-161-170,87,ZIDOVUDINE,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 13:26:49,1642624625,5/24/2015 13:26:03,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,151,87,,,155,97,AID,ZIDOVUDINE,"AIDS 2′,3′ dideoxycytidine zidovudine patients immunodeficiency syndrome (AIDS) AIDS",0-67-87-101-124-141-150-170-61,0-61-67-87-101-124-141-150-170,"AIDS 2′,3′ dideoxycytidine ZIDOVUDINE patients immunodeficiency syndrome (AIDS) AIDS","AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 13:34:27,1642626009,5/24/2015 13:33:47,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,151,87,,,155,97,AID,ZIDOVUDINE,acquired immunodeficiency syndrome (AIDS),124-141-150-115,61-67-83-87-98-101-110,"2′,3′ dideoxycytidine and ZIDOVUDINE in patients with","AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 13:36:40,1642626548,5/24/2015 13:36:17,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,151,87,,,155,97,AID,ZIDOVUDINE,acquired immunodeficiency syndrome (AIDS),115-124-141-150,87,ZIDOVUDINE,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 13:40:47,1642627262,5/24/2015 13:40:32,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,151,87,,,155,97,AID,ZIDOVUDINE,immunodeficiency syndrome (AIDS),124-141-150,87,ZIDOVUDINE,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 13:54:23,1642629623,5/24/2015 13:53:46,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,151,87,,,155,97,AID,ZIDOVUDINE,immunodeficiency syndrome (AIDS),124-141-150,87,ZIDOVUDINE,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 13:56:28,1642630009,5/24/2015 13:55:38,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,151,87,,,155,97,AID,ZIDOVUDINE,AIDS dideoxycytidine zidovudine immunodeficiency syndrome (AIDS) AIDS,0-67-87-124-141-150-170,0-67-87-124-141-150-170,AIDS dideoxycytidine ZIDOVUDINE immunodeficiency syndrome (AIDS) AIDS,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 13:56:58,1642630073,5/24/2015 13:54:40,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,151,87,,,155,97,AID,ZIDOVUDINE,acquired immunodeficiency syndrome (AIDS),115-124-141-150,87,ZIDOVUDINE,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343067,5/24/2015 14:00:56,1642630779,5/24/2015 14:00:28,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,151,87,,,155,97,AID,ZIDOVUDINE,immunodeficiency syndrome (AIDS) and advanced AIDS related complex.,124-141-150-157-161-170-175-183,87-115-124-141-150,ZIDOVUDINE acquired immunodeficiency syndrome (AIDS),"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.",,87,151,87,-1,155,97,TWrex-cause,800967,"AIDS clinical trials groups: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex",aid,zidovudine
725343068,5/24/2015 12:25:04,1642613193,5/24/2015 12:24:49,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,Chronic PAIN,101-109,73-81-86,CHRONIC PAIN SYNDROME,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 12:26:42,1642613453,5/24/2015 12:25:40,false,clixsense,1,31482589,NLD,,,31.201.11.16,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,Chronic PAIN,101-109,73-81-86,CHRONIC PAIN SYNDROME,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 13:24:52,1642624324,5/24/2015 13:23:43,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,"Vulvar vestibulitis vulvar dysesthesia) chronic pain syndrome Chronic PAIN vulva, nervous peripheral cerebral cortex,",0-7-31-38-73-81-86-101-109-123-143-164-192-201,0-7-31-38-73-81-86-101-109-123-143-164-192-201,"Vulvar vestibulitis vulvar dysesthesia) CHRONIC PAIN SYNDROME Chronic Pain vulva, nervous peripheral cerebral cortex,","Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 13:32:28,1642625609,5/24/2015 13:31:33,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,"chronic pain PAIN of the vulva, peripheral receptors to the cerebral cortex, is sensitized",73-81-109-116-119-123-164-175-185-188-192-201-209-212,73-81-86-143-151-175,"CHRONIC PAIN SYNDROME nervous system, receptors","Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 13:34:39,1642626042,5/24/2015 13:34:16,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,Chronic PAIN,101-109,73-81-86,CHRONIC PAIN SYNDROME,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 13:39:58,1642627070,5/24/2015 13:39:45,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,Chronic PAIN,101-109,73-81-86,CHRONIC PAIN SYNDROME,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 13:51:34,1642629143,5/24/2015 13:51:13,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,Chronic PAIN,101-109,73-81-86,CHRONIC PAIN SYNDROME,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 13:52:19,1642629268,5/24/2015 13:51:36,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,Chronic PAIN,101-109,73-81-86,CHRONIC PAIN SYNDROME,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 13:54:23,1642629626,5/24/2015 13:53:06,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,"Vulvar vestibulitis vulvar dysesthesia) syndrome (see Chronic PAIN vulva, nervous system, peripheral receptors cerebral cortex,",0-31-38-86-95-101-109-123-143-151-164-175-192-201-7,0-7-31-38-73-81-86-101-109-123-143-151-164-175-192-201,"Vulvar vestibulitis vulvar dysesthesia) CHRONIC PAIN SYNDROME Chronic Pain vulva, nervous system, peripheral receptors cerebral cortex,","Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343068,5/24/2015 13:57:54,1642630245,5/24/2015 13:57:51,false,neodev,1,31977841,USA,IL,Chicago,65.60.20.66,109,73,,,113,94,PAIN,CHRONIC PAIN SYNDROME,"syndrome (see Chronic PAIN of the vulva,",86-95-101-109-116-119-123,63-65-70-73-81-86-101-109,a form of CHRONIC PAIN SYNDROME Chronic Pain,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",109,73 81 86,109,73,1,113,94,TWrex-cause,812911,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of chronic pain syndrome (see  Chronic Pain ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons",pain,chronic pain syndrome
725343069,5/24/2015 14:15:30,1642633323,5/24/2015 14:14:45,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS,0-9-20,68-76-82,measles VIRUS infection,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:18:17,1642633885,5/24/2015 14:17:55,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE),0-9-20-36,57-68-76-82-98-92,persistent measles VIRUS infection (see Measles.,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:18:43,1642633992,5/24/2015 14:18:22,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS,0-9-20,57-68-76-82,persistent measles VIRUS infection,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:30:09,1642636236,5/24/2015 14:29:45,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS,0-9-20,68-76-82,measles VIRUS infection,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:32:07,1642636640,5/24/2015 14:31:26,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS,0-9-20,68-76,measles VIRUS,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:32:20,1642636692,5/24/2015 14:31:45,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS is probably persistent measles virus infection,0-9-20-43-46-57-68-76-82,55-57-68-76-82-98,a persistent measles VIRUS infection Measles.,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:34:34,1642637238,5/24/2015 14:33:54,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS,0-9-20,57-68-76-82,persistent measles VIRUS infection,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:36:41,1642637701,5/24/2015 14:36:32,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS,0-9-20,68-76-82,measles VIRUS infection,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:37:55,1642637980,5/24/2015 14:37:26,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS,0-9-20,57-68-76-82,persistent measles VIRUS infection,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343069,5/24/2015 14:38:01,1642638023,5/24/2015 14:36:22,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,0,76,,,35,81,SUBACUTE SCLEROSING PANENCEPHALITIS,VIRUS,SUBACUTE SCLEROSING PANENCEPHALITIS is,0-9-20-43,57-68-76-82,persistent measles VIRUS infection,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles.,0 9 20,76,0,76,1,35,81,TWrex-cause,814948,Subacute sclerosing panencephalitis (SSPE) is probably a persistent measles virus infection (see  Measles,subacute sclerosing panencephalitis,virus
725343070,5/24/2015 13:27:53,1642624795,5/24/2015 13:27:28,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,Vibrio Infections Treatment CHOLERA Vibrio cholerae.,3-10-22-35-54-61,3-10-22-35-54-61,Vibrio Infections Treatment cholera VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 13:37:30,1642626679,5/24/2015 13:37:05,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,54-61,VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 13:41:22,1642627362,5/24/2015 13:41:11,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,54-61,VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 13:55:59,1642629943,5/24/2015 13:55:09,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,54-61,VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 13:57:51,1642630233,5/24/2015 13:57:04,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,Vibrio Infections CHOLERA Vibrio cholerae.,3-10-35-54-61,3-10-35-54-61,Vibrio Infections cholera VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 13:59:34,1642630576,5/24/2015 13:59:04,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,54-61,VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 14:01:35,1642630849,5/24/2015 14:01:19,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,CHOLERA Vibrio cholerae.,35-54-61,35-54-61,cholera VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 14:08:18,1642632036,5/24/2015 14:07:34,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,Infections Treatment of CHOLERA caused by,22-32-35-43-50-10,32-35-43-50-54-61-22,Treatment of cholera caused by VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 14:12:25,1642632724,5/24/2015 14:11:17,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,CHOLERA,35,54-61,VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343070,5/24/2015 14:16:23,1642633546,5/24/2015 14:16:07,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,35,54,,,42,69,CHOLERA,VIBRIO CHOLERA,Infections Treatment of CHOLERA,10-22-32-35,35-43-50-54-61,cholera caused by VIBRIO CHOLERAE.,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae.,35,54 61,35,54,1,42,69,TWrex-cause,811336,f  Vibrio Infections  Treatment of cholera caused by  Vibrio cholerae,cholera,vibrio cholera
725343071,5/24/2015 14:32:43,1642636764,5/24/2015 14:32:24,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,80,0,,,92,8,HYPERTENSION,LOSARTAN,essential HYPERTENSION,70-80,0,LOSARTAN,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 14:35:03,1642637349,5/24/2015 14:34:17,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,80,0,,,92,8,HYPERTENSION,LOSARTAN,atenolol in essential HYPERTENSION Keywords: Hypertension Atenolol Losartan ACP,58-67-70-80-94-104-117-126-136,0-9-17-25-29-33-39,LOSARTAN reduced strokes and new onset diabetes,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 14:38:44,1642638254,5/24/2015 14:38:00,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,80,0,,,92,8,HYPERTENSION,LOSARTAN,atenolol in essential HYPERTENSION,58-67-70-80,0-9-17,LOSARTAN reduced strokes,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 14:40:55,1642638862,5/24/2015 14:40:38,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,80,0,,,92,8,HYPERTENSION,LOSARTAN,HYPERTENSION,80,0,LOSARTAN,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 14:44:23,1642639664,5/24/2015 14:42:20,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,80,0,,,92,8,HYPERTENSION,LOSARTAN,essential HYPERTENSION,80-70,0,LOSARTAN,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 14:50:52,1642641046,5/24/2015 14:50:40,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,80,0,,,92,8,HYPERTENSION,LOSARTAN,HYPERTENSION,80,0,LOSARTAN,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 14:51:03,1642641067,5/24/2015 14:50:53,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,80,0,,,92,8,HYPERTENSION,LOSARTAN,HYPERTENSION,80,0,LOSARTAN,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 15:15:43,1642645955,5/24/2015 15:15:05,false,points4rewards,1,28703583,USA,,,97.73.85.209,80,0,,,92,8,HYPERTENSION,LOSARTAN,new onset diabetes HYPERTENSION,29-33-80-39,0-29-33-39,LOSARTAN new onset diabetes,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 15:17:25,1642646392,5/24/2015 15:17:13,false,neodev,1,32087449,USA,DE,,108.59.10.153,80,0,,,92,8,HYPERTENSION,LOSARTAN,atenolol in HYPERTENSION Hypertension Atenolol,58-67-80-104-117,0,LOSARTAN,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343071,5/24/2015 15:23:30,1642647676,5/24/2015 15:22:48,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,80,0,,,92,8,HYPERTENSION,LOSARTAN,HYPERTENSION,80,0,LOSARTAN,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club.,80,0,80,0,-1,92,8,TWrex-cause,803339,Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension  Keywords: Hypertension Atenolol Losartan  ACP Journal Club,hypertension,losartan
725343072,5/24/2015 15:30:51,1642649168,5/24/2015 15:30:39,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"progressive LYMPHADENOPATHY,",108-120,10-12,• CLL,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 15:52:04,1642654489,5/24/2015 15:51:42,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"LYMPHADENOPATHY,",120,10-12,• CLL,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 15:54:34,1642654895,5/24/2015 15:54:21,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"progressive LYMPHADENOPATHY,",108-120,10-12,• CLL,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 16:22:46,1642660736,5/24/2015 16:22:31,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"LYMPHADENOPATHY,",120,10-12,• CLL,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 16:35:44,1642663563,5/24/2015 16:35:17,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"progressive LYMPHADENOPATHY,",108-120,10-12,• CLL,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 17:02:40,1642671174,5/24/2015 17:02:21,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"B symptoms, progressive LYMPHADENOPATHY,",96-98-108-120,10-12-16,• CLL patients,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 17:05:16,1642671944,5/24/2015 17:04:18,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"onset of B symptoms, progressive LYMPHADENOPATHY, extra nodal involvement, an M spike, increased LDH, and hypercalcemia.",87-93-96-98-108-120-137-143-149-162-165-167-174-184-189-196,0-10-12-16-25-30-40-75-80-87-93-98-96,"Evidence: • CLL patients with Richter's transformation have sudden onset of B symptoms,","Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 17:10:12,1642673729,5/24/2015 17:10:00,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"LYMPHADENOPATHY,",120,10-12,• CLL,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 17:11:24,1642674150,5/24/2015 17:10:41,false,clixsense,1,29752264,CAN,ON,Bourget,74.56.122.95,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"progressive LYMPHADENOPATHY,",108-120,10-12-16-25-30-40,• CLL patients with Richter's transformation,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343072,5/24/2015 17:12:48,1642674590,5/24/2015 17:12:32,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,120,10,,,135,15,LYMPHADENOPATHY,• CLL,"progressive LYMPHADENOPATHY,",108-120,10-12,• CLL,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia.",120,10 12,120,10,1,135,15,TWrex-cause,813930,"Evidence: • CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, progressive lymphadenopathy, extra-nodal involvement, an M-spike, increased LDH, and/or hypercalcemia",lymphadenopathy,• CLL
725343073,5/24/2015 14:50:16,1642640892,5/24/2015 14:49:57,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,clostridial MYONECROSIS,74-86,159,CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 15:00:25,1642643023,5/24/2015 15:00:02,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,clostridial MYONECROSIS,74-86,159,CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 15:30:01,1642649008,5/24/2015 15:29:48,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,clostridial MYONECROSIS,74-86,159,CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 15:34:13,1642650009,5/24/2015 15:33:34,false,points4rewards,1,28703583,USA,,,97.73.85.209,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,clostridial MYONECROSIS (gas gangrene),74-86-103-98,74-86-98-159-103,clostridial myonecrosis (gas gangrene) CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 15:51:10,1642654316,5/24/2015 15:50:54,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,clostridial MYONECROSIS,74-86,159,CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 15:53:29,1642654691,5/24/2015 15:53:08,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,clostridial MYONECROSIS,74-86,159,CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 16:21:52,1642660566,5/24/2015 16:21:42,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,MYONECROSIS,86,159,CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 16:34:43,1642663457,5/24/2015 16:34:22,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,clostridial MYONECROSIS (gas gangrene),74-86-98-103,159,CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 16:58:32,1642669646,5/24/2015 16:57:13,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,clostridial MYONECROSIS (gas gangrene),74-86-98-103,159,CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343073,5/24/2015 17:00:03,1642670122,5/24/2015 16:59:14,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,86,159,,,97,170,MYONECROSIS,CLOSTRIDIUM,Clostridium Infections Alternative penicillin G treatment clostridial MYONECROSIS (gas gangrene) Clostridium Clostridium.,5-17-29-44-55-61-74-86-98-103-124-159,5-17-29-44-55-61-74-86-98-103-124-159,Clostridium Infections Alternative penicillin G treatment clostridial myonecrosis (gas gangrene) Clostridium CLOSTRIDIUM.,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium.,86,159,86,159,1,97,170,TWrex-cause,810254,120  Clostridium Infections  Alternative to penicillin G for treatment of clostridial myonecrosis (gas gangrene) caused by  Clostridium perfringens  or other  Clostridium,myonecrosis,clostridium
725343074,5/24/2015 14:16:08,1642633439,5/24/2015 14:15:31,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,132-144,40-54,Pyrimethamine CLINDAMYCIN,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:18:43,1642633993,5/24/2015 14:18:21,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,therapy for toxoplasmic ENCEPHALITIS in patients with AIDS.,120-128-132-144-157-160-169-174,40-54-66-70-84,Pyrimethamine CLINDAMYCIN vs. pyrimethamine sulfadiazine,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:19:50,1642634237,5/24/2015 14:18:45,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,132-144,40-54,Pyrimethamine CLINDAMYCIN,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:30:34,1642636341,5/24/2015 14:30:11,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,therapy toxoplasmic ENCEPHALITIS,120-132-144,40-54,Pyrimethamine CLINDAMYCIN,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:32:45,1642636773,5/24/2015 14:32:22,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,therapy for toxoplasmic ENCEPHALITIS in patients with AIDS.,120-128-132-144-157-160-169-174,33-36-40-54-66-84-100-110-115-120-70,et al. Pyrimethamine CLINDAMYCIN vs. pyrimethamine sulfadiazine acute long term therapy,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:35:08,1642637381,5/24/2015 14:34:35,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,therapy for toxoplasmic ENCEPHALITIS in patients with AIDS.,120-128-132-144-157-160-169-174,54-66-70,CLINDAMYCIN vs. pyrimethamine,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:37:55,1642637987,5/24/2015 14:37:40,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,132-144,40-54,Pyrimethamine CLINDAMYCIN,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:38:32,1642638199,5/24/2015 14:37:57,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,132-144,40-54,Pyrimethamine CLINDAMYCIN,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:38:51,1642638280,5/24/2015 14:38:02,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,132-144,40-54-66-84-70,Pyrimethamine CLINDAMYCIN vs. pyrimethamine sulfadiazine,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343074,5/24/2015 14:40:16,1642638698,5/24/2015 14:38:46,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,144,54,,,156,65,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,144-132,40-54,Pyrimethamine CLINDAMYCIN,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.",144,54,144,54,-1,156,65,TWrex-cause,800313,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS",encephalitis,clindamycin
725343075,5/24/2015 13:34:43,1642626050,5/24/2015 13:34:09,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,"Oxybutynin anticholinergic side effects constipation, dry mouth, exacerbation GLAUCOMA.",0-58-74-79-90-104-108-119-135,0-58-74-79-90-104-108-135-119,"OXYBUTYNIN anticholinergic side effects constipation, dry mouth, exacerbation glaucoma.","Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 13:46:47,1642628245,5/24/2015 13:46:35,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,GLAUCOMA.,135,0,OXYBUTYNIN,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 13:47:50,1642628462,5/24/2015 13:47:39,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,GLAUCOMA.,135,0,OXYBUTYNIN,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 14:04:44,1642631449,5/24/2015 14:04:04,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,GLAUCOMA.,135,0,OXYBUTYNIN,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 14:05:53,1642631625,5/24/2015 14:05:22,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,"Oxybutynin anticholinergic constipation, GLAUCOMA.",0-58-90-135,0-58-90-135,"OXYBUTYNIN anticholinergic constipation, glaucoma.","Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 14:07:19,1642631844,5/24/2015 14:06:51,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,GLAUCOMA.,135,0,OXYBUTYNIN,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 14:12:41,1642632787,5/24/2015 14:12:07,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,exacerbation of GLAUCOMA.,119-132-135,0-46-58-74-79-90,"OXYBUTYNIN significant anticholinergic side effects constipation,","Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 14:21:57,1642634649,5/24/2015 14:20:50,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,GLAUCOMA.,135,0,OXYBUTYNIN,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 14:23:55,1642635065,5/24/2015 14:23:39,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,GLAUCOMA.,135,0,OXYBUTYNIN,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343075,5/24/2015 14:23:59,1642635080,5/24/2015 14:23:44,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,135,0,,,143,10,GLAUCOMA,OXYBUTYNIN,and exacerbation of GLAUCOMA.,115-119-132-135,0-11-14,OXYBUTYNIN is short,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma.",135,0,135,0,1,143,10,TWrex-cause,811093,"Oxybutynin is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of glaucoma",glaucoma,oxybutynin
725343076,5/24/2015 11:37:38,1642605407,5/24/2015 11:37:20,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"myocardial INFARCTION,",187-198,80,CLOPIDOGREL,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 11:39:02,1642605615,5/24/2015 11:38:42,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"clopidogrel INFARCTION,",198-80,80-177-187-198,"CLOPIDOGREL recurrent myocardial infarction,","In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 11:55:54,1642608389,5/24/2015 11:55:28,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"recurrent myocardial INFARCTION,",177-187-198,80,CLOPIDOGREL,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 11:59:02,1642608799,5/24/2015 11:58:45,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"myocardial INFARCTION,",187-198,80,CLOPIDOGREL,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 12:20:56,1642612474,5/24/2015 12:20:38,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"myocardial INFARCTION,",187-198,80,CLOPIDOGREL,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 12:21:47,1642612643,5/24/2015 12:21:19,false,clixsense,1,31482589,NLD,,,31.201.11.16,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"recurrent myocardial INFARCTION,",177-187-198,80,CLOPIDOGREL,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 12:34:29,1642614726,5/24/2015 12:33:36,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"In patients with ST elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial INFARCTION, and stroke.",0-3-12-17-20-30-41-52-60-65-80-92-105-112-125-134-147-170-177-187-198-210-214-155,0-3-12-17-20-30-41-52-60-65-80-92-105-112-125-134-147-155-170-177-187-198-210-214,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.","In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 12:38:15,1642615529,5/24/2015 12:38:01,false,elite,1,31913360,GBR,,,5.152.201.148,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"death, recurrent myocardial INFARCTION, and stroke.",170-177-187-198-210-214,52-60-65-80-92-105-112,"treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous","In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 12:55:32,1642618621,5/24/2015 12:55:21,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"INFARCTION,",198,80,CLOPIDOGREL,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343076,5/24/2015 12:56:02,1642618771,5/24/2015 12:55:24,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,198,80,,,208,91,INFARCTION,CLOPIDOGREL,"fibrinolytics, clopidogrel percutaneous coronary death, myocardial INFARCTION, and stroke.",65-80-112-170-187-198-210-214-125,30-52-60-65-80-92-105-112-125-187-198-155,"myocardial treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary cardiovascular myocardial infarction,","In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke.",198,80,198,80,-1,208,91,TWrex-cause,800294,"In patients with ST-elevation myocardial infarction treated with fibrinolytics, clopidogrel pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent myocardial infarction, and stroke",infarction,clopidogrel
725343077,5/24/2015 14:39:03,1642638327,5/24/2015 14:38:52,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,54,0,,,60,9,SEPSIS,CEFOTETAN,Cefotetan treatment serious intra abdominal SEPSIS: a controlled clinical,17-30-38-44-54-62-64-75-0,0-10-13-17-30-38-44-54,CEFOTETAN in the treatment serious intra abdominal sepsis:,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 14:46:09,1642640010,5/24/2015 14:45:48,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,54,0,,,60,9,SEPSIS,CEFOTETAN,intra abdominal SEPSIS:,38-44-54,0,CEFOTETAN,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 14:53:25,1642641578,5/24/2015 14:52:54,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,54,0,,,60,9,SEPSIS,CEFOTETAN,serious intra abdominal SEPSIS:,30-38-44-54,0,CEFOTETAN,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 15:04:37,1642643850,5/24/2015 15:04:01,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,54,0,,,60,9,SEPSIS,CEFOTETAN,intra abdominal SEPSIS:,38-44-54,0,CEFOTETAN,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 15:21:38,1642647259,5/24/2015 15:21:19,false,neodev,1,32087449,USA,DE,,108.59.10.153,54,0,,,60,9,SEPSIS,CEFOTETAN,intra abdominal SEPSIS:,38-44-54,0,CEFOTETAN,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 15:26:31,1642648354,5/24/2015 15:25:58,false,points4rewards,1,28703583,USA,,,97.73.85.209,54,0,,,60,9,SEPSIS,CEFOTETAN,serious intra abdominal SEPSIS:,38-44-54-30,0-30-38-44-54,CEFOTETAN serious intra abdominal sepsis:,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 15:27:00,1642648468,5/24/2015 15:26:45,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,54,0,,,60,9,SEPSIS,CEFOTETAN,serious intra abdominal SEPSIS:,30-38-44-54,0,CEFOTETAN,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 15:33:33,1642649819,5/24/2015 15:32:33,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,54,0,,,60,9,SEPSIS,CEFOTETAN,intra abdominal SEPSIS:,38-44-54,0,CEFOTETAN,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 15:48:13,1642653647,5/24/2015 15:47:59,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,54,0,,,60,9,SEPSIS,CEFOTETAN,intra abdominal SEPSIS:,38-44-54,0,CEFOTETAN,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343077,5/24/2015 15:49:08,1642653855,5/24/2015 15:48:57,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,54,0,,,60,9,SEPSIS,CEFOTETAN,intra abdominal SEPSIS:,38-44-54,0,CEFOTETAN,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.,54,0,54,0,-1,60,9,TWrex-cause,800991,Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial,sepsis,cefotetan
725343078,5/24/2015 14:33:55,1642637017,5/24/2015 14:33:26,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,recurrent BLISTERING,117-107,27-37-48-62,Recessive DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 14:36:16,1642637623,5/24/2015 14:35:57,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,"disease with recurrent BLISTERING and scarring, particularly on the hands and feet",94-102-107-117-128-132-142-155-162-168-172-158,4-18-27-37-48-62-70-73-75-86-94-107-117,Epidermolysis Bullosa Recessive DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease recurrent blistering,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 14:42:11,1642639114,5/24/2015 14:41:46,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,BLISTERING,117,4-18-37-48-62-27,Epidermolysis Bullosa Recessive DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 14:47:26,1642640258,5/24/2015 14:45:52,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,recurrent BLISTERING,107-117,37-48-62-27,Recessive DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 14:51:46,1642641228,5/24/2015 14:51:32,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,BLISTERING,117,27-37-48-62,Recessive DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 14:54:15,1642641710,5/24/2015 14:53:23,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,recurrent BLISTERING,117-107,37-48-62,DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 15:18:30,1642646593,5/24/2015 15:18:11,false,neodev,1,32087449,USA,DE,,108.59.10.153,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,BLISTERING,117,37-48-62,DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 15:18:38,1642646612,5/24/2015 15:17:17,false,points4rewards,1,28703583,USA,,,97.73.85.209,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,Recessive dystrophic epidermolysis bullosa BLISTERING,27-37-48-62-117,27-37-48-62,Recessive DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 15:24:23,1642647892,5/24/2015 15:24:05,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,recurrent BLISTERING,107-117,4-18-27-37-48-62,Epidermolysis Bullosa Recessive DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343078,5/24/2015 15:30:10,1642649032,5/24/2015 15:29:51,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,117,37,,,127,69,BLISTERING,DYSTROPHIC EPIDERMOLYSIS BULLOSA,"BLISTERING and scarring,",117-128-132,37-48-62,DYSTROPHIC EPIDERMOLYSIS BULLOSA,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",117,37 48 62,117,37,1,127,69,TWrex-cause,814860,"33  Epidermolysis Bullosa  Recessive dystrophic epidermolysis bullosa is a congenital bullous disease with recurrent blistering and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases",blistering,dystrophic epidermolysis bullosa
725343079,5/24/2015 14:50:55,1642641053,5/24/2015 14:50:17,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,135-142,191,WARFARIN,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 15:30:25,1642649086,5/24/2015 15:30:03,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION Cerebrovascular,135-142-155,180-191-201-205-213,Hemorrhage WARFARIN ACP Journal Club.,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 15:35:14,1642650247,5/24/2015 15:34:18,false,points4rewards,1,28703583,USA,,,97.73.85.209,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage,135-142-155-171-180,135-142-155-171-180-191,Atrial fibrillation Cerebrovascular accident Hemorrhage WARFARIN,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 15:51:26,1642654355,5/24/2015 15:51:10,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,135-142,191,WARFARIN,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 15:54:06,1642654807,5/24/2015 15:53:36,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,135-142,191,WARFARIN,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 16:22:10,1642660633,5/24/2015 16:21:53,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,135-142,191,WARFARIN,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 16:35:02,1642663500,5/24/2015 16:34:44,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,135-142,191,WARFARIN,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 17:00:52,1642670386,5/24/2015 17:00:05,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,Warfarin stroke nonrheumatic atrial fibrillation risk hemorrhage agents ATRIAL FIBRILLATION Cerebrovascular Hemorrhage Warfarin ACP,8-26-36-49-56-86-95-117-135-142-155-180-191-201,8-26-36-49-56-86-95-117-135-142-155-180-191-201,Warfarin stroke nonrheumatic atrial fibrillation risk hemorrhage agents Atrial fibrillation Cerebrovascular Hemorrhage WARFARIN ACP,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 17:01:30,1642670623,5/24/2015 16:58:34,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,135-142,191,WARFARIN,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343079,5/24/2015 17:03:20,1642671374,5/24/2015 17:02:38,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,135,191,,,154,199,ATRIAL FIBRILLATION,WARFARIN,a higher risk for hemorrhage than other agents Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage Warfarin ACP Journal Club.,77-79-86-91-95-106-111-117-125-135-142-155-171-180-191-201-205-213,135-142-155-171-180-191-201-205-213,Atrial fibrillation Cerebrovascular accident Hemorrhage WARFARIN ACP Journal Club.,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club.,135 142,191,135,191,-1,154,199,TWrex-cause,805034,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: Atrial fibrillation Cerebrovascular accident Hemorrhage Warfarin  ACP Journal Club,atrial fibrillation,warfarin
725343080,5/24/2015 15:31:33,1642649372,5/24/2015 15:31:22,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,47,92,,,58,102,EYE DISEASE,PREDNISONE,"EYE DISEASE,",47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 15:53:41,1642654742,5/24/2015 15:53:25,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,47,92,,,58,102,EYE DISEASE,PREDNISONE,"EYE DISEASE,",47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 15:56:01,1642655277,5/24/2015 15:55:42,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,47,92,,,58,102,EYE DISEASE,PREDNISONE,"EYE DISEASE,",47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 16:23:39,1642660901,5/24/2015 16:23:24,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,47,92,,,58,102,EYE DISEASE,PREDNISONE,"EYE DISEASE,",47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 16:37:17,1642663847,5/24/2015 16:37:01,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,47,92,,,58,102,EYE DISEASE,PREDNISONE,"EYE DISEASE,",47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 17:05:35,1642672116,5/24/2015 17:05:10,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,47,92,,,58,102,EYE DISEASE,PREDNISONE,"clinically important EYE DISEASE,",26-37-47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 17:08:00,1642672963,5/24/2015 17:07:17,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,47,92,,,58,102,EYE DISEASE,PREDNISONE,"in patients with clinically important EYE DISEASE, especially those with diplopia,",9-12-21-26-37-47-51-60-71-77-82,92-103-112-122-125-129-136-139-152-163-172-175,PREDNISONE prevents worsening in one fourth of patients alleviates symptoms in most.,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 17:10:57,1642673980,5/24/2015 17:10:46,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,47,92,,,58,102,EYE DISEASE,PREDNISONE,"EYE DISEASE,",47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 17:12:33,1642674511,5/24/2015 17:12:15,false,clixsense,1,29752264,CAN,ON,Bourget,74.56.122.95,47,92,,,58,102,EYE DISEASE,PREDNISONE,"EYE DISEASE,",47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343080,5/24/2015 17:13:43,1642674868,5/24/2015 17:13:29,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,47,92,,,58,102,EYE DISEASE,PREDNISONE,"EYE DISEASE,",47-51,92,PREDNISONE,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most.",47 51,92,47,92,-1,58,102,TWrex-cause,804893,"However, in patients with clinically important eye disease, especially those with diplopia, prednisone prevents worsening in one fourth of patients and alleviates symptoms in most",eye disease,prednisone
725343081,5/24/2015 11:33:00,1642604781,5/24/2015 11:32:44,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,33,0,,,37,10,PAIN,GABAPENTIN,acute and chronic PAIN.,15-25-33-21,0,GABAPENTIN,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 11:34:32,1642604951,5/24/2015 11:34:21,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,33,0,,,37,10,PAIN,GABAPENTIN,Gabapentin PAIN.,33-0,0-25-33,GABAPENTIN chronic pain.,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 11:48:29,1642607126,5/24/2015 11:46:40,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,33,0,,,37,10,PAIN,GABAPENTIN,chronic PAIN.,25-33,0,GABAPENTIN,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 11:54:24,1642608132,5/24/2015 11:54:10,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,33,0,,,37,10,PAIN,GABAPENTIN,PAIN.,33,0,GABAPENTIN,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 11:56:27,1642608454,5/24/2015 11:56:18,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,33,0,,,37,10,PAIN,GABAPENTIN,PAIN.,33,0,GABAPENTIN,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 12:08:38,1642610527,5/24/2015 12:08:22,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,33,0,,,37,10,PAIN,GABAPENTIN,acute and chronic PAIN.,15-21-25-33,0,GABAPENTIN,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 12:12:47,1642611197,5/24/2015 12:12:10,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,33,0,,,37,10,PAIN,GABAPENTIN,Gabapentin for PAIN.,0-33-11,0-33-11,GABAPENTIN for pain.,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 12:16:49,1642611808,5/24/2015 12:16:32,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,33,0,,,37,10,PAIN,GABAPENTIN,acute and chronic PAIN.,15-21-25-33,0,GABAPENTIN,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 12:17:40,1642611991,5/24/2015 12:16:28,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,33,0,,,37,10,PAIN,GABAPENTIN,Gabapentin for acute and chronic PAIN.,0-15-21-25-33-11,0-11-15-21-25-33,GABAPENTIN for acute and chronic pain.,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343081,5/24/2015 12:17:50,1642612000,5/24/2015 12:17:33,false,clixsense,1,31482589,NLD,,,31.201.11.16,33,0,,,37,10,PAIN,GABAPENTIN,acute and chronic PAIN.,15-21-25-33,0,GABAPENTIN,Gabapentin for acute and chronic pain.,33,0,33,0,-1,37,10,TWrex-cause,804161,Gabapentin for acute and chronic pain,pain,gabapentin
725343082,5/24/2015 14:48:20,1642640411,5/24/2015 14:48:03,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 14:56:33,1642642174,5/24/2015 14:56:11,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 15:11:18,1642645186,5/24/2015 15:10:07,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 15:28:52,1642648741,5/24/2015 15:28:42,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 15:30:27,1642649098,5/24/2015 15:29:42,false,points4rewards,1,28703583,USA,,,97.73.85.209,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69-95-99,MAGNESIUM SULPHATE pre eclampsia.,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 15:34:49,1642650144,5/24/2015 15:34:36,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 15:49:48,1642653984,5/24/2015 15:49:36,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 15:50:51,1642654255,5/24/2015 15:50:10,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 16:19:49,1642659975,5/24/2015 16:19:37,false,elite,1,32610458,CAN,ON,Thunder Bay,216.26.216.62,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343082,5/24/2015 16:20:33,1642660211,5/24/2015 16:20:20,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,95,59,,,108,77,PRE-ECLAMPSIA,MAGNESIUM SULPHATE,PRE ECLAMPSIA.,95-99,59-69,MAGNESIUM SULPHATE,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.,95 99,59 69,95,59,-1,108,77,TWrex-cause,804675,2007-03-11  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia,pre-eclampsia,magnesium sulphate
725343083,5/24/2015 14:19:54,1642634236,5/24/2015 14:19:20,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,88,29,,,98,31,SPASTICITY,MS,SPASTICITY and increased reflexes.,88-99-103-113,4-13-24-29-32-35-38-42-48-54-61,weakness associated with MS is of the upper motor neuron type,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 14:31:31,1642636515,5/24/2015 14:31:13,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,88,29,,,98,31,SPASTICITY,MS,SPASTICITY,88,29,MS,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 14:33:31,1642636915,5/24/2015 14:33:17,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,88,29,,,98,31,SPASTICITY,MS,motor neuron type is accompanied by SPASTICITY and increased reflexes.,48-54-70-73-85-88-99-103-113-61,4-13-24-29-32-35-38-42-48-54-61-103-113-88,weakness associated with MS is of the upper motor neuron type spasticity increased reflexes.,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 14:36:39,1642637687,5/24/2015 14:36:18,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,88,29,,,98,31,SPASTICITY,MS,accompanied by SPASTICITY and increased reflexes.,73-85-88-99-103-113,4-13-24-29,weakness associated with MS,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 14:39:16,1642638447,5/24/2015 14:38:56,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,88,29,,,98,31,SPASTICITY,MS,SPASTICITY,88,29,MS,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 14:40:42,1642638777,5/24/2015 14:40:08,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,88,29,,,98,31,SPASTICITY,MS,SPASTICITY,88,29,MS,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 14:41:24,1642638960,5/24/2015 14:40:13,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,88,29,,,98,31,SPASTICITY,MS,SPASTICITY,88,29,MS,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 14:45:11,1642639858,5/24/2015 14:44:08,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,88,29,,,98,31,SPASTICITY,MS,SPASTICITY,88,29,MS,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 14:50:17,1642640895,5/24/2015 14:50:04,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,88,29,,,98,31,SPASTICITY,MS,SPASTICITY,88,29,MS,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343083,5/24/2015 15:13:23,1642645538,5/24/2015 15:12:47,false,points4rewards,1,28703583,USA,,,97.73.85.209,88,29,,,98,31,SPASTICITY,MS,MS SPASTICITY,29-88,29-88,MS spasticity,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes.,88,29,88,29,1,98,31,TWrex-cause,814039,The weakness associated with MS is of the upper motor neuron type and is accompanied by spasticity and increased reflexes,spasticity,MS
725343084,5/24/2015 11:33:55,1642604870,5/24/2015 11:33:15,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,294,253,,,300,262,KIDNEY,DYSPLASIA,Autosomal recessive polycystic KIDNEY disease,263-273-283-294-301,225-235-247-253,segmental multicystic renal DYSPLASIA,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 11:35:19,1642605023,5/24/2015 11:34:52,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,294,253,,,300,262,KIDNEY,DYSPLASIA,ADPKD KIDNEY,294-131,253-131,ADPKD DYSPLASIA,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 11:49:51,1642607332,5/24/2015 11:49:21,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,294,253,,,300,262,KIDNEY,DYSPLASIA,Autosomal recessive polycystic KIDNEY disease,263-273-283-294-301,225-235-247-253,segmental multicystic renal DYSPLASIA,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 11:55:10,1642608331,5/24/2015 11:54:45,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,294,253,,,300,262,KIDNEY,DYSPLASIA,Autosomal recessive polycystic KIDNEY disease dilatation,263-273-283-294-301-319,225-235-247-253,segmental multicystic renal DYSPLASIA,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 12:10:01,1642610759,5/24/2015 12:09:09,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,294,253,,,300,262,KIDNEY,DYSPLASIA,Autosomal recessive polycystic KIDNEY disease,263-273-283-294-301,225-235-247-253,segmental multicystic renal DYSPLASIA,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 12:13:49,1642611349,5/24/2015 12:13:19,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,294,253,,,300,262,KIDNEY,DYSPLASIA,renal dysplasia KIDNEY disease,253-294-301-247,253-294-301-247,renal DYSPLASIA kidney disease,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 12:17:36,1642611973,5/24/2015 12:17:05,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,294,253,,,300,262,KIDNEY,DYSPLASIA,Autosomal recessive polycystic KIDNEY disease,263-273-283-294-301,225-235-247-253-263-273-283,segmental multicystic renal DYSPLASIA Autosomal recessive polycystic,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 12:18:40,1642612171,5/24/2015 12:18:12,false,clixsense,1,31482589,NLD,,,31.201.11.16,294,253,,,300,262,KIDNEY,DYSPLASIA,Autosomal recessive polycystic KIDNEY disease,263-273-283-294-301,225-235-247-253,segmental multicystic renal DYSPLASIA,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 12:20:06,1642612339,5/24/2015 12:18:17,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,294,253,,,300,262,KIDNEY,DYSPLASIA,"Can be asymptomatic or rarely cause pain Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic KIDNEY disease Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",0-4-7-20-23-30-36-42-49-52-67-70-74-87-98-103-114-128-131-137-141-147-156-162-175-182-192-199-205-210-221-225-235-247-253-263-273-283-294-301-310-319-330-333-344-350-355-362-368-380-383,0-4-7-20-23-30-36-42-49-52-67-70-74-87-98-103-114-128-131-137-141-147-156-162-175-182-192-199-205-210-221-225-235-247-253-263-273-283-294-301-310-319-330-333-344-350-355-362-368-383-380,"Can be asymptomatic or rarely cause pain Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal DYSPLASIA Autosomal recessive polycystic kidney disease Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.","Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343084,5/24/2015 12:24:12,1642613088,5/24/2015 12:23:29,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,294,253,,,300,262,KIDNEY,DYSPLASIA,Autosomal recessive polycystic KIDNEY disease,263-273-283-294-301,225-235-247-253,segmental multicystic renal DYSPLASIA,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",294,253,294,253,-1,300,262,TWrex-cause,802183,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and segmental multicystic renal dysplasia Autosomal recessive polycystic kidney disease  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy",kidney,dysplasia
725343085,5/24/2015 11:36:57,1642605225,5/24/2015 11:36:40,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,90,42,,,100,49,INFARCTION,ASPIRIN,myocardial INFARCTION,79-90,42,ASPIRIN,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 11:38:26,1642605492,5/24/2015 11:38:06,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,90,42,,,100,49,INFARCTION,ASPIRIN,fibrinolytic therapy INFARCTION,54-90-67,42-79-90,ASPIRIN myocardial infarction,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 11:55:03,1642608281,5/24/2015 11:54:27,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,90,42,,,100,49,INFARCTION,ASPIRIN,myocardial INFARCTION,79-90,42,ASPIRIN,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 11:58:26,1642608723,5/24/2015 11:58:07,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,90,42,,,100,49,INFARCTION,ASPIRIN,myocardial INFARCTION,79-90,42,ASPIRIN,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 12:12:12,1642611125,5/24/2015 12:12:05,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,90,42,,,100,49,INFARCTION,ASPIRIN,therapy for myocardial INFARCTION with ST segment,67-75-79-90-101-106-109,24-27-39-42-50-54-67,of clopidogrel to ASPIRIN and fibrinolytic therapy,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 12:20:21,1642612395,5/24/2015 12:20:04,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,90,42,,,100,49,INFARCTION,ASPIRIN,myocardial INFARCTION,79-90,42,ASPIRIN,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 12:21:02,1642612516,5/24/2015 12:20:39,false,clixsense,1,31482589,NLD,,,31.201.11.16,90,42,,,100,49,INFARCTION,ASPIRIN,myocardial INFARCTION,79-90,42,ASPIRIN,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 12:26:24,1642613393,5/24/2015 12:26:15,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,90,42,,,100,49,INFARCTION,ASPIRIN,fibrinolytic therapy for myocardial INFARCTION with ST segment,67-75-79-90-101-106-109-54,24-27-39-42-50-54-67-79-90,of clopidogrel to ASPIRIN and fibrinolytic therapy myocardial infarction,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 12:27:57,1642613677,5/24/2015 12:27:31,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,90,42,,,100,49,INFARCTION,ASPIRIN,myocardial INFARCTION,79-90,42,ASPIRIN,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343085,5/24/2015 12:32:47,1642614433,5/24/2015 12:30:53,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,90,42,,,100,49,INFARCTION,ASPIRIN,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial INFARCTION with ST segment elevation.,15-24-27-39-42-50-54-67-75-79-90-101-106-109-117,15-24-27-39-42-50-54-67-75-79-90-101-106-109-117,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for myocardial infarction with ST segment elevation.,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,90,42,90,42,-1,100,49,TWrex-cause,804205,2005-03-24     Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation,infarction,aspirin
725343086,5/24/2015 15:31:07,1642649233,5/24/2015 15:30:52,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,97,70,,,102,81,SHOCK,HYPOVOLEMIA,hypovolemia or hemorrhagic SHOCK,70-82-85-97,70-85-97-82,HYPOVOLEMIA or hemorrhagic shock,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 15:52:25,1642654558,5/24/2015 15:52:05,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,97,70,,,102,81,SHOCK,HYPOVOLEMIA,hemorrhagic SHOCK,85-97,70,HYPOVOLEMIA,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 15:54:48,1642654920,5/24/2015 15:54:35,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,97,70,,,102,81,SHOCK,HYPOVOLEMIA,SHOCK,97,70,HYPOVOLEMIA,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 16:23:03,1642660786,5/24/2015 16:22:47,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,97,70,,,102,81,SHOCK,HYPOVOLEMIA,hemorrhagic SHOCK,85-97,70,HYPOVOLEMIA,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 16:36:02,1642663666,5/24/2015 16:35:49,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,97,70,,,102,81,SHOCK,HYPOVOLEMIA,hypovolemia or hemorrhagic SHOCK,70-82-85-97,70-82-85-97,HYPOVOLEMIA or hemorrhagic shock,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 17:04:19,1642671688,5/24/2015 17:02:41,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,97,70,,,102,81,SHOCK,HYPOVOLEMIA,hemorrhagic SHOCK,85-97,70,HYPOVOLEMIA,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 17:06:38,1642672499,5/24/2015 17:05:17,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,97,70,,,102,81,SHOCK,HYPOVOLEMIA,any patient with hypovolemia or hemorrhagic SHOCK (see Intravenous Fluid Resuscitation,53-57-65-70-82-85-97-103-109-121-127,0-6-22-25-32-36-46-53-57-65-70-82-85-97-163-169-176-183-49,Fluid resuscitation: IV fluids are initiated as for any patient with HYPOVOLEMIA or hemorrhagic shock given normal saline IV,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 17:10:23,1642673785,5/24/2015 17:10:13,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,97,70,,,102,81,SHOCK,HYPOVOLEMIA,hemorrhagic SHOCK,85-97,70,HYPOVOLEMIA,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 17:12:00,1642674313,5/24/2015 17:11:25,false,clixsense,1,29752264,CAN,ON,Bourget,74.56.122.95,97,70,,,102,81,SHOCK,HYPOVOLEMIA,hypovolemia or hemorrhagic SHOCK,70-82-85-97,70,HYPOVOLEMIA,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343086,5/24/2015 17:13:13,1642674719,5/24/2015 17:12:49,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,97,70,,,102,81,SHOCK,HYPOVOLEMIA,hemorrhagic SHOCK,85-97,70,HYPOVOLEMIA,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",97,70,97,70,1,102,81,TWrex-cause,812361,"Fluid resuscitation:  IV fluids are initiated as for any patient with hypovolemia or hemorrhagic shock (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500- to 1000-mL aliquots until signs of hypovolemia remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once",shock,hypovolemia
725343087,5/24/2015 14:34:32,1642637241,5/24/2015 14:34:16,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,confirmation of PREGNANCY.,239-252-255,171,BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 14:37:02,1642637769,5/24/2015 14:36:36,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,missed menses subsequent confirmation of PREGNANCY.,210-217-228-252-255-239,154-159-162-171-185-188-192-210-217-228-239-255,then to withdraw BROMOCRIPTINE at the time missed menses subsequent confirmation pregnancy.,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 14:43:12,1642639481,5/24/2015 14:42:46,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,PREGNANCY.,255,171,BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 14:48:17,1642640389,5/24/2015 14:47:52,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,PREGNANCY.,255,171,BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 14:52:19,1642641343,5/24/2015 14:52:08,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,PREGNANCY.,255,171,BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 14:57:12,1642642295,5/24/2015 14:55:53,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,PREGNANCY.,255,171,BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 15:19:13,1642646732,5/24/2015 15:18:53,false,neodev,1,32087449,USA,DE,,108.59.10.153,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,PREGNANCY.,255,171,BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 15:20:08,1642646910,5/24/2015 15:19:28,false,points4rewards,1,28703583,USA,,,97.73.85.209,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,prolactin secreting microadenomas PREGNANCY.,49-59-255-69,49-59-171-69,prolactin secreting microadenomas BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 15:24:54,1642648053,5/24/2015 15:24:42,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,PREGNANCY.,255,171,BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343087,5/24/2015 15:30:57,1642649210,5/24/2015 15:30:40,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,255,171,,,264,184,PREGNANCY,BROMOCRIPTINE,PREGNANCY.,255,171,BROMOCRIPTINE,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy.",255,171,255,171,-1,264,184,TWrex-cause,803131,"B]  Specific recommendation: • Advise women with prolactin-secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw bromocriptine at the time of the first missed menses and subsequent confirmation of pregnancy",pregnancy,bromocriptine
725343088,5/24/2015 11:29:54,1642604285,5/24/2015 11:29:39,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,183,137,,,191,144,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,173-183,110-122-137,intravenous unfractionated HEPARIN,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 11:31:43,1642604488,5/24/2015 11:31:08,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,183,137,,,191,144,EMBOLISM,HEPARIN,intravenous unfractionated heparin treatment EMBOLISM.,122-137-160-183-110,137-173-183,HEPARIN pulmonary embolism.,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 11:35:09,1642605013,5/24/2015 11:35:00,false,elite,1,26544151,GBR,,,213.205.252.203,183,137,,,191,144,EMBOLISM,HEPARIN,EMBOLISM.,183,137,HEPARIN,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 11:41:02,1642605961,5/24/2015 11:40:16,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,183,137,,,191,144,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,173-183,110-122-137,intravenous unfractionated HEPARIN,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 11:42:26,1642606120,5/24/2015 11:42:15,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,183,137,,,191,144,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,173-183,110-122-137,intravenous unfractionated HEPARIN,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 11:51:36,1642607575,5/24/2015 11:51:20,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,183,137,,,191,144,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,173-183,122-137,unfractionated HEPARIN,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 11:54:32,1642608152,5/24/2015 11:54:18,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,183,137,,,191,144,EMBOLISM,HEPARIN,EMBOLISM.,183,137,HEPARIN,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 12:06:13,1642610008,5/24/2015 12:06:01,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,183,137,,,191,144,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,173-183,110-122-137,intravenous unfractionated HEPARIN,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 12:09:03,1642610615,5/24/2015 12:08:52,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,183,137,,,191,144,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,173-183,137-148,HEPARIN the,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343088,5/24/2015 12:09:29,1642610662,5/24/2015 12:08:49,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,183,137,,,191,144,EMBOLISM,HEPARIN,heparin pulmonary EMBOLISM.,173-183-137,137-173-183,HEPARIN pulmonary embolism.,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",183,137,183,137,-1,191,144,TWrex-cause,800998,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725343089,5/24/2015 14:14:13,1642633100,5/24/2015 14:13:44,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,103,167,,,113,178,INFECTION,GONORRHOEA,disseminated gonococcal INFECTIONS,79-92-103,136-153-164-167-124,susceptible nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:17:13,1642633753,5/24/2015 14:15:33,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,103,167,,,113,178,INFECTION,GONORRHOEA,gonococcal INFECTIONS,92-103,167,GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:17:37,1642633811,5/24/2015 14:17:19,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,103,167,,,113,178,INFECTION,GONORRHOEA,uncomplicated gonorrhea and disseminated gonococcal INFECTIONS,51-65-75-79-92-103,136-153-164-167-124,susceptible nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:28:37,1642635973,5/24/2015 14:28:18,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,103,167,,,113,178,INFECTION,GONORRHOEA,disseminated gonococcal INFECTIONS,79-92-103,136-153-164-167,nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:30:41,1642636356,5/24/2015 14:29:56,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,103,167,,,113,178,INFECTION,GONORRHOEA,disseminated gonococcal INFECTIONS,79-92-103,136-164-167-153,nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:30:48,1642636376,5/24/2015 14:30:25,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,103,167,,,113,178,INFECTION,GONORRHOEA,disseminated gonococcal INFECTIONS caused by susceptible nonpenicillinase producing N. gonorrhoeae.,79-92-103-114-121-124-136-153-164-167,136-153-164-167-124,susceptible nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:33:04,1642636836,5/24/2015 14:32:41,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,103,167,,,113,178,INFECTION,GONORRHOEA,disseminated gonococcal INFECTIONS caused by susceptible,79-92-103-114-121-124,136-153-164-167,nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:35:19,1642637391,5/24/2015 14:33:36,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,103,167,,,113,178,INFECTION,GONORRHOEA,disseminated gonococcal INFECTIONS,79-92-103,136-153-164-167,nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:36:09,1642637621,5/24/2015 14:35:56,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,103,167,,,113,178,INFECTION,GONORRHOEA,gonococcal INFECTIONS,92-103,136-153-164-167,nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343089,5/24/2015 14:36:34,1642637689,5/24/2015 14:36:25,false,neodev,1,32562748,CAN,BC,Vancouver,108.180.140.140,103,167,,,113,178,INFECTION,GONORRHOEA,disseminated gonococcal INFECTIONS,79-92-103,136-153-164-167,nonpenicillinase producing N. GONORRHOEAE.,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae.",103,167,103,167,1,113,178,TWrex-cause,811255,"7 ,   14 ,   15   Previously used for treatment of uncomplicated gonorrhea and disseminated gonococcal infections caused by susceptible nonpenicillinase-producing  N. gonorrhoeae",infection,gonorrhoea
725343090,5/24/2015 14:14:44,1642633200,5/24/2015 14:14:14,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,chronic intestinal schistosomiasis VISCERAL LEISHMANIASIS,161-169-180-196-205,230-241-251,LEISHMANIA parasites transmitted,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:17:53,1642633853,5/24/2015 14:17:38,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,chronic intestinal schistosomiasis VISCERAL LEISHMANIASIS Caused by Leishmania parasites,161-169-180-196-205-220-227-230-241,205-220-227-230-241-251-263-266-271-275,leishmaniasis Caused by LEISHMANIA parasites transmitted by sand fly bites.,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:18:19,1642633909,5/24/2015 14:17:16,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,chronic intestinal schistosomiasis VISCERAL LEISHMANIASIS,161-169-180-196-205,230-241,LEISHMANIA parasites,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:29:44,1642636173,5/24/2015 14:29:17,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,VISCERAL LEISHMANIASIS,196-205,230-241,LEISHMANIA parasites,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:31:25,1642636504,5/24/2015 14:30:42,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,VISCERAL LEISHMANIASIS,196-205,230-241,LEISHMANIA parasites,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:31:43,1642636539,5/24/2015 14:30:49,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,chronic intestinal schistosomiasis VISCERAL LEISHMANIASIS Caused by Leishmania parasites sand fly bites.,161-169-180-196-205-220-227-230-241-266-275-271,205-220-227-230-241-251-263-266-275,leishmaniasis Caused by LEISHMANIA parasites transmitted by sand bites.,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:33:54,1642636999,5/24/2015 14:33:05,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,chronic intestinal schistosomiasis VISCERAL LEISHMANIASIS,161-169-180-196-205,205-220-227-230-241,leishmaniasis Caused by LEISHMANIA parasites,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:36:21,1642637632,5/24/2015 14:35:33,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,chronic intestinal schistosomiasis VISCERAL LEISHMANIASIS,161-169-180-196-205,230-241,LEISHMANIA parasites,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:36:31,1642637661,5/24/2015 14:36:11,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,chronic intestinal schistosomiasis VISCERAL LEISHMANIASIS,161-169-180-196-205,205-230,leishmaniasis LEISHMANIA,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343090,5/24/2015 14:38:45,1642638261,5/24/2015 14:37:21,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,196,230,,,218,240,VISCERAL LEISHMANIASIS,LEISHMANIA,VISCERAL LEISHMANIASIS,196-205,230-241,LEISHMANIA parasites,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites.",196 205,230,196,230,1,218,240,TWrex-cause,810929,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from chronic intestinal schistosomiasis Visceral leishmaniasis  Caused by Leishmania parasites transmitted by sand fly bites",visceral leishmaniasis,Leishmania
725343091,5/24/2015 14:49:14,1642640671,5/24/2015 14:48:47,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 14:58:07,1642642529,5/24/2015 14:57:25,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 15:29:22,1642648842,5/24/2015 15:29:08,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 15:32:12,1642649493,5/24/2015 15:31:14,false,points4rewards,1,28703583,USA,,,97.73.85.209,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70-190-198,ACYCLOVIR genital herpes,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 15:35:44,1642650379,5/24/2015 15:35:30,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 15:50:27,1642654127,5/24/2015 15:50:14,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 15:52:06,1642654492,5/24/2015 15:51:18,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 16:20:24,1642660177,5/24/2015 16:20:08,false,elite,1,32610458,CAN,ON,Thunder Bay,216.26.216.62,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 16:21:15,1642660402,5/24/2015 16:21:02,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343091,5/24/2015 16:33:46,1642663267,5/24/2015 16:32:30,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,190,70,,,204,79,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,190-198,70,ACYCLOVIR,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29.,190 198,70,190,70,-1,204,79,TWrex-cause,800603,• An analysis of five trials with a total of 799 patients showed that acyclovir begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for genital herpes ( 29,genital herpes,acyclovir
725343092,5/24/2015 14:48:02,1642640369,5/24/2015 14:47:39,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,10,33,,,16,44,TREMOR,PROPRANOLOL,TREMOR:,10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 14:56:07,1642642122,5/24/2015 14:55:39,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,10,33,,,16,44,TREMOR,PROPRANOLOL,Essential TREMOR:,0-10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 15:10:06,1642644984,5/24/2015 15:08:53,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,10,33,,,16,44,TREMOR,PROPRANOLOL,Essential TREMOR:,0-10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 15:28:40,1642648715,5/24/2015 15:28:30,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,10,33,,,16,44,TREMOR,PROPRANOLOL,Essential TREMOR:,0-10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 15:29:36,1642648908,5/24/2015 15:29:20,false,points4rewards,1,28703583,USA,,,97.73.85.209,10,33,,,16,44,TREMOR,PROPRANOLOL,Essential TREMOR:,0-10,0-10-33,Essential tremor: PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 15:34:35,1642650093,5/24/2015 15:34:22,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,10,33,,,16,44,TREMOR,PROPRANOLOL,TREMOR:,10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 15:49:34,1642653954,5/24/2015 15:49:23,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,10,33,,,16,44,TREMOR,PROPRANOLOL,Essential TREMOR:,0-10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 15:50:09,1642654042,5/24/2015 15:49:59,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,10,33,,,16,44,TREMOR,PROPRANOLOL,TREMOR:,10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 16:06:34,1642657479,5/24/2015 16:06:25,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,10,33,,,16,44,TREMOR,PROPRANOLOL,Essential TREMOR:,0-10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343092,5/24/2015 16:19:36,1642659910,5/24/2015 16:19:24,false,elite,1,32610458,CAN,ON,Thunder Bay,216.26.216.62,10,33,,,16,44,TREMOR,PROPRANOLOL,Essential TREMOR:,0-10,33,PROPRANOLOL.,Essential tremor: treatment with propranolol.,10,33,10,33,-1,16,44,TWrex-cause,800913,Essential tremor: treatment with propranolol,tremor,propranolol
725343093,5/24/2015 15:30:37,1642649130,5/24/2015 15:30:27,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,73,98,,,77,113,BONE,PAGET'S DISEASE,metabolic BONE disease,63-73-78,98-106,PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 15:35:50,1642650396,5/24/2015 15:35:20,false,points4rewards,1,28703583,USA,,,97.73.85.209,73,98,,,77,113,BONE,PAGET'S DISEASE,Paget's disease BONE,0-8-73,98-106,PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 15:51:41,1642654409,5/24/2015 15:51:27,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,73,98,,,77,113,BONE,PAGET'S DISEASE,BONE,73,98-106,PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 15:54:20,1642654862,5/24/2015 15:54:09,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,73,98,,,77,113,BONE,PAGET'S DISEASE,metabolic BONE disease,63-73-78,98-106,PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 16:22:30,1642660670,5/24/2015 16:22:11,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,73,98,,,77,113,BONE,PAGET'S DISEASE,metabolic BONE disease,63-73-78,98-106,PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 16:35:16,1642663523,5/24/2015 16:35:03,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,73,98,,,77,113,BONE,PAGET'S DISEASE,metabolic BONE disease,63-73-78,98-106,PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 17:02:20,1642671005,5/24/2015 17:01:30,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,73,98,,,77,113,BONE,PAGET'S DISEASE,metabolic BONE disease,63-73-78,98-106,PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 17:04:17,1642671676,5/24/2015 17:03:21,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,73,98,,,77,113,BONE,PAGET'S DISEASE,the metabolic BONE disease also called Paget's disease.,59-63-73-78-86-91-98-106,0-8-38-42-45-54-59-63-73-86-91-98-106-78,Paget's disease not be confused with the metabolic bone disease also called PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 17:06:29,1642672436,5/24/2015 17:06:23,false,clixsense,1,22518719,GBR,J8,Nottingham,86.10.69.152,73,98,,,77,113,BONE,PAGET'S DISEASE,BONE,73,98-106,PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343093,5/24/2015 17:10:41,1642673912,5/24/2015 17:08:36,false,clixsense,1,29752264,CAN,ON,Bourget,74.56.122.95,73,98,,,77,113,BONE,PAGET'S DISEASE,metabolic BONE disease,63-73-78,98-106-73,bone PAGET'S DISEASE.,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease.,73,98 106,73,98,-1,77,113,TWrex-cause,802098,Paget's disease of the nipples should not be confused with the metabolic bone disease also called Paget's disease,bone,paget's disease
725343094,5/24/2015 11:31:54,1642604543,5/24/2015 11:31:24,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,TRAVELER'S DIARRHEA,21-32,70-86-87-99,ENTEROTOXIGENIC  ESCHERICHIA COLI,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 11:33:40,1642604853,5/24/2015 11:33:19,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,"TRAVELER'S DIARRHEA bacteria,",21-32-55,21-70-86-32,traveler's diarrhea ENTEROTOXIGENIC,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 11:43:43,1642606362,5/24/2015 11:43:20,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,TRAVELER'S DIARRHEA,21-32,70-86-99-87,ENTEROTOXIGENIC  ESCHERICHIA COLI,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 11:45:54,1642606638,5/24/2015 11:44:42,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,TRAVELER'S DIARRHEA,21-32,70-86-87-99,ENTEROTOXIGENIC  ESCHERICHIA COLI,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 11:53:28,1642607992,5/24/2015 11:53:03,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,TRAVELER'S DIARRHEA,21-32,70-86-99-87,ENTEROTOXIGENIC  ESCHERICHIA COLI,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 11:55:51,1642608386,5/24/2015 11:55:34,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,TRAVELER'S DIARRHEA,21-32,70-86-87-99,ENTEROTOXIGENIC  ESCHERICHIA COLI,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 12:07:52,1642610419,5/24/2015 12:07:34,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,TRAVELER'S DIARRHEA,21-32,70-86-87-99,ENTEROTOXIGENIC  ESCHERICHIA COLI,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 12:10:08,1642610765,5/24/2015 12:09:52,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,TRAVELER'S DIARRHEA,21-32,70-86-87-99,ENTEROTOXIGENIC  ESCHERICHIA COLI,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 12:11:24,1642610950,5/24/2015 12:10:28,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,TRAVELER'S DIARRHEA enterotoxigenic Escherichia coli,21-32-70-87-99,21-32-70-86-87-99,traveler's diarrhea ENTEROTOXIGENIC  ESCHERICHIA COLI,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343094,5/24/2015 12:12:24,1642611136,5/24/2015 12:11:59,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,21,70,,,40,103,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC ESCHERICHIA COLI,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with enterotoxigenic Escherichia coli being the most frequent cause.",0-5-9-12-18-21-32-41-45-52-55-65-70-87-99-105-111-115-120-129,0-5-9-12-18-21-32-41-45-52-55-65-70-86-87-99-105-111-115-120-129,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI being the most frequent cause.","Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause.",21 32,70 86,21,70,1,40,103,TWrex-cause,810012,"Over 75% of cases of traveler's diarrhea are caused by bacteria, with enterotoxigenic  Escherichia coli  being the most frequent cause",traveler's diarrhea,enterotoxigenic escherichia coli
725343095,5/24/2015 14:47:38,1642640292,5/24/2015 14:47:16,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0,LACTULOSE,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 14:55:36,1642641987,5/24/2015 14:55:16,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0,LACTULOSE,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 15:08:53,1642644775,5/24/2015 15:08:01,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0,LACTULOSE,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 15:22:23,1642647369,5/24/2015 15:22:14,false,neodev,1,32087449,USA,DE,,108.59.10.153,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,symptoms of hepatic ENCEPHALOPATHY in an RCT,18-27-30-38-53-56-59,0-10-18-27,LACTULOSE reduced symptoms of,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 15:28:28,1642648684,5/24/2015 15:28:16,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0,LACTULOSE,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 15:29:14,1642648796,5/24/2015 15:28:42,false,points4rewards,1,28703583,USA,,,97.73.85.209,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0-30-38,LACTULOSE hepatic encephalopathy,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 15:34:21,1642650043,5/24/2015 15:34:07,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0,LACTULOSE,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 15:49:23,1642653902,5/24/2015 15:49:12,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0,LACTULOSE,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 15:49:57,1642654017,5/24/2015 15:49:46,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0,LACTULOSE,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343095,5/24/2015 15:58:36,1642655782,5/24/2015 15:58:28,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,38,0,,,52,9,ENCEPHALOPATHY,LACTULOSE,hepatic ENCEPHALOPATHY,30-38,0,LACTULOSE,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties.,38,0,38,0,-1,52,9,TWrex-cause,804252,Lactulose reduced symptoms of hepatic encephalopathy in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b-blocker with a-1 blocking properties,encephalopathy,lactulose
725343096,5/24/2015 11:35:38,1642605095,5/24/2015 11:35:26,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,PSYCHOSIS.,157,0,MEFLOQUINE,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 11:36:56,1642605223,5/24/2015 11:36:42,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,Mefloquine PSYCHOSIS.,157-0,0-157,MEFLOQUINE psychosis.,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 11:52:41,1642607834,5/24/2015 11:52:05,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,PSYCHOSIS.,157,0,MEFLOQUINE,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 11:56:51,1642608494,5/24/2015 11:56:34,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,PSYCHOSIS.,157,0,MEFLOQUINE,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 12:11:10,1642610909,5/24/2015 12:10:57,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,PSYCHOSIS.,157,0,MEFLOQUINE,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 12:19:09,1642612190,5/24/2015 12:18:57,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,PSYCHOSIS.,157,0,MEFLOQUINE,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 12:19:52,1642612280,5/24/2015 12:19:40,false,clixsense,1,31482589,NLD,,,31.201.11.16,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,PSYCHOSIS.,157,0,MEFLOQUINE,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 12:24:21,1642613095,5/24/2015 12:23:38,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light - headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS.",0-11-18-23-32-42-50-61-70-75-76-87-98-101-104-114-117-135-143-153-157-131,0-11-18-23-32-42-50-61-70-75-76-87-98-101-104-114-117-131-135-143-153-157,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light - headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.","Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 12:24:58,1642613170,5/24/2015 12:24:47,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,"bad dreams, seizures, and PSYCHOSIS.",135-143-153-157-131,0-11-18-23-42-50-61-70-76,"MEFLOQUINE causes side effects, nausea, dizziness, vertigo, light headedness","Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343096,5/24/2015 12:26:05,1642613315,5/24/2015 12:25:39,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,157,0,,,166,10,PSYCHOSIS,MEFLOQUINE,PSYCHOSIS.,157,0,MEFLOQUINE,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis.",157,0,157,0,1,166,10,TWrex-cause,811256,"Mefloquine causes side effects, including nausea, dizziness, vertigo, light-headedness (described as an inability to concentrate), bad dreams, seizures, and psychosis",psychosis,mefloquine
725343097,5/24/2015 14:49:32,1642640757,5/24/2015 14:49:15,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,HYDROCEPHALUS,12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 14:59:08,1642642775,5/24/2015 14:58:09,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,Progressive HYDROCEPHALUS,0-12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 15:29:34,1642648906,5/24/2015 15:29:24,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,Progressive HYDROCEPHALUS,0-12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 15:32:43,1642649672,5/24/2015 15:32:18,false,points4rewards,1,28703583,USA,,,97.73.85.209,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,Progressive HYDROCEPHALUS porencephaly.,0-12-45,0-12-45,Progressive hydrocephalus PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 15:35:53,1642650408,5/24/2015 15:35:45,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,HYDROCEPHALUS,12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 15:50:39,1642654186,5/24/2015 15:50:29,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,HYDROCEPHALUS,12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 15:52:52,1642654635,5/24/2015 15:52:07,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,HYDROCEPHALUS,12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 16:20:34,1642660212,5/24/2015 16:20:25,false,elite,1,32610458,CAN,ON,Thunder Bay,216.26.216.62,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,Progressive HYDROCEPHALUS,0-12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 16:21:26,1642660455,5/24/2015 16:21:16,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,HYDROCEPHALUS,12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343097,5/24/2015 16:33:59,1642663314,5/24/2015 16:33:47,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,12,45,,,25,57,HYDROCEPHALUS,PORENCEPHALY,HYDROCEPHALUS,12,45,PORENCEPHALY.,Progressive hydrocephalus occurs rarely with porencephaly.,12,45,12,45,1,25,57,TWrex-cause,813879,Progressive hydrocephalus occurs rarely with porencephaly,hydrocephalus,porencephaly
725343098,5/24/2015 12:24:33,1642613126,5/24/2015 12:24:13,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,65,46,,,72,53,TOXEMIA,SULFATE,TOXEMIA,65,36-46,magnesium SULFATE,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 12:25:25,1642613231,5/24/2015 12:25:08,false,clixsense,1,31482589,NLD,,,31.201.11.16,65,46,,,72,53,TOXEMIA,SULFATE,TOXEMIA,65,36-46-54,magnesium SULFATE therapy,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 12:42:31,1642616291,5/24/2015 12:42:13,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,65,46,,,72,53,TOXEMIA,SULFATE,Potentiation of muscle relaxants by magnesium sulfate therapy in TOXEMIA of pregnancy.,0-13-16-23-33-46-54-62-65-73-76-36,0-13-16-23-33-36-46-54-62-65-73-76,Potentiation of muscle relaxants by magnesium SULFATE therapy in toxemia of pregnancy.,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 13:16:13,1642622611,5/24/2015 13:16:04,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,65,46,,,72,53,TOXEMIA,SULFATE,TOXEMIA,65,36-46,magnesium SULFATE,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 13:23:20,1642624082,5/24/2015 13:22:49,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,65,46,,,72,53,TOXEMIA,SULFATE,muscle relaxants therapy TOXEMIA pregnancy.,16-23-54-65-76,16-23-46-54-65-76,muscle relaxants SULFATE therapy toxemia pregnancy.,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 13:29:13,1642625078,5/24/2015 13:29:01,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.35,65,46,,,72,53,TOXEMIA,SULFATE,sulfate therapy in TOXEMIA,46-54-62-65,46-54-62-65,SULFATE therapy in toxemia,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 13:31:07,1642625398,5/24/2015 13:28:59,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,65,46,,,72,53,TOXEMIA,SULFATE,Potentiation muscle relaxants by magnesium TOXEMIA of pregnancy.,0-16-23-33-36-65-73-76,23-33-36-46-54-62-65,relaxants by magnesium SULFATE therapy in toxemia,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 13:33:33,1642625849,5/24/2015 13:33:21,false,clixsense,1,6340330,USA,NY,Canajoharie,67.248.115.74,65,46,,,72,53,TOXEMIA,SULFATE,TOXEMIA,65,46,SULFATE,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 13:33:55,1642625910,5/24/2015 13:33:35,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,65,46,,,72,53,TOXEMIA,SULFATE,TOXEMIA of pregnancy.,65-73-76,36-46-54,magnesium SULFATE therapy,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343098,5/24/2015 13:39:31,1642627001,5/24/2015 13:39:15,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,65,46,,,72,53,TOXEMIA,SULFATE,TOXEMIA,65,36-46-54,magnesium SULFATE therapy,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy.,65,46,65,46,-1,72,53,TWrex-cause,800336,Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy,toxemia,sulfate
725343099,5/24/2015 15:31:20,1642649289,5/24/2015 15:31:08,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,130,167,,,137,174,ATROPHY,DISEASE,Type III spinal muscular ATROPHY,110-114-121-130-105,138-148-158-167,(Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 15:53:08,1642654667,5/24/2015 15:52:26,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,130,167,,,137,174,ATROPHY,DISEASE,ATROPHY,130,138-148-158-167,(Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 15:55:41,1642655177,5/24/2015 15:54:51,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,130,167,,,137,174,ATROPHY,DISEASE,spinal muscular ATROPHY,114-121-130,138-148-158-167,(Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 16:23:23,1642660853,5/24/2015 16:23:04,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,130,167,,,137,174,ATROPHY,DISEASE,Type III spinal muscular ATROPHY (Wohlfart Kugelberg Welander disease),105-110-114-121-130-138-148-158-167,138-148-158-167,(Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 16:37:00,1642663811,5/24/2015 16:36:03,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,130,167,,,137,174,ATROPHY,DISEASE,Type III spinal muscular ATROPHY (Wohlfart Kugelberg Welander disease),105-110-114-121-130-138-148-158-167,105-110-114-121-130-138-148-158-167,Type III spinal muscular atrophy (Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 17:05:09,1642671900,5/24/2015 17:04:20,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,130,167,,,137,174,ATROPHY,DISEASE,Type III spinal muscular ATROPHY,105-110-114-121-130,138-148-158-167,(Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 17:07:16,1642672693,5/24/2015 17:06:39,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,130,167,,,137,174,ATROPHY,DISEASE,Type III spinal muscular ATROPHY (Wohlfart Kugelberg Welander disease) manifests between age 15 mo and 19 yr.,105-110-114-121-130-138-148-158-167-185-195-203-207-210-213-217-220,138-148-158-167-177-185-195-203-207-210-213-217-220,(Wohlfart Kugelberg Welander DISEASE) usually manifests between age 15 mo and 19 yr.,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 17:10:44,1642673926,5/24/2015 17:10:25,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,130,167,,,137,174,ATROPHY,DISEASE,Type III spinal muscular ATROPHY,105-114-121-130-110,138-148-158-167,(Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 17:12:14,1642674424,5/24/2015 17:12:01,false,clixsense,1,29752264,CAN,ON,Bourget,74.56.122.95,130,167,,,137,174,ATROPHY,DISEASE,Type III spinal muscular ATROPHY Welander,105-110-114-121-130-158,138-148-158-167,(Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343099,5/24/2015 17:13:27,1642674798,5/24/2015 17:13:15,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,130,167,,,137,174,ATROPHY,DISEASE,Type III spinal muscular ATROPHY,105-110-114-121-130,138-148-158-167,(Wohlfart Kugelberg Welander DISEASE),"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",130,167,130,167,1,137,174,TWrex-cause,814190,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  Type III spinal muscular atrophy (Wohlfart-Kugelberg-Welander disease)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span",atrophy,disease
725343100,5/24/2015 12:23:54,1642612978,5/24/2015 12:23:36,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,ventricular ARRHYTHMIA,20-32,58,"ENCAINIDE,","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 12:24:53,1642613165,5/24/2015 12:24:33,false,clixsense,1,31482589,NLD,,,31.201.11.16,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,ventricular ARRHYTHMIA suppression,20-32-43,58,"ENCAINIDE,","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 12:41:40,1642616124,5/24/2015 12:41:17,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,"Mortality following ventricular ARRHYTHMIA suppression by encainide, flecainide, and moricizine after myocardial infarction:",0-10-20-32-43-55-58-69-81-85-96-102-113,0-10-20-32-43-55-58-69-81-85-96-102-113,"Mortality following ventricular arrhythmia suppression by ENCAINIDE, flecainide, and moricizine after myocardial infarction:","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 12:59:27,1642619304,5/24/2015 12:59:09,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,"Mortality following ventricular ARRHYTHMIA suppression by encainide, flecainide, moricizine myocardial infarction: Cardiac Arrhythmia Suppression",0-10-20-32-43-55-58-69-85-102-113-160-168-179,32-43-55-58-69-81-85-102-160-168-179-113,"arrhythmia suppression by ENCAINIDE, flecainide, and moricizine myocardial infarction: Cardiac Arrhythmia Suppression","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 13:15:48,1642622476,5/24/2015 13:15:32,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,ventricular ARRHYTHMIA,20-32,58,"ENCAINIDE,","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 13:22:11,1642623863,5/24/2015 13:21:09,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,"Mortality ventricular ARRHYTHMIA encainide, flecainide, moricizine myocardial infarction: Cardiac Arrhythmia Suppression",0-20-32-58-69-85-102-113-160-168-179,0-20-32-58-69-85-102-113-160-168-179,"Mortality ventricular arrhythmia ENCAINIDE, flecainide, moricizine myocardial infarction: Cardiac Arrhythmia Suppression","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 13:27:53,1642624794,5/24/2015 13:27:13,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,"Mortality following ventricular ARRHYTHMIA suppression by encainide,",0-10-20-32-43-55-58,20-32-43-55-58,"ventricular arrhythmia suppression by ENCAINIDE,","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 13:28:45,1642624962,5/24/2015 13:28:32,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.35,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,ventricular ARRHYTHMIA suppression,20-32-43,32-43-55-58,"arrhythmia suppression by ENCAINIDE,","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 13:29:05,1642625022,5/24/2015 13:28:55,false,clixsense,1,27754226,GBR,O3,South Ockendon,92.232.236.243,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,ARRHYTHMIA,32,58,"ENCAINIDE,","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343100,5/24/2015 13:32:07,1642625528,5/24/2015 13:31:42,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,32,58,,,42,67,ARRHYTHMIA,ENCAINIDE,ventricular ARRHYTHMIA suppression,20-32-43,58,"ENCAINIDE,","Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",32,58,32,58,-1,42,67,TWrex-cause,804674,"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST",arrhythmia,encainide
725343101,5/24/2015 14:21:31,1642634573,5/24/2015 14:21:14,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"renovascular HYPERTENSION, Cushing's syndrome,",124-137-151-161,151-161-171-174,"Cushing's syndrome, or PHEOCHROMOCYTOMA","C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 14:32:23,1642636699,5/24/2015 14:31:58,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"renovascular HYPERTENSION,",124-137,174,PHEOCHROMOCYTOMA,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 14:34:16,1642637150,5/24/2015 14:33:55,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"endocrinologist when renovascular HYPERTENSION, Cushing's syndrome, or pheochromocytoma diagnostic consideration,",103-119-124-137-151-161-171-174-196-207,151-161-171-174-191-194-196-207,"Cushing's syndrome, or PHEOCHROMOCYTOMA is a diagnostic consideration,","C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 14:37:59,1642638011,5/24/2015 14:37:13,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"endocrinologist when renovascular HYPERTENSION,",103-119-124-137,151-161-171-174-191-194-196-207,"Cushing's syndrome, or PHEOCHROMOCYTOMA is a diagnostic consideration,","C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 14:40:32,1642638717,5/24/2015 14:39:57,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"HYPERTENSION, Cushing's syndrome,",137-151-161,174-194,PHEOCHROMOCYTOMA a,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 14:42:18,1642639175,5/24/2015 14:41:36,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"renovascular HYPERTENSION,",124-137,151-161-171-174,"Cushing's syndrome, or PHEOCHROMOCYTOMA","C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 14:47:26,1642640259,5/24/2015 14:46:43,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"renovascular HYPERTENSION,",124-137,174,PHEOCHROMOCYTOMA,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 14:50:53,1642641043,5/24/2015 14:50:38,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"renovascular HYPERTENSION,",124-137,174,PHEOCHROMOCYTOMA,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 15:14:59,1642645814,5/24/2015 15:14:25,false,points4rewards,1,28703583,USA,,,97.73.85.209,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"renovascular HYPERTENSION, Cushing's syndrome,",124-137-151-161,151-161-174,"Cushing's syndrome, PHEOCHROMOCYTOMA","C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343101,5/24/2015 15:16:12,1642646059,5/24/2015 15:15:16,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,137,174,,,149,190,HYPERTENSION,PHEOCHROMOCYTOMA,"renovascular HYPERTENSION,",124-137,174,PHEOCHROMOCYTOMA,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms.",137,174,137,174,1,149,190,TWrex-cause,813217,"C]  Specific recommendation: • Consider consultation with an hypertension specialist, nephrologist, or endocrinologist when renovascular hypertension, Cushing's syndrome, or pheochromocytoma is a diagnostic consideration, especially in patients with difficult-to-control BP or atypical signs and symptoms",hypertension,pheochromocytoma
725343102,5/24/2015 13:31:32,1642625457,5/24/2015 13:30:43,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,125,62,,,132,66,ANEMIA,IRON,deferasirox deferoxamine iron patients hemolytic ANEMIAS.,15-30-101-115-125-62,15-30-62-115-125,deferasirox deferoxamine IRON hemolytic anemias.,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 13:42:23,1642627541,5/24/2015 13:42:10,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,125,62,,,132,66,ANEMIA,IRON,hemolytic ANEMIAS.,115-125,62-67-79-91-101,"IRON overloaded, transfusion dependent patients","7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 13:43:35,1642627727,5/24/2015 13:41:25,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,125,62,,,132,66,ANEMIA,IRON,hemolytic ANEMIAS.,115-125,62-67-79-90-91-101,"IRON overloaded, transfusion - dependent patients","7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 14:00:04,1642630651,5/24/2015 13:58:54,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,125,62,,,132,66,ANEMIA,IRON,hemolytic ANEMIAS.,115-125,62-67,"IRON overloaded,","7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 14:01:07,1642630795,5/24/2015 14:00:23,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,125,62,,,132,66,ANEMIA,IRON,deferasirox deferoxamine chelate iron transfusion hemolytic ANEMIAS.,15-30-46-54-115-125-79,15-30-46-54-62-79-115-125,deferasirox deferoxamine chelate iron IRON transfusion hemolytic anemias.,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 14:02:20,1642630982,5/24/2015 14:01:22,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,125,62,,,132,66,ANEMIA,IRON,hemolytic ANEMIAS.,115-125,62-67,"IRON overloaded,","7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 14:03:26,1642631172,5/24/2015 14:02:55,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,125,62,,,132,66,ANEMIA,IRON,transfusion dependent patients with hemolytic ANEMIAS.,79-101-110-115-125-91,62-67,"IRON overloaded,","7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 14:10:17,1642632371,5/24/2015 14:09:46,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,125,62,,,132,66,ANEMIA,IRON,hemolytic ANEMIAS.,115-125,46-54-59-62-67-79-91-110-115-125,"chelate iron in IRON overloaded, transfusion dependent with hemolytic anemias.","7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 14:17:34,1642633804,5/24/2015 14:16:46,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,125,62,,,132,66,ANEMIA,IRON,hemolytic ANEMIAS.,115-125,62-67-79-91,"IRON overloaded, transfusion dependent","7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343102,5/24/2015 14:20:03,1642634296,5/24/2015 14:19:21,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,125,62,,,132,66,ANEMIA,IRON,patients with hemolytic ANEMIAS.,101-110-115-125,46-54-59-62-67,"chelate iron in IRON overloaded,","7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias.",125,62,125,62,-1,132,66,TWrex-cause,803236,"7.6 Administer deferasirox or deferoxamine to chelate iron in iron-overloaded, transfusion-dependent patients with hemolytic anemias",anemia,iron
725343103,5/24/2015 14:49:57,1642640843,5/24/2015 14:49:33,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,28,81,,,44,85,HYPERSENSITIVITY,DRUG,Drug HYPERSENSITIVITY,23-28,81,DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 14:59:57,1642642894,5/24/2015 14:59:12,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,28,81,,,44,85,HYPERSENSITIVITY,DRUG,Drug HYPERSENSITIVITY,23-28,81,DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 15:29:47,1642648952,5/24/2015 15:29:36,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,28,81,,,44,85,HYPERSENSITIVITY,DRUG,Drug HYPERSENSITIVITY,23-28,81,DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 15:33:29,1642649781,5/24/2015 15:32:48,false,points4rewards,1,28703583,USA,,,97.73.85.209,28,81,,,44,85,HYPERSENSITIVITY,DRUG,Drug HYPERSENSITIVITY,23-28,0-5-81,DRUG HYPERSENSITIVITY DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 15:50:53,1642654259,5/24/2015 15:50:40,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,28,81,,,44,85,HYPERSENSITIVITY,DRUG,Drug HYPERSENSITIVITY,23-28,81,DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 15:53:06,1642654663,5/24/2015 15:52:54,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,28,81,,,44,85,HYPERSENSITIVITY,DRUG,Drug HYPERSENSITIVITY,23-28,81,DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 16:21:41,1642660526,5/24/2015 16:21:30,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,28,81,,,44,85,HYPERSENSITIVITY,DRUG,HYPERSENSITIVITY,28,81,DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 16:34:20,1642663397,5/24/2015 16:33:59,false,neodev,1,11014534,GBR,B8,Bromley,86.18.149.6,28,81,,,44,85,HYPERSENSITIVITY,DRUG,Drug HYPERSENSITIVITY,23-28,81,DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 16:52:11,1642667731,5/24/2015 16:52:06,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,28,81,,,44,85,HYPERSENSITIVITY,DRUG,DRUG HYPERSENSITIVITY Drug HYPERSENSITIVITY is an immune,0-5-23-28-45-48-51,67-76-79-81,reaction to a DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343103,5/24/2015 16:57:12,1642669148,5/24/2015 16:56:48,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,28,81,,,44,85,HYPERSENSITIVITY,DRUG,Drug HYPERSENSITIVITY,23-28,81,DRUG.,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug.,28,81,28,81,1,44,85,TWrex-cause,810180,DRUG HYPERSENSITIVITY  Drug hypersensitivity is an immune-mediated reaction to a drug,hypersensitivity,drug
725343104,5/24/2015 14:48:46,1642640572,5/24/2015 14:48:22,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,0-2-7-9-20-34,a Type I AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 14:57:23,1642642376,5/24/2015 14:56:38,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,9-20-34,AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 15:11:47,1642645266,5/24/2015 15:11:18,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,2-9-20-34-7,Type I AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 15:29:06,1642648781,5/24/2015 15:28:54,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,2-7-9-20-34,Type I AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 15:31:08,1642649252,5/24/2015 15:30:32,false,points4rewards,1,28703583,USA,,,97.73.85.209,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"Type I autoimmune polyglandular syndrome HYPOPARATHYROIDISM,",2-7-9-20-34-85,0-2-7-9-20-34,a Type I AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 15:35:29,1642650339,5/24/2015 15:34:50,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,9-20-34,AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 15:50:13,1642654059,5/24/2015 15:49:49,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,9-20-34,AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 15:51:17,1642654347,5/24/2015 15:50:53,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,9-20-34,AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 16:20:07,1642660069,5/24/2015 16:19:50,false,elite,1,32610458,CAN,ON,Thunder Bay,216.26.216.62,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,2-7-9-20-34,Type I AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343104,5/24/2015 16:21:01,1642660348,5/24/2015 16:20:34,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,85,9,,,103,42,HYPOPARATHYROIDISM,AUTOIMMUNE POLYGLANDULAR SYNDROME,"HYPOPARATHYROIDISM,",85,9-20-34,AUTOIMMUNE POLYGLANDULAR SYNDROME,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis.",85,9 20 34,85,9,1,103,42,TWrex-cause,814748,"a Type I autoimmune polyglandular syndrome consists mainly of adrenal insufficiency, hypoparathyroidism, and mucocutaneous candidiasis",hypoparathyroidism,autoimmune polyglandular syndrome
725343105,5/24/2015 13:33:25,1642625817,5/24/2015 13:32:55,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,patients MEN1 FACIAL ANGIOFIBROMAS collagenomas disease,44-58-78-85-103-154,44-58-78-85-103-154,patients MEN1 facial angiofibromas collagenomas disease,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 13:43:04,1642627617,5/24/2015 13:42:52,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,multiple FACIAL ANGIOFIBROMAS,69-78-85,58,MEN1,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 13:45:47,1642628081,5/24/2015 13:44:58,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,multiple FACIAL ANGIOFIBROMAS,69-78-85,58,MEN1,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 14:03:16,1642631144,5/24/2015 14:02:15,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,multiple FACIAL ANGIOFIBROMAS,69-78-85,58,MEN1,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 14:04:20,1642631372,5/24/2015 14:02:58,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,MEN1 FACIAL ANGIOFIBROMAS collagenomas manifestations disease,58-78-85-103-132-154,58-78-85-103-132-154,MEN1 facial angiofibromas collagenomas manifestations disease,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 14:06:32,1642631778,5/24/2015 14:04:50,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,FACIAL ANGIOFIBROMAS,78-85,58,MEN1,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 14:11:20,1642632525,5/24/2015 14:10:57,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations disease 22.,78-85-99-103-116-119-122-132-154-164,41-44-53-58-63-69-78,of patients with MEN1 found multiple facial,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 14:20:05,1642634290,5/24/2015 14:19:26,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,multiple FACIAL ANGIOFIBROMAS,69-78-85,58,MEN1,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 14:22:30,1642634768,5/24/2015 14:22:17,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,MEN1 found multiple FACIAL ANGIOFIBROMAS,58-63-69-78-85,44-53-58-63-69-78,patients with MEN1 found multiple facial,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343105,5/24/2015 14:23:12,1642634949,5/24/2015 14:22:12,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,78,58,,,98,62,FACIAL ANGIOFIBROMA,MEN1,FACIAL ANGIOFIBROMAS,78-85,58,MEN1,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22.,78 85,58,78,58,1,98,62,TWrex-cause,813841,• A survey study of a consecutive sample of patients with MEN1 found multiple facial angiofibromas and collagenomas to be cutaneous manifestations of the disease ( 22,facial angiofibroma,men1
725343106,5/24/2015 14:47:14,1642640234,5/24/2015 14:46:42,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,67,124,,,80,132,ASPERGILLOSIS,REACTION,ASPERGILLOSIS Allergic bronchopulmonary ASPERGILLOSIS (ABPA),26-41-50-67-81,94-98-107-124,IgE mediated hypersensitivity REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 14:55:13,1642641910,5/24/2015 14:54:45,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,67,124,,,80,132,ASPERGILLOSIS,REACTION,ASPERGILLOSIS Allergic bronchopulmonary ASPERGILLOSIS,26-41-50-67,94-98-107-124,IgE mediated hypersensitivity REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 15:08:01,1642644652,5/24/2015 15:07:10,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,67,124,,,80,132,ASPERGILLOSIS,REACTION,Allergic bronchopulmonary ASPERGILLOSIS,41-67-50,94-98-107-124,IgE mediated hypersensitivity REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 15:22:11,1642647346,5/24/2015 15:22:01,false,neodev,1,32087449,USA,DE,,108.59.10.153,67,124,,,80,132,ASPERGILLOSIS,REACTION,ASPERGILLOSIS Allergic bronchopulmonary ASPERGILLOSIS is an,26-41-50-67-88-91,94-98-107-124-133-136-149,IgE mediated hypersensitivity REACTION to colonization of,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 15:28:14,1642648648,5/24/2015 15:27:37,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,67,124,,,80,132,ASPERGILLOSIS,REACTION,Allergic bronchopulmonary ASPERGILLOSIS,41-50-67,94-98-107-124,IgE mediated hypersensitivity REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 15:28:37,1642648686,5/24/2015 15:27:41,false,points4rewards,1,28703583,USA,,,97.73.85.209,67,124,,,80,132,ASPERGILLOSIS,REACTION,Allergic bronchopulmonary ASPERGILLOSIS,41-50-67,41-50-67-124-149-81,Allergic bronchopulmonary aspergillosis (ABPA) REACTION of,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 15:34:06,1642649979,5/24/2015 15:33:51,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,67,124,,,80,132,ASPERGILLOSIS,REACTION,Allergic bronchopulmonary ASPERGILLOSIS,41-50-67,107-124,hypersensitivity REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 15:49:11,1642653873,5/24/2015 15:48:49,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,67,124,,,80,132,ASPERGILLOSIS,REACTION,ASPERGILLOSIS,67,94-98-107-124,IgE mediated hypersensitivity REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 15:49:45,1642653977,5/24/2015 15:49:29,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,67,124,,,80,132,ASPERGILLOSIS,REACTION,Allergic bronchopulmonary ASPERGILLOSIS,41-50-67,98-107-124-94,IgE mediated hypersensitivity REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343106,5/24/2015 15:58:27,1642655757,5/24/2015 15:58:05,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,67,124,,,80,132,ASPERGILLOSIS,REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS Allergic bronchopulmonary ASPERGILLOSIS,0-9-26-41-50-67,94-98-107-124,IgE mediated hypersensitivity REACTION,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species.,67,124,67,124,1,80,132,TWrex-cause,811127,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  Allergic bronchopulmonary aspergillosis (ABPA) is an IgE-mediated hypersensitivity reaction to colonization of the airways by  Aspergillus  species,aspergillosis,reaction
725343107,5/24/2015 13:50:20,1642628985,5/24/2015 13:49:39,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,RICKETTSIAL INFECTION,69-81,19,RICKETTSIA,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:10:31,1642632395,5/24/2015 14:09:58,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,RICKETTSIAL INFECTION,69-81,19,RICKETTSIA,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:11:19,1642632523,5/24/2015 14:10:42,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,RICKETTSIAL INFECTION,69-81,19,RICKETTSIA,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:16:01,1642633397,5/24/2015 14:15:42,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,"with Corresponding Etiologic Agent] RICKETTSIAL INFECTION leads to endothelial damage,",32-37-51-61-69-81-91-97-100-112,0-11-15-19-32-37-51-61-69-81,Infections Due to RICKETTSIA with Corresponding Etiologic Agent] Rickettsial infection,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:26:56,1642635708,5/24/2015 14:26:22,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,RICKETTSIAL INFECTION,69-81,19,RICKETTSIA,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:27:55,1642635869,5/24/2015 14:27:08,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,RICKETTSIAL INFECTION,69-81,19,RICKETTSIA,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:28:14,1642635906,5/24/2015 14:27:29,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,"Corresponding Etiologic Agent] RICKETTSIAL INFECTION leads to endothelial associated with widespread vasculitis; biologic disorders,",37-51-61-69-81-91-97-100-129-140-145-156-212-221,0-11-15-19-32-37-51-129-140-145-156,Infections Due to RICKETTSIA with Corresponding Etiologic associated with widespread vasculitis;,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:28:47,1642635983,5/24/2015 14:27:43,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,RICKETTSIAL INFECTION,69-81,19,RICKETTSIA,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:28:53,1642636034,5/24/2015 14:27:27,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,Corresponding Etiologic Agent] RICKETTSIAL INFECTION,37-51-61-69-81,0-11-15-19-32-37-51-61,Infections Due to RICKETTSIA with Corresponding Etiologic Agent],"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343107,5/24/2015 14:33:27,1642636894,5/24/2015 14:32:12,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,69,19,,,90,29,RICKETTSIAL INFECTION,RICKETTSIA,RICKETTSIAL INFECTION,69-81,19,RICKETTSIA,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ.",69 81,19,69,19,1,90,29,TWrex-cause,810728,"Infections Due to  Rickettsia , with Corresponding Etiologic Agent]  Rickettsial infection leads to endothelial damage, which is associated with widespread vasculitis; the clinical signs and symptoms, as well as biologic disorders, are related to the affected organ",rickettsial infection,rickettsia
725343108,5/24/2015 12:25:30,1642613241,5/24/2015 12:25:06,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY,30-41,138-150,"Waldenstrsm MACROGLOBULINEMIA,","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 12:27:02,1642613484,5/24/2015 12:26:43,false,clixsense,1,31482589,NLD,,,31.201.11.16,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY,30-41,150,"MACROGLOBULINEMIA,","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 13:25:32,1642624432,5/24/2015 13:24:54,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"Plasma cell MONOCLONAL GAMMOPATHY myeloma, solitary plasmacytoma, Waldenstrsm macroglobulinemia, amyloidosis.",0-7-30-41-91-100-124-138-150-173,0-7-30-41-91-100-124-138-150-173,"Plasma cell monoclonal gammopathy myeloma, solitary plasmacytoma, Waldenstrsm MACROGLOBULINEMIA, amyloidosis.","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 13:33:15,1642625800,5/24/2015 13:32:29,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance,",7-12-22-30-41-52-55-68,109-124-138-150-169-173,"extramedullary plasmacytoma, Waldenstrsm MACROGLOBULINEMIA, and amyloidosis.","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 13:35:50,1642626356,5/24/2015 13:34:41,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY,30-41,138-150,"Waldenstrsm MACROGLOBULINEMIA,","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 13:40:15,1642627127,5/24/2015 13:39:59,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"MONOCLONAL GAMMOPATHY significance,",30-41-68,138-150,"Waldenstrsm MACROGLOBULINEMIA,","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 13:53:01,1642629406,5/24/2015 13:51:43,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY,30-41,138-150,"Waldenstrsm MACROGLOBULINEMIA,","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 13:53:55,1642629540,5/24/2015 13:52:19,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY,30-41,138-150,"Waldenstrsm MACROGLOBULINEMIA,","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 13:55:11,1642629833,5/24/2015 13:54:24,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"Plasma cell MONOCLONAL GAMMOPATHY myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, amyloidosis.",0-30-41-91-100-109-124-138-150-173-7,30-41-91-109-124-138-150-173,"monoclonal gammopathy myeloma, extramedullary plasmacytoma, Waldenstrsm MACROGLOBULINEMIA, amyloidosis.","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343108,5/24/2015 13:59:46,1642630600,5/24/2015 13:58:22,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,30,150,,,51,167,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance,",7-12-22-30-41-52-55-68-0,109-124-138-150-169-173-100,"solitary extramedullary plasmacytoma, Waldenstrsm MACROGLOBULINEMIA, and amyloidosis.","Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis.",30 41,150,30,150,1,51,167,TWrex-cause,814890,"Plasma cell disorders include monoclonal gammopathy of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, Waldenstrsm macroglobulinemia, and amyloidosis",monoclonal gammopathy,macroglobulinemia
725343109,5/24/2015 14:37:23,1642637881,5/24/2015 14:37:05,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,"Hospitalize patients when SEIZURES may be due acute brain pathology, consciousness",31-43-52-57-66-70-73-80-86-92-106,147-150-154-164-171-57,seizures or for impending STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 14:43:36,1642639554,5/24/2015 14:43:14,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,SEIZURES,57,164-171,STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 14:49:11,1642640629,5/24/2015 14:48:20,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,SEIZURES,57,154-164-171,impending STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 14:52:28,1642641356,5/24/2015 14:52:20,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,SEIZURES,57,164-171,STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 14:58:13,1642642542,5/24/2015 14:57:14,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,SEIZURES,57,164-171,STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 15:19:34,1642646797,5/24/2015 15:19:17,false,neodev,1,32087449,USA,DE,,108.59.10.153,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,SEIZURES,57,164-171,STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 15:20:58,1642647079,5/24/2015 15:20:13,false,points4rewards,1,28703583,USA,,,97.73.85.209,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,"SEIZURES acute brain pathology,",57-80-86-92,164-171,STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 15:25:13,1642648106,5/24/2015 15:24:56,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,SEIZURES,57,164-171,STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 15:31:11,1642649266,5/24/2015 15:30:58,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,SEIZURES,57,164-171,STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343109,5/24/2015 15:32:05,1642649477,5/24/2015 15:31:53,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,57,164,,,65,182,SEIZURE,STATUS EPILEPTICUS,SEIZURES,57,164-171,STATUS EPILEPTICUS.,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus.",57,164 171,57,164,1,65,182,TWrex-cause,814003,"HOSPITALIZATION  Introduction  Hospitalize patients when seizures may be due to acute brain pathology, if consciousness does not return to normal, or for impending status epilepticus",seizure,status epilepticus
725343110,5/24/2015 12:24:48,1642613158,5/24/2015 12:24:33,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,80,61,,,87,67,MYCOSIS,FUNGUS,MYCOSIS.,80,61,FUNGUS;,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 12:25:39,1642613253,5/24/2015 12:25:25,false,clixsense,1,31482589,NLD,,,31.201.11.16,80,61,,,87,67,MYCOSIS,FUNGUS,MYCOSIS.,80,61,FUNGUS;,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 13:16:21,1642622638,5/24/2015 13:16:14,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,80,61,,,87,67,MYCOSIS,FUNGUS,MYCOSIS.,80,61,FUNGUS;,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 13:23:41,1642624129,5/24/2015 13:23:21,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,80,61,,,87,67,MYCOSIS,FUNGUS,mycotic infected fungus; MYCOSIS.,0-47-61-80,0-47-61-80,mycotic infected FUNGUS; mycosis.,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 13:29:23,1642625116,5/24/2015 13:29:14,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.35,80,61,,,87,67,MYCOSIS,FUNGUS,MYCOSIS.,80,61,FUNGUS;,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 13:31:32,1642625455,5/24/2015 13:31:07,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,80,61,,,87,67,MYCOSIS,FUNGUS,infected fungus; concerning MYCOSIS.,61-69-80-47,47-61-80,infected FUNGUS; mycosis.,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 13:33:43,1642625870,5/24/2015 13:33:34,false,clixsense,1,6340330,USA,NY,Canajoharie,67.248.115.74,80,61,,,87,67,MYCOSIS,FUNGUS,MYCOSIS.,80,61,FUNGUS;,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 13:34:14,1642625970,5/24/2015 13:33:56,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,80,61,,,87,67,MYCOSIS,FUNGUS,MYCOSIS.,80,61,FUNGUS;,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 13:39:44,1642627047,5/24/2015 13:39:33,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,80,61,,,87,67,MYCOSIS,FUNGUS,MYCOSIS.,80,61,FUNGUS;,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343110,5/24/2015 13:46:56,1642628288,5/24/2015 13:45:15,false,fusioncash,1,5656294,USA,TN,Cookeville,75.136.162.83,80,61,,,87,67,MYCOSIS,FUNGUS,MYCOSIS.,80,61-80,FUNGUS; mycosis.,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis.,80,61,80,61,1,87,67,TWrex-cause,812383,mycotic    (             audio )  Caused by or infected with fungus; concerning mycosis,mycosis,fungus
725343111,5/24/2015 13:36:40,1642626542,5/24/2015 13:36:17,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,acute diarrhea initial stages chronic DIARRHEA.,9-15-42-50-60-68,9-15-42-50-60-68,ACUTE DIARRHEA initial stages chronic diarrhea.,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 13:47:45,1642628416,5/24/2015 13:47:32,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,chronic DIARRHEA.,60-68,9-15,ACUTE DIARRHEA,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 13:49:06,1642628726,5/24/2015 13:48:56,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,chronic DIARRHEA.,60-68,9-15,ACUTE DIARRHEA,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 14:07:27,1642631858,5/24/2015 14:06:34,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,chronic DIARRHEA.,60-68,9-15,ACUTE DIARRHEA,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 14:08:28,1642632060,5/24/2015 14:08:09,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,chronic DIARRHEA.,60-68,9-15,ACUTE DIARRHEA,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 14:08:47,1642632179,5/24/2015 14:08:13,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,acute diarrhea chronic DIARRHEA.,9-15-68-60,9-15-68-60,ACUTE DIARRHEA chronic diarrhea.,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 14:14:22,1642633105,5/24/2015 14:13:52,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,chronic DIARRHEA.,60-68,9-15,ACUTE DIARRHEA,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 14:24:26,1642635136,5/24/2015 14:23:48,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,chronic DIARRHEA.,60-68,9-15,ACUTE DIARRHEA,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 14:25:08,1642635352,5/24/2015 14:24:54,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,DIARRHEA.,68,9-15,ACUTE DIARRHEA,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343111,5/24/2015 14:25:38,1642635456,5/24/2015 14:24:45,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,68,9,,,76,23,DIARRHEA,ACUTE DIARRHEA,stages of chronic DIARRHEA.,50-57-60-68,9-15,ACUTE DIARRHEA,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea.",68,9 15,68,9,1,76,23,TWrex-cause,813242,"Finally, acute diarrhea may represent the initial stages of chronic diarrhea",diarrhea,acute diarrhea
725343112,5/24/2015 11:30:50,1642604405,5/24/2015 11:30:34,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,111,5,,,117,13,STROKE,WARFARIN,thromboembolic STROKE,96-111,5,WARFARIN,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 11:32:34,1642604686,5/24/2015 11:32:12,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,111,5,,,117,13,STROKE,WARFARIN,warfarin STROKE,111-5,5-96-111,WARFARIN thromboembolic stroke,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 11:35:45,1642605097,5/24/2015 11:35:32,false,elite,1,26544151,GBR,,,213.205.252.203,111,5,,,117,13,STROKE,WARFARIN,STROKE,111,5,WARFARIN,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 11:42:49,1642606192,5/24/2015 11:41:57,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,111,5,,,117,13,STROKE,WARFARIN,thromboembolic STROKE,96-111,5,WARFARIN,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 11:42:56,1642606209,5/24/2015 11:42:46,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,111,5,,,117,13,STROKE,WARFARIN,thromboembolic STROKE,96-111,5,WARFARIN,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 11:52:20,1642607701,5/24/2015 11:52:01,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,111,5,,,117,13,STROKE,WARFARIN,thromboembolic STROKE,96-111,5,WARFARIN,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 11:55:02,1642608280,5/24/2015 11:54:50,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,111,5,,,117,13,STROKE,WARFARIN,STROKE,111,5,WARFARIN,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 12:07:08,1642610213,5/24/2015 12:06:56,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,111,5,,,117,13,STROKE,WARFARIN,thromboembolic STROKE,96-111,5,WARFARIN,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 12:09:28,1642610652,5/24/2015 12:09:16,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,111,5,,,117,13,STROKE,WARFARIN,thromboembolic STROKE,96-111,5,WARFARIN,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343112,5/24/2015 12:10:04,1642610758,5/24/2015 12:09:30,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,111,5,,,117,13,STROKE,WARFARIN,warfarin thromboembolic STROKE,96-111-5,5-96-111,WARFARIN thromboembolic stroke,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes.",111,5,111,5,-1,117,13,TWrex-cause,804630,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and thromboembolic stroke than the aspirin-alone group (Table); the 2 warfarin groups did not differ for these outcomes",stroke,warfarin
725343113,5/24/2015 11:28:58,1642604158,5/24/2015 11:28:40,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,IRON DEFICIENCY,2-7,38-45,CELIAC DISEASE,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 11:30:10,1642604304,5/24/2015 11:29:55,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,IRON DEFICIENCY celiac disease,2-7-38-45,2-7-38-45,Iron deficiency CELIAC DISEASE,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 11:34:26,1642604943,5/24/2015 11:34:03,false,elite,1,26544151,GBR,,,213.205.252.203,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,IRON DEFICIENCY,2-7,38-45,CELIAC DISEASE,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 11:37:02,1642605260,5/24/2015 11:36:29,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,IRON DEFICIENCY,2-7,38-45,CELIAC DISEASE,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 11:41:42,1642606074,5/24/2015 11:41:16,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,IRON DEFICIENCY,2-7,38-45,CELIAC DISEASE,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 11:50:38,1642607461,5/24/2015 11:50:13,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,IRON DEFICIENCY,2-7,38-45,CELIAC DISEASE,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 11:53:47,1642608032,5/24/2015 11:53:33,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,IRON DEFICIENCY,2-7,38-45,CELIAC DISEASE,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 11:54:12,1642608103,5/24/2015 11:54:00,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,• IRON DEFICIENCY is a common celiac,0-2-7-18-21-23-38,23-30-35-38-45-53-57-60,common sign of CELIAC DISEASE and is often,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 12:03:41,1642609644,5/24/2015 12:03:36,false,neodev,1,31789301,USA,NY,New York,162.243.171.213,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,• IRON DEFICIENCY is a common,0-2-7-18-21-23,23-30-35-38-45-53-57-60,common sign of CELIAC DISEASE and is often,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343113,5/24/2015 12:05:12,1642609920,5/24/2015 12:05:02,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,2,38,,,17,52,IRON DEFICIENCY,CELIAC DISEASE,IRON DEFICIENCY,2-7,38-45,CELIAC DISEASE,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients.,2 7,38 45,2,38,1,17,52,TWrex-cause,814232,• Iron deficiency is a common sign of celiac disease and is often seen in newly diagnosed patients,iron deficiency,celiac disease
725343114,5/24/2015 11:38:32,1642605537,5/24/2015 11:38:02,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,136,82,,,140,95,PAIN,ENDOMETRIOMA,PAIN,136,82,ENDOMETRIOMAS,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 11:39:40,1642605730,5/24/2015 11:39:21,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,136,82,,,140,95,PAIN,ENDOMETRIOMA,Endometriomas PAIN,136-82,82-104-113,ENDOMETRIOMAS surgical excision,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 11:57:19,1642608534,5/24/2015 11:56:44,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,136,82,,,140,95,PAIN,ENDOMETRIOMA,PAIN,136,82,ENDOMETRIOMAS,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 12:00:05,1642608992,5/24/2015 11:59:26,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,136,82,,,140,95,PAIN,ENDOMETRIOMA,PAIN,136,82,ENDOMETRIOMAS,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 12:21:39,1642612596,5/24/2015 12:21:14,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,136,82,,,140,95,PAIN,ENDOMETRIOMA,PAIN,136,82,ENDOMETRIOMAS,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 12:22:44,1642612781,5/24/2015 12:22:23,false,clixsense,1,31482589,NLD,,,31.201.11.16,136,82,,,140,95,PAIN,ENDOMETRIOMA,PAIN,136,45-59-82,Endometriosis Cysts ENDOMETRIOMAS,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 12:35:54,1642615069,5/24/2015 12:35:21,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,136,82,,,140,95,PAIN,ENDOMETRIOMA,SURGICAL EXCISION OF OVARIAN MASSES Ovarian Endometriosis Cysts (Endometriomas) Endometriomas require surgical excision if they cause PAIN or become enlarged.,0-9-18-21-29-37-45-59-65-82-96-104-122-125-130-136-141-144-151-113,0-9-18-21-29-37-45-59-65-82-96-104-113-122-125-130-136-141-144-151,SURGICAL EXCISION OF OVARIAN MASSES Ovarian Endometriosis Cysts (Endometriomas) ENDOMETRIOMAS require surgical excision if they cause pain or become enlarged.,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 12:56:37,1642618824,5/24/2015 12:55:47,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,136,82,,,140,95,PAIN,ENDOMETRIOMA,PAIN,136,82,ENDOMETRIOMAS,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 12:56:45,1642618826,5/24/2015 12:56:26,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,136,82,,,140,95,PAIN,ENDOMETRIOMA,SURGICAL EXCISION Endometriosis Cysts if they cause PAIN or become enlarged.,0-9-45-122-125-130-136-141-144-151-59,21-45-59-65-82-96-104-113-29,OVARIAN MASSES Endometriosis Cysts (Endometriomas) ENDOMETRIOMAS require surgical excision,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343114,5/24/2015 13:14:14,1642622265,5/24/2015 13:14:02,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,136,82,,,140,95,PAIN,ENDOMETRIOMA,PAIN,136,82,ENDOMETRIOMAS,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged.,136,82,136,82,1,140,95,TWrex-cause,813004,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  Endometriomas require surgical excision if they cause pain or become enlarged,pain,endometrioma
725343115,5/24/2015 14:33:24,1642636896,5/24/2015 14:33:01,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"breast SWELLING,",58-65,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 14:35:53,1642637543,5/24/2015 14:35:36,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"breast cancer clinical presentation of breast SWELLING, erythema, warmth, and",20-33-42-55-58-65-75-85-93-13,0-13-20-27-31-33-42-58-65,"INFLAMMATORY BREAST CANCER has a clinical presentation breast swelling,","Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 14:41:45,1642639052,5/24/2015 14:41:20,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"SWELLING,",65,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 14:45:49,1642639986,5/24/2015 14:45:27,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"breast SWELLING,",58-65,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 14:51:32,1642641167,5/24/2015 14:51:16,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"breast SWELLING,",58-65,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 14:53:22,1642641574,5/24/2015 14:51:38,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"SWELLING,",65,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 15:17:12,1642646299,5/24/2015 15:16:31,false,points4rewards,1,28703583,USA,,,97.73.85.209,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer SWELLING,",0-13-65-20,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 15:18:05,1642646513,5/24/2015 15:17:47,false,neodev,1,32087449,USA,DE,,108.59.10.153,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"SWELLING,",65,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 15:24:03,1642647802,5/24/2015 15:23:48,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"breast SWELLING,",58-65,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343115,5/24/2015 15:29:50,1642648984,5/24/2015 15:29:28,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,65,0,,,73,26,SWELLING,INFLAMMATORY BREAST CANCER,"SWELLING, erythema,",65-75,0-13-20,INFLAMMATORY BREAST CANCER,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",65,0 13 20,65,0,1,73,26,TWrex-cause,813963,"Inflammatory breast cancer has a clinical presentation of breast swelling, erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases",swelling,inflammatory breast cancer
725343116,5/24/2015 11:35:59,1642605123,5/24/2015 11:35:39,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,182,251,,,186,263,LOUSE,PEDICULICIDE,LICE,182,251,PEDICULICIDE,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 11:37:32,1642605378,5/24/2015 11:36:57,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,182,251,,,186,263,LOUSE,PEDICULICIDE,permethrin cream LICE,93-182-104,93-251-104,permethrin cream PEDICULICIDE,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 11:53:13,1642607965,5/24/2015 11:52:45,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,182,251,,,186,263,LOUSE,PEDICULICIDE,live LICE,177-182,251,PEDICULICIDE,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 11:57:18,1642608527,5/24/2015 11:56:52,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,182,251,,,186,263,LOUSE,PEDICULICIDE,LICE,182,251,PEDICULICIDE,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 12:11:31,1642610992,5/24/2015 12:11:11,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,182,251,,,186,263,LOUSE,PEDICULICIDE,live LICE,177-182,251,PEDICULICIDE,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 12:19:27,1642612220,5/24/2015 12:19:09,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,182,251,,,186,263,LOUSE,PEDICULICIDE,treatment LICE,164-182,251,PEDICULICIDE,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 12:20:06,1642612340,5/24/2015 12:19:53,false,clixsense,1,31482589,NLD,,,31.201.11.16,182,251,,,186,263,LOUSE,PEDICULICIDE,LICE,182,251,PEDICULICIDE,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 12:25:20,1642613213,5/24/2015 12:24:59,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,182,251,,,186,263,LOUSE,PEDICULICIDE,initial treatment or live LICE are observed,164-174-177-182-187-191-156,233-236-239-251-264-270-272-275-280-283-291,or an alternative PEDICULICIDE after 7 10 days if lice nits,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 12:26:24,1642613392,5/24/2015 12:24:21,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,182,251,,,186,263,LOUSE,PEDICULICIDE,"1 , 89 One treatment usually is successful; 1 , 65 treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live LICE are observed ≥7 days after initial treatment) or an alternative pediculicide after 7 - 10 days if lice or nits are detected at the hair - skin junction.",0-2-6-10-14-24-32-35-48-54-59-69-73-76-85-90-93-104-110-122-125-130-133-143-145-150-156-164-174-177-182-187-191-200-203-208-214-222-233-236-239-251-264-270-271-272-275-280-283-288-291-296-300-309-312-316-320-321-326-50,0-2-6-10-14-24-32-35-48-50-54-59-69-73-76-85-90-93-104-110-122-125-130-133-143-145-150-156-164-174-177-182-187-191-200-203-208-214-222-233-236-239-251-264-270-272-275-280-283-288-291-296-300-309-312-316-321-326,"1 , 89 One treatment usually is successful; 1 , 65 treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if lice or nits are detected at the hair skin junction.","1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343116,5/24/2015 12:29:40,1642613945,5/24/2015 12:29:01,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,182,251,,,186,263,LOUSE,PEDICULICIDE,LICE,182,251,PEDICULICIDE,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction.",182,251,182,251,-1,186,263,TWrex-cause,805130,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative pediculicide after 7-10 days if lice or nits are detected at the hair-skin junction",louse,pediculicide
725343117,5/24/2015 13:34:07,1642625961,5/24/2015 13:33:26,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,"hepatocellular carcinoma, chronic granulomatous disease, cancer obstructive JAUNDICE.",40-55-72-80-94-188-199-211,40-55-72-80-94-199-211-188,"HEPATOCELLULAR CARCINOMA, chronic granulomatous disease, cancer obstructive jaundice.","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 13:46:33,1642628215,5/24/2015 13:45:48,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,obstructive JAUNDICE.,211-199,40-55,"HEPATOCELLULAR CARCINOMA,","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 13:47:38,1642628390,5/24/2015 13:47:22,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,obstructive JAUNDICE.,199-211,40-55,"HEPATOCELLULAR CARCINOMA,","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 14:04:02,1642631336,5/24/2015 14:03:19,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,obstructive JAUNDICE.,199-211,40-55,"HEPATOCELLULAR CARCINOMA,","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 14:05:10,1642631509,5/24/2015 14:04:22,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,"hepatocellular carcinoma, granulomatous disease, percutaneous transhepatic biliary drainage cancer JAUNDICE.",40-55-80-94-117-130-143-151-188-211,40-55-80-94-117-130-143-151-188-211,"HEPATOCELLULAR CARCINOMA, granulomatous disease, percutaneous transhepatic biliary drainage cancer jaundice.","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 14:06:50,1642631799,5/24/2015 14:06:33,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,obstructive JAUNDICE.,199-211,40-55,"HEPATOCELLULAR CARCINOMA,","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 14:12:06,1642632647,5/24/2015 14:11:21,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,obstructive JAUNDICE.,199-211,40-55,"HEPATOCELLULAR CARCINOMA,","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 14:20:49,1642634447,5/24/2015 14:20:06,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,obstructive JAUNDICE.,199-211,40-55,"HEPATOCELLULAR CARCINOMA,","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 14:23:38,1642635040,5/24/2015 14:23:13,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,obstructive JAUNDICE.,199-211,40-55,"HEPATOCELLULAR CARCINOMA,","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343117,5/24/2015 14:23:43,1642635055,5/24/2015 14:22:30,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,211,40,,,219,64,JAUNDICE,HEPATOCELLULAR CARCINOMA,cancer and obstructive JAUNDICE.,188-195-199-211,23-37-40-55-67-72-80,"complications of HEPATOCELLULAR CARCINOMA, 90 chronic granulomatous","They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice.",211,40 55,211,40,1,219,64,TWrex-cause,814090,"They may also occur as complications of hepatocellular carcinoma,  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and obstructive jaundice",jaundice,hepatocellular carcinoma
725343118,5/24/2015 14:33:00,1642636821,5/24/2015 14:32:44,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,PANIC DISORDER.,57-63,18,CLONAZEPAM,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 14:35:28,1642637441,5/24/2015 14:35:05,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,alprazolam clonazepam the treatment of PANIC DISORDER.,4-40-44-54-57-63-18,15-18-29-36-40-44-54-57-63,to CLONAZEPAM switch for the treatment of panic disorder.,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 14:41:19,1642638954,5/24/2015 14:40:57,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,of PANIC DISORDER.,54-57-63,18,CLONAZEPAM,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 14:45:25,1642639940,5/24/2015 14:44:25,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,PANIC DISORDER.,57-63,18,CLONAZEPAM,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 14:51:15,1642641115,5/24/2015 14:51:04,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,PANIC DISORDER.,57-63,18,CLONAZEPAM,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 14:51:37,1642641192,5/24/2015 14:50:53,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,PANIC DISORDER.,57-63,18,CLONAZEPAM,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 15:16:26,1642646110,5/24/2015 15:15:49,false,points4rewards,1,28703583,USA,,,97.73.85.209,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,PANIC DISORDER.,57-63,18-57-63,CLONAZEPAM panic disorder.,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 15:17:44,1642646450,5/24/2015 15:17:29,false,neodev,1,32087449,USA,DE,,108.59.10.153,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,PANIC DISORDER.,57-63,4-18,alprazolam CLONAZEPAM,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 15:23:46,1642647771,5/24/2015 15:23:32,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,PANIC DISORDER.,57-63,18-29,CLONAZEPAM switch,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343118,5/24/2015 15:24:08,1642647822,5/24/2015 15:24:03,false,clixsense,1,22751911,NLD,4,Groningen,195.241.153.97,57,18,,,71,28,PANIC DISORDER,CLONAZEPAM,the treatment of PANIC DISORDER.,40-44-54-57-63,0-4-15-18-29-36-40,The alprazolam to CLONAZEPAM switch for the,The alprazolam to clonazepam switch for the treatment of panic disorder.,57 63,18,57,18,-1,71,28,TWrex-cause,803398,The alprazolam to clonazepam switch for the treatment of panic disorder,panic disorder,clonazepam
725343119,5/24/2015 11:32:42,1642604717,5/24/2015 11:32:27,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,47,0,,,51,10,PAIN,GABAPENTIN,PAIN,47,0,GABAPENTIN,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 11:34:21,1642604941,5/24/2015 11:34:05,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,47,0,,,51,10,PAIN,GABAPENTIN,Gabapentin PAIN,47-0,0-47-52,GABAPENTIN pain relief,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 11:44:06,1642606440,5/24/2015 11:43:57,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,47,0,,,51,10,PAIN,GABAPENTIN,PAIN relief,47-52,0,GABAPENTIN,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 11:46:37,1642606777,5/24/2015 11:46:18,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,47,0,,,51,10,PAIN,GABAPENTIN,PAIN relief,47-52,0,GABAPENTIN,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 11:54:09,1642608101,5/24/2015 11:53:50,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,47,0,,,51,10,PAIN,GABAPENTIN,PAIN,47,0,GABAPENTIN,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 11:56:17,1642608436,5/24/2015 11:56:06,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,47,0,,,51,10,PAIN,GABAPENTIN,PAIN,47,0,GABAPENTIN,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 12:08:22,1642610509,5/24/2015 12:08:08,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,47,0,,,51,10,PAIN,GABAPENTIN,PAIN relief,47-52,0,GABAPENTIN,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 12:12:09,1642611124,5/24/2015 12:11:50,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,47,0,,,51,10,PAIN,GABAPENTIN,Gabapentin PAIN,47-0,0-47,GABAPENTIN pain,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 12:16:27,1642611745,5/24/2015 12:13:35,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,47,0,,,51,10,PAIN,GABAPENTIN,Gabapentin was more effective than placebo for PAIN relief and improvement in sleep and quality of life,0-11-15-20-30-35-43-47-52-59-63-75-78-84-88-96-99,0-11-15-20-30-35-43-47-52-59-63-75-78-84-88-96-99,GABAPENTIN was more effective than placebo for pain relief and improvement in sleep and quality of life,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343119,5/24/2015 12:16:31,1642611763,5/24/2015 12:16:18,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,47,0,,,51,10,PAIN,GABAPENTIN,PAIN,47,0,GABAPENTIN,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial.,47,0,47,0,-1,51,10,TWrex-cause,804326,Gabapentin was more effective than placebo for pain relief and improvement in sleep and quality of life (1 trial,pain,gabapentin
725343120,5/24/2015 14:38:36,1642638234,5/24/2015 14:38:26,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,86,60,,,98,68,HYPERTENSION,LOSARTAN,"in patients with HYPERTENSION and left ventricular hypertrophy,",69-72-81-86-99-103-108-120,47-52-56-60-69-72-81-86-108-120,"with the ARB LOSARTAN in patients with hypertension ventricular hypertrophy,","In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 14:45:06,1642639848,5/24/2015 14:44:46,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,86,60,,,98,68,HYPERTENSION,LOSARTAN,HYPERTENSION,86,56-60,ARB LOSARTAN,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 14:52:06,1642641273,5/24/2015 14:51:41,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,86,60,,,98,68,HYPERTENSION,LOSARTAN,HYPERTENSION,86,56-60,ARB LOSARTAN,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 15:03:37,1642643650,5/24/2015 15:02:35,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,86,60,,,98,68,HYPERTENSION,LOSARTAN,HYPERTENSION,86,60-56,ARB LOSARTAN,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 15:20:57,1642647077,5/24/2015 15:20:40,false,neodev,1,32087449,USA,DE,,108.59.10.153,86,60,,,98,68,HYPERTENSION,LOSARTAN,HYPERTENSION ventricular,86-108,56-60,ARB LOSARTAN,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 15:24:57,1642648057,5/24/2015 15:23:57,false,points4rewards,1,28703583,USA,,,97.73.85.209,86,60,,,98,68,HYPERTENSION,LOSARTAN,"ARB losartan HYPERTENSION left ventricular hypertrophy,",56-86-103-108-120-60,56-60-86,ARB LOSARTAN hypertension,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 15:26:28,1642648352,5/24/2015 15:26:15,false,clixsense,1,31579138,AUS,2,Hurstville,14.200.129.68,86,60,,,98,68,HYPERTENSION,LOSARTAN,HYPERTENSION,86,56-60,ARB LOSARTAN,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 15:32:05,1642649478,5/24/2015 15:31:53,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,86,60,,,98,68,HYPERTENSION,LOSARTAN,HYPERTENSION,86,60,LOSARTAN,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 15:33:00,1642649706,5/24/2015 15:32:50,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,86,60,,,98,68,HYPERTENSION,LOSARTAN,HYPERTENSION,86,56-60,ARB LOSARTAN,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343120,5/24/2015 15:47:37,1642653524,5/24/2015 15:47:16,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,86,60,,,98,68,HYPERTENSION,LOSARTAN,HYPERTENSION,86,60,LOSARTAN,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",86,60,86,60,-1,98,68,TWrex-cause,804792,"In a trial comparing the beta blocker atenolol with the ARB losartan in patients with hypertension and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB",hypertension,losartan
725343121,5/24/2015 13:29:44,1642625188,5/24/2015 13:29:13,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,TYPHOID FEVER Salmonella Infections typhoid fever (enteric fever) Salmonella typhi.,5-13-29-40-81-89-102-111-141-152,5-13-29-40-81-89-102-111-141-152,Typhoid Fever Salmonella Infections typhoid fever (enteric fever) SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 13:39:38,1642627033,5/24/2015 13:39:22,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,TYPHOID FEVER,5-13,141-152,SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 13:41:50,1642627444,5/24/2015 13:41:39,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,TYPHOID FEVER,5-13,128-141-152,susceptible SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 13:58:00,1642630287,5/24/2015 13:56:47,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,280 TYPHOID FEVER,0-5-13,141-152,SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 13:59:37,1642630590,5/24/2015 13:59:01,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,TYPHOID FEVER Salmonella Infections typhoid fever (enteric fever) Salmonella typhi.,5-13-29-40-81-89-102-111-141-152,5-13-29-40-81-89-102-111-118-141-152,Typhoid Fever Salmonella Infections typhoid fever (enteric fever) caused SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 14:00:42,1642630740,5/24/2015 14:00:13,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,TYPHOID FEVER,5-13,128-141-152,susceptible SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 14:02:36,1642631028,5/24/2015 14:02:13,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,TYPHOID FEVER Salmonella Infections,5-13-29-40,141-152,SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 14:09:15,1642632228,5/24/2015 14:08:47,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,280 TYPHOID FEVER and Other Salmonella Infections,0-5-13-19-23-29-40,128-141-152,susceptible SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 14:15:21,1642633301,5/24/2015 14:13:49,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,TYPHOID FEVER,5-13,128-141-152,susceptible SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343121,5/24/2015 14:18:19,1642633952,5/24/2015 14:17:40,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,5,141,,,18,157,TYPHOID FEVER,SALMONELLA TYPHI,280 TYPHOID FEVER,0-5-13,118-125-128-141-152,caused by susceptible SALMONELLA TYPHI.,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi.,5 13,141 152,5,141,1,18,157,TWrex-cause,810843,280  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  Salmonella typhi,typhoid fever,salmonella typhi
725343122,5/24/2015 11:35:25,1642605056,5/24/2015 11:34:44,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,dermatophyte toe ONYCHOMYCOSIS,114-127-131,29-40-45-53,CICLOPIROX nail lacquer solution,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 11:36:41,1642605196,5/24/2015 11:36:10,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,antifungal agents ONYCHOMYCOSIS,82-131-93,29-82-93,CICLOPIROX antifungal agents,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 11:52:02,1642607663,5/24/2015 11:51:16,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,dermatophyte toe ONYCHOMYCOSIS,114-127-131,29-40-45-53-62,CICLOPIROX nail lacquer solution 8%,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 11:56:34,1642608482,5/24/2015 11:56:04,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,ONYCHOMYCOSIS,131,29,CICLOPIROX,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 12:10:56,1642610888,5/24/2015 12:10:36,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,dermatophyte toe ONYCHOMYCOSIS,114-127-131,29-40-45-53,CICLOPIROX nail lacquer solution,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 12:18:57,1642612189,5/24/2015 12:18:31,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,dermatophyte toe ONYCHOMYCOSIS,114-127-131,29-40-45-53,CICLOPIROX nail lacquer solution,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 12:19:39,1642612272,5/24/2015 12:19:19,false,clixsense,1,31482589,NLD,,,31.201.11.16,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,dermatophyte toe ONYCHOMYCOSIS,114-127-131,29-40-45-53-62,CICLOPIROX nail lacquer solution 8%,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 12:23:37,1642612908,5/24/2015 12:22:38,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe ONYCHOMYCOSIS,0-17-26-29-40-45-53-62-65-69-73-77-82-93-100-105-108-114-127-131,0-17-26-29-40-45-53-62-65-69-73-77-82-93-100-105-108-114-127-131,Pharmacoeconomic analysis of CICLOPIROX nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 12:24:46,1642613130,5/24/2015 12:24:30,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,dermatophyte toe ONYCHOMYCOSIS,114-127-131,0-17-26-29-40-45-53-62,Pharmacoeconomic analysis of CICLOPIROX nail lacquer solution 8%,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343122,5/24/2015 12:25:37,1642613251,5/24/2015 12:24:49,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,131,29,,,144,39,ONYCHOMYCOSIS,CICLOPIROX,dermatophyte toe ONYCHOMYCOSIS,114-127-131,29,CICLOPIROX,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.,131,29,131,29,-1,144,39,TWrex-cause,804289,Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States,onychomycosis,ciclopirox
725343123,5/24/2015 13:50:44,1642629026,5/24/2015 13:50:22,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES,0-9,30-41-44,PERMETHRIN 5% cream.,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:11:36,1642632572,5/24/2015 14:10:34,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES,0-9,30-44-41,PERMETHRIN 5% cream.,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:11:47,1642632592,5/24/2015 14:11:20,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES,0-9,30-41-44,PERMETHRIN 5% cream.,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:16:17,1642633488,5/24/2015 14:16:02,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES,0-9,30-41-44,PERMETHRIN 5% cream.,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:27:13,1642635760,5/24/2015 14:26:57,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES,0-9,30-41-44,PERMETHRIN 5% cream.,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:28:18,1642635912,5/24/2015 14:27:56,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES,0-9,30-41-44,PERMETHRIN 5% cream.,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:28:29,1642635970,5/24/2015 14:28:16,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES treated with permethrin,0-9-17-25-30,9-17-25-30-41-44,scabies treated with PERMETHRIN 5% cream.,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:29:26,1642636116,5/24/2015 14:28:48,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES,0-9,30-41-44,PERMETHRIN 5% cream.,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:29:28,1642636119,5/24/2015 14:28:54,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES treated with permethrin,0-9-17-25-30,9-17-25-30,scabies treated with PERMETHRIN,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343123,5/24/2015 14:34:12,1642637143,5/24/2015 14:33:28,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,9,30,,,16,40,SCABIES,PERMETHRIN,Neonatal SCABIES,0-9,30,PERMETHRIN,Neonatal scabies treated with permethrin 5% cream.,9,30,9,30,-1,16,40,TWrex-cause,805159,Neonatal scabies treated with permethrin 5% cream,scabies,permethrin
725343124,5/24/2015 11:38:01,1642605447,5/24/2015 11:37:39,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,147,180,,,156,191,PREGNANCY,THALIDOMIDE,PREGNANCY,147,180,THALIDOMIDE,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 11:39:20,1642605649,5/24/2015 11:39:02,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,147,180,,,156,191,PREGNANCY,THALIDOMIDE,PREGNANCY thalidomide,147-180,102-180-108,birth defects THALIDOMIDE,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 11:56:41,1642608490,5/24/2015 11:55:58,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,147,180,,,156,191,PREGNANCY,THALIDOMIDE,PREGNANCY receiving,147-170,157-180,occurs THALIDOMIDE,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 11:59:24,1642608878,5/24/2015 11:59:03,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,147,180,,,156,191,PREGNANCY,THALIDOMIDE,PREGNANCY,147,180,THALIDOMIDE,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 12:21:13,1642612540,5/24/2015 12:20:57,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,147,180,,,156,191,PREGNANCY,THALIDOMIDE,PREGNANCY,147,180,THALIDOMIDE,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 12:22:22,1642612722,5/24/2015 12:21:47,false,clixsense,1,31482589,NLD,,,31.201.11.16,147,180,,,156,191,PREGNANCY,THALIDOMIDE,PREGNANCY,147,180,THALIDOMIDE,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 12:35:20,1642614924,5/24/2015 12:34:31,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,147,180,,,156,191,PREGNANCY,THALIDOMIDE,Precautions Warnings Fetal Neonatal Morbidity and Mortality Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving thalidomide in any amount.,9-22-32-38-47-57-61-72-82-87-92-95-102-108-116-126-131-144-147-157-164-170-180-192-195-199,9-22-32-38-47-57-61-72-82-87-92-95-102-108-116-126-131-144-157-164-170-180-192-195-199-147,Precautions Warnings Fetal Neonatal Morbidity and Mortality Extremely high risk of severe birth defects (possibly life threatening) if pregnancy occurs while receiving THALIDOMIDE in any amount.,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 12:38:25,1642615548,5/24/2015 12:38:16,false,elite,1,31913360,GBR,,,5.152.201.148,147,180,,,156,191,PREGNANCY,THALIDOMIDE,life threatening) if PREGNANCY occurs while receiving,126-131-144-147-157-164-170,157-164-170-180-192-195-199,occurs while receiving THALIDOMIDE in any amount.,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 12:55:46,1642618699,5/24/2015 12:55:33,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,147,180,,,156,191,PREGNANCY,THALIDOMIDE,PREGNANCY,147,180,THALIDOMIDE,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343124,5/24/2015 12:56:25,1642618811,5/24/2015 12:56:03,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,147,180,,,156,191,PREGNANCY,THALIDOMIDE,Fetal Neonatal Morbidity life threatening) if PREGNANCY occurs while receiving,38-47-126-131-144-147-157-164-170-32,38-157-164-170-180-192-195-199-47,Neonatal Morbidity occurs while receiving THALIDOMIDE in any amount.,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount.,147,180,147,180,-1,156,191,TWrex-cause,803143,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life-threatening) if pregnancy occurs while receiving thalidomide in any amount,pregnancy,thalidomide
725343125,5/24/2015 13:52:02,1642629213,5/24/2015 13:50:45,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,parenchymal NEUROCYSTICERCOSIS,88-100,160-172,CYSTICERCUS CELLULOSAE,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:12:16,1642632669,5/24/2015 14:11:49,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,parenchymal NEUROCYSTICERCOSIS,88-100,160-172,CYSTICERCUS CELLULOSAE,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:13:56,1642633077,5/24/2015 14:11:38,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,parenchymal NEUROCYSTICERCOSIS,88-100,160-172,CYSTICERCUS CELLULOSAE,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:16:35,1642633551,5/24/2015 14:16:17,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,parenchymal NEUROCYSTICERCOSIS,88-100,160-172-185-189-196-201-205-212-220-226,CYSTICERCUS CELLULOSAE the larval form of Taenia solium (pork tapeworm.,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:27:39,1642635800,5/24/2015 14:27:14,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,parenchymal NEUROCYSTICERCOSIS,88-100,160-172,CYSTICERCUS CELLULOSAE,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:28:50,1642636031,5/24/2015 14:28:31,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,Treatment of parenchymal NEUROCYSTICERCOSIS resulting from active lesions caused by Cysticercus cellulosae,75-85-88-100-119-129-134-141-149-156-160-172,141-149-156-160-172-185-189-196-205-212-220-226-134,active lesions caused by CYSTICERCUS CELLULOSAE the larval form Taenia solium (pork tapeworm.,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:28:55,1642636033,5/24/2015 14:28:19,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,parenchymal NEUROCYSTICERCOSIS,88-100,160-172,CYSTICERCUS CELLULOSAE,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:30:13,1642636246,5/24/2015 14:29:29,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,Treatment of parenchymal NEUROCYSTICERCOSIS,75-85-88-100,141-149-156-160-172,lesions caused by CYSTICERCUS CELLULOSAE,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:30:34,1642636343,5/24/2015 14:29:27,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,parenchymal NEUROCYSTICERCOSIS,88-100,160-172,CYSTICERCUS CELLULOSAE,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343125,5/24/2015 14:35:34,1642637466,5/24/2015 14:34:12,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,100,160,,,118,182,NEUROCYSTICERCOSIS,CYSTICERCUS CELLULOSAE,parenchymal NEUROCYSTICERCOSIS,100-88,160-172,CYSTICERCUS CELLULOSAE,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm.",100,160 172,100,160,1,118,182,TWrex-cause,810828,"1 ,   4  Class:  Anthelmintics 8:08; AP200 (VA)  Uses  Neurocysticercosis  Treatment of parenchymal neurocysticercosis resulting from active lesions caused by  Cysticercus cellulosae , the larval form of  Taenia solium  (pork tapeworm",neurocysticercosis,cysticercus cellulosae
725343126,5/24/2015 14:19:18,1642634138,5/24/2015 14:18:59,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,primary stage II cutaneous MELANOMA.,100-106-109-119-92,25-42-51-62-67-70,Steiner Adjuvant INTERFERON ALFA 2A treatment,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 14:31:11,1642636456,5/24/2015 14:30:54,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,stage II cutaneous MELANOMA.,100-106-109-119,42-51-62-67,Adjuvant INTERFERON ALFA 2A,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 14:33:15,1642636866,5/24/2015 14:32:59,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,Adjuvant - treatment resected primary stage II cutaneous MELANOMA.,42-66-70-83-100-106-109-119-92,35-38-42-51-62-67-70-80-83-92-100-109-119-106,et al. Adjuvant INTERFERON ALFA 2A treatment in resected primary stage II cutaneous melanoma.,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 14:36:16,1642637624,5/24/2015 14:35:34,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,stage II cutaneous MELANOMA.,100-106-109-119,51-62-67-70-80-83,INTERFERON ALFA 2A treatment in resected,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 14:38:56,1642638308,5/24/2015 14:38:35,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,stage II cutaneous MELANOMA.,106-109-119-100,42-51-62-67,Adjuvant INTERFERON ALFA 2A,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 14:40:02,1642638577,5/24/2015 14:39:29,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,stage II cutaneous MELANOMA.,100-106-109-119,42-51-62-67,Adjuvant INTERFERON ALFA 2A,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 14:40:13,1642638646,5/24/2015 14:39:36,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,stage II cutaneous MELANOMA.,100-106-109-119,42-51-62-67-70,Adjuvant INTERFERON ALFA 2A treatment,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 14:44:07,1642639623,5/24/2015 14:41:27,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,stage II cutaneous MELANOMA.,100-106-109-119,42-51-62-67,Adjuvant INTERFERON ALFA 2A,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 14:50:03,1642640872,5/24/2015 14:49:47,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,stage II cutaneous MELANOMA.,100-109-119-106,51-62-67,INTERFERON ALFA 2A,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343126,5/24/2015 15:12:42,1642645417,5/24/2015 15:11:41,false,points4rewards,1,28703583,USA,,,97.73.85.209,119,51,,,127,69,MELANOMA,INTERFERON ALFA 2A,resected primary stage II cutaneous MELANOMA.,83-100-106-109-119-92,42-51-62-67-92-100-106-109-119,Adjuvant INTERFERON ALFA 2A primary stage II cutaneous melanoma.,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma.",119,51 62 67,119,51,-1,127,69,TWrex-cause,800844,"Pehamberger H, Soyer HP, Steiner A et al. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma",melanoma,interferon alfa 2a
725343127,5/24/2015 13:32:08,1642625527,5/24/2015 13:31:34,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,clofazimine rifampin treat LEPROMATOUS LEPROSY.,18-52-91-97-109,18-52-91-97-109,CLOFAZIMINE rifampin treat lepromatous leprosy.,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 13:42:36,1642627571,5/24/2015 13:42:24,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,LEPROMATOUS LEPROSY.,97-109,18,CLOFAZIMINE,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 13:44:40,1642627932,5/24/2015 13:43:37,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,LEPROMATOUS LEPROSY.,97-109,18,CLOFAZIMINE,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 14:01:07,1642630789,5/24/2015 14:00:06,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,LEPROMATOUS LEPROSY.,97-109,18,CLOFAZIMINE,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 14:01:36,1642630850,5/24/2015 14:01:09,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,dapsone clofazimine rifampin LEPROMATOUS LEPROSY.,6-18-52-97-109,6-18-52-97-109,dapsone CLOFAZIMINE rifampin lepromatous leprosy.,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 14:03:03,1642631117,5/24/2015 14:02:22,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,LEPROMATOUS LEPROSY.,97-109,18,CLOFAZIMINE,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 14:03:47,1642631235,5/24/2015 14:03:27,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,LEPROMATOUS LEPROSY.,97-109,6-14-18-52-97-109,dapsone and CLOFAZIMINE rifampin lepromatous leprosy.,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 14:10:40,1642632408,5/24/2015 14:10:18,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,LEPROMATOUS LEPROSY.,97-109,0-6-18-30-35-43-49-52,Daily dapsone CLOFAZIMINE plus monthly doses of rifampin,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 14:18:40,1642633988,5/24/2015 14:17:35,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,LEPROMATOUS LEPROSY.,97-109,18,CLOFAZIMINE,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343127,5/24/2015 14:21:48,1642634627,5/24/2015 14:20:04,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,97,18,,,116,29,LEPROMATOUS LEPROSY,CLOFAZIMINE,required to treat LEPROMATOUS LEPROSY.,79-88-91-97-109,0-6-14-18,Daily dapsone and CLOFAZIMINE,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy.,97 109,18,97,18,-1,116,29,TWrex-cause,804521,Daily dapsone and clofazimine plus monthly doses of rifampin for 24 months are required to treat lepromatous leprosy,lepromatous leprosy,clofazimine
725343128,5/24/2015 11:39:54,1642605766,5/24/2015 11:39:32,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,neuropathic PAIN,55-67,123-136,POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 11:41:01,1642605957,5/24/2015 11:40:43,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,PAIN diabetic peripheral neuropathy,67-88-97-108,55-123-136-67,neuropathic pain POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 11:59:21,1642608866,5/24/2015 11:58:54,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,neuropathic PAIN,55-67,123-136,POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 12:02:26,1642609370,5/24/2015 12:01:39,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,neuropathic PAIN,55-67,123-136,POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 12:22:45,1642612782,5/24/2015 12:22:30,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,neuropathic PAIN,55-67,123-136,POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 12:24:03,1642613046,5/24/2015 12:23:40,false,clixsense,1,31482589,NLD,,,31.201.11.16,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,neuropathic PAIN,55-67,123-136,POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 12:40:06,1642615842,5/24/2015 12:39:14,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,Cost effectiveness of pregabalin for the management of neuropathic PAIN associated with diabetic peripheral neuropathy and postherpetic neuralgia:,0-5-19-22-33-37-41-55-67-72-83-88-97-108-119-123-136-52,0-5-19-22-33-37-41-52-55-67-72-83-88-97-108-119-123-136,Cost effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 12:58:34,1642619157,5/24/2015 12:58:14,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,management of neuropathic PAIN associated with diabetic postherpetic neuralgia:,41-52-55-67-72-83-88-136-123,97-108-119-123-136-147-149-158,peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 12:59:59,1642619343,5/24/2015 12:58:39,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,PAIN,67,123-136,POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343128,5/24/2015 13:15:00,1642622362,5/24/2015 13:14:49,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,67,123,,,71,145,PAIN,POSTHERPETIC NEURALGIA,neuropathic PAIN,55-67,123-136,POSTHERPETIC NEURALGIA:,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.,67,123 136,67,123,1,71,145,TWrex-cause,813425,Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective,pain,postherpetic neuralgia
725343129,5/24/2015 14:13:42,1642633023,5/24/2015 14:13:11,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,163,97,,,170,105,ANXIETY,DISORDER,ANXIETY.,163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:15:30,1642633321,5/24/2015 14:14:41,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,163,97,,,170,105,ANXIETY,DISORDER,ANXIETY.,163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:17:18,1642633754,5/24/2015 14:17:00,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,163,97,,,170,105,ANXIETY,DISORDER,depression and ANXIETY.,148-159-163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:28:17,1642635910,5/24/2015 14:28:02,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,163,97,,,170,105,ANXIETY,DISORDER,depression and ANXIETY.,148-159-163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:29:55,1642636185,5/24/2015 14:29:31,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,163,97,,,170,105,ANXIETY,DISORDER,ANXIETY.,163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:30:22,1642636267,5/24/2015 14:30:02,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,163,97,,,170,105,ANXIETY,DISORDER,posttraumatic disorder on depression and ANXIETY.,76-145-148-159-163-97,73-76-90-97-106-111-115-129-148-163,on posttraumatic stress DISORDER from the international consensus depression anxiety.,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:32:41,1642636750,5/24/2015 14:31:15,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,163,97,,,170,105,ANXIETY,DISORDER,on depression and ANXIETY.,145-148-159-163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:33:35,1642636930,5/24/2015 14:31:50,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,163,97,,,170,105,ANXIETY,DISORDER,ANXIETY.,163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:35:55,1642637547,5/24/2015 14:35:39,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,163,97,,,170,105,ANXIETY,DISORDER,depression and ANXIETY.,148-159-163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343129,5/24/2015 14:36:24,1642637641,5/24/2015 14:36:09,false,neodev,1,32562748,CAN,BC,Vancouver,108.180.140.140,163,97,,,170,105,ANXIETY,DISORDER,depression ANXIETY.,148-163,76-90-97,posttraumatic stress DISORDER,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.",163,97,163,97,1,170,105,TWrex-cause,813962,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety",anxiety,disorder
725343130,5/24/2015 12:23:34,1642612907,5/24/2015 12:23:19,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS,0,99-106,genus PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 12:24:32,1642613122,5/24/2015 12:24:20,false,clixsense,1,31482589,NLD,,,31.201.11.16,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS,0,106,PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 12:41:15,1642616093,5/24/2015 12:40:43,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS A disease caused by infection with bacteria of the genus Pasteurella.,0-48-50-58-65-68-78-83-92-95-99-106,0-48-50-58-65-68-78-92-95-99-106-83,pasteurellosis A disease caused by infection with bacteria of the genus PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 12:59:08,1642619246,5/24/2015 12:58:46,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS audio A disease genus Pasteurella.,0-39-48-50-106-99,92-95-99-106-0,pasteurellosis of the genus PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 13:01:51,1642619724,5/24/2015 13:01:43,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS,0,106,PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 13:15:26,1642622409,5/24/2015 13:15:16,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS,0,106,PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 13:21:08,1642623635,5/24/2015 13:20:45,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS disease infection bacteria genus Pasteurella.,0-50-68-83-99-106,0-50-68-83-99-106,pasteurellosis disease infection bacteria genus PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 13:27:12,1642624696,5/24/2015 13:26:18,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS A disease caused by infection with bacteria,0-48-50-58-65-68-78-83,68-78-92-95-99-106-83,infection with bacteria of the genus PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 13:28:27,1642624931,5/24/2015 13:28:15,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.35,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS,0,106,PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343130,5/24/2015 13:28:54,1642625003,5/24/2015 13:28:39,false,clixsense,1,27754226,GBR,O3,South Ockendon,92.232.236.243,0,106,,,14,117,PASTEURELLOSIS,PASTEURELLA,PASTEURELLOSIS,0,106,PASTEURELLA.,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella.,0,106,0,106,1,14,117,TWrex-cause,810361,pasteurellosis    (                    audio )  A disease caused by infection with bacteria of the genus  Pasteurella,pasteurellosis,pasteurella
725343131,5/24/2015 12:25:56,1642613276,5/24/2015 12:25:31,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA,12-20,38-42-53,IV ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 12:27:15,1642613528,5/24/2015 12:27:03,false,clixsense,1,31482589,NLD,,,31.201.11.16,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA,12-20,42-53,ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 13:26:01,1642624487,5/24/2015 13:25:34,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA IV Ergonovine maleate:,12-20-38-42-53,12-20-38-42-53,Variant Angina IV ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 13:33:46,1642625897,5/24/2015 13:33:16,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,Test for VARIANT ANGINA IV Ergonovine maleate:,3-8-12-20-38-42-53,3-8-12-42-53-20,Test for Variant Angina ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 13:36:16,1642626473,5/24/2015 13:35:51,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA,12-20,38-42-53,IV ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 13:40:31,1642627157,5/24/2015 13:40:16,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA,12-20,38-42-53,IV ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 13:53:43,1642629503,5/24/2015 13:53:03,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA,12-20,38-42-53,IV ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 13:54:39,1642629671,5/24/2015 13:53:56,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA,12-20,38-42-53,IV ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 13:55:37,1642629867,5/24/2015 13:55:13,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA IV Ergonovine maleate:,12-20-38-42-53,12-20-42-53,Variant Angina ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343131,5/24/2015 14:00:26,1642630694,5/24/2015 13:59:47,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,12,42,,,26,60,VARIANT ANGINA,ERGONOVINE MALEATE,VARIANT ANGINA,12-20,42-53,ERGONOVINE MALEATE:,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used.,12 20,42 53,12,42,-1,26,60,TWrex-cause,803031,b  Test for Variant Angina   +  >     IV  Ergonovine maleate: 0.1-0.4 mg has been used,variant angina,ergonovine maleate
725343132,5/24/2015 11:34:23,1642604935,5/24/2015 11:33:57,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,58,42,,,68,45,AMENORRHEA,PG.,Adult onset AMENORRHEA:,46-52-58,42,PG.,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 11:35:45,1642605096,5/24/2015 11:35:20,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,58,42,,,68,45,AMENORRHEA,PG.,PG. AMENORRHEA:,58-42,42-58,PG. amenorrhea:,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 11:50:42,1642607464,5/24/2015 11:49:55,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,58,42,,,68,45,AMENORRHEA,PG.,Adult onset AMENORRHEA:,46-52-58,42,PG.,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 11:55:39,1642608359,5/24/2015 11:55:11,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,58,42,,,68,45,AMENORRHEA,PG.,Adult onset AMENORRHEA:,46-52-58,42,PG.,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 12:10:17,1642610770,5/24/2015 12:10:03,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,58,42,,,68,45,AMENORRHEA,PG.,AMENORRHEA:,58,42,PG.,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 12:14:05,1642611384,5/24/2015 12:13:49,false,clixsense,1,6488338,USA,HI,Honolulu,72.130.214.250,58,42,,,68,45,AMENORRHEA,PG.,PG. AMENORRHEA:,58-42,42-58,PG. amenorrhea:,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 12:18:09,1642612057,5/24/2015 12:17:37,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,58,42,,,68,45,AMENORRHEA,PG.,Adult onset AMENORRHEA:,46-52-58,42-46-52-58,PG. Adult onset amenorrhea:,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 12:18:56,1642612188,5/24/2015 12:18:41,false,clixsense,1,31482589,NLD,,,31.201.11.16,58,42,,,68,45,AMENORRHEA,PG.,Adult onset AMENORRHEA:,46-52-58,42,PG.,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 12:20:37,1642612422,5/24/2015 12:20:06,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,58,42,,,68,45,AMENORRHEA,PG.,PG. Adult onset AMENORRHEA:,46-52-58-42,42-46-52-58,PG. Adult onset amenorrhea:,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343132,5/24/2015 12:24:17,1642613093,5/24/2015 12:24:03,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,58,42,,,68,45,AMENORRHEA,PG.,Adult onset AMENORRHEA: a study of,46-52-58-70-72-78,32-42-46-52-58,McDonough PG. Adult onset amenorrhea:,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients.",58,42,58,42,-1,68,45,TWrex-cause,803793,"Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients",amenorrhea,pg.
725343133,5/24/2015 11:29:21,1642604188,5/24/2015 11:28:59,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,125,67,,,134,75,ARTHRITIS,BACTERIUM,septic ARTHRITIS,118-125,67,BACTERIA,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 11:30:36,1642604360,5/24/2015 11:30:10,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,125,67,,,134,75,ARTHRITIS,BACTERIUM,bacteria ARTHRITIS,125-67,67-118-125,BACTERIA septic arthritis,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 11:34:44,1642604967,5/24/2015 11:34:28,false,elite,1,26544151,GBR,,,213.205.252.203,125,67,,,134,75,ARTHRITIS,BACTERIUM,ARTHRITIS,125,67,BACTERIA,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 11:38:30,1642605532,5/24/2015 11:37:05,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,125,67,,,134,75,ARTHRITIS,BACTERIUM,septic ARTHRITIS,118-125,67,BACTERIA,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 11:42:00,1642606091,5/24/2015 11:41:43,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,125,67,,,134,75,ARTHRITIS,BACTERIUM,septic ARTHRITIS,118-125,67,BACTERIA,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 11:51:00,1642607517,5/24/2015 11:50:40,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,125,67,,,134,75,ARTHRITIS,BACTERIUM,septic ARTHRITIS,118-125,67,BACTERIA,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 11:54:01,1642608064,5/24/2015 11:53:48,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,125,67,,,134,75,ARTHRITIS,BACTERIUM,ARTHRITIS,125,67,BACTERIA,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 11:54:23,1642608122,5/24/2015 11:54:13,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,125,67,,,134,75,ARTHRITIS,BACTERIUM,cause of septic ARTHRITIS in your local,109-115-118-125-135-138-143,47-59-64-67-76-79-88,sensitivity data of BACTERIA in addition to,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 12:05:47,1642609983,5/24/2015 12:05:18,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,125,67,,,134,75,ARTHRITIS,BACTERIUM,septic ARTHRITIS,118-125,67,BACTERIA,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343133,5/24/2015 12:08:41,1642610528,5/24/2015 12:08:25,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,125,67,,,134,75,ARTHRITIS,BACTERIUM,septic ARTHRITIS,118-125,67,BACTERIA,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,125,67,125,67,1,134,75,TWrex-cause,811119,BC]  Specific recommendation: • Know the local sensitivity data of bacteria in addition to the most frequent cause of septic arthritis in your local community to aid the selection of antimicrobial agents before culture and sensitivity results,arthritis,bacterium
725343134,5/24/2015 11:36:38,1642605178,5/24/2015 11:36:20,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,91,40,,,101,49,INFECTION,AZTREONAM,urinary tract INFECTIONS,77-85-91,40,AZTREONAM,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 11:38:05,1642605471,5/24/2015 11:37:48,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,91,40,,,101,49,INFECTION,AZTREONAM,Aztreonam INFECTIONS,91-40,40-77-85-91,AZTREONAM urinary tract infections,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 11:54:24,1642608129,5/24/2015 11:53:43,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,91,40,,,101,49,INFECTION,AZTREONAM,INFECTIONS,91,40,AZTREONAM,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 11:58:06,1642608672,5/24/2015 11:57:44,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,91,40,,,101,49,INFECTION,AZTREONAM,urinary tract INFECTIONS,77-85-91,40,AZTREONAM,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 12:12:05,1642611116,5/24/2015 12:11:52,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,91,40,,,101,49,INFECTION,AZTREONAM,severe urinary tract INFECTIONS,70-77-85-91,40,AZTREONAM,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 12:20:03,1642612338,5/24/2015 12:19:47,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,91,40,,,101,49,INFECTION,AZTREONAM,urinary tract INFECTIONS,77-85-91,40,AZTREONAM,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 12:20:38,1642612423,5/24/2015 12:20:24,false,clixsense,1,31482589,NLD,,,31.201.11.16,91,40,,,101,49,INFECTION,AZTREONAM,severe urinary tract INFECTIONS,70-77-85-91,40,AZTREONAM,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 12:26:14,1642613327,5/24/2015 12:26:01,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,91,40,,,101,49,INFECTION,AZTREONAM,severe urinary tract INFECTIONS,70-77-85-91,31-33-36-40-50-53-57-70-77-85-91,A et al. AZTREONAM in the treatment severe urinary tract infections,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 12:27:30,1642613584,5/24/2015 12:27:06,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,91,40,,,101,49,INFECTION,AZTREONAM,urinary tract INFECTIONS,77-85-91,40,AZTREONAM,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343134,5/24/2015 12:30:48,1642614075,5/24/2015 12:27:53,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,91,40,,,101,49,INFECTION,AZTREONAM,Aztreonam in the treatment of severe urinary tract INFECTIONS in pediatric patients.,40-50-53-57-70-77-85-91-102-105-115-67,40-50-53-57-67-70-77-85-91-102-105-115,AZTREONAM in the treatment of severe urinary tract infections in pediatric patients.,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.",91,40,91,40,-1,101,49,TWrex-cause,803635,"Rusconi F, Assael BM, Boccazzi A et al. Aztreonam in the treatment of severe urinary tract infections in pediatric patients",infection,aztreonam
725343135,5/24/2015 11:30:29,1642604318,5/24/2015 11:29:55,false,clixsense,1,6338946,CAN,ON,Richmond Hill,23.91.225.202,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,23-37,130-142,"susceptible STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 11:32:11,1642604595,5/24/2015 11:31:43,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,"STREPTOCOCCAL INFECTIONS susceptible streptococci,",23-37-130-142,23-142-37,"Streptococcal Infections STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 11:35:31,1642605075,5/24/2015 11:35:15,false,elite,1,26544151,GBR,,,213.205.252.203,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,23-37,142,"STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 11:41:54,1642606081,5/24/2015 11:41:04,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,23-37,130-142,"susceptible STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 11:42:44,1642606179,5/24/2015 11:42:28,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,23-37,142,"STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 11:51:59,1642607652,5/24/2015 11:51:37,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,23-37,142,"STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 11:54:49,1642608255,5/24/2015 11:54:32,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,23-37,142,"STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 12:06:55,1642610162,5/24/2015 12:06:13,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,23-37,130-142,"susceptible STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 12:09:16,1642610635,5/24/2015 12:09:04,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,", STREPTOCOCCAL INFECTIONS",9-23-37,142,"STREPTOCOCCI,","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343135,5/24/2015 12:09:47,1642610720,5/24/2015 12:09:01,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,23,142,,,47,154,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,", Other STREPTOCOCCAL INFECTIONS Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",9-17-23-37-49-59-62-67-70-81-88-99-108-120-127-130-142-156-166-172-184-190-201-205-213,17-23-37-49-59-62-67-70-81-88-99-108-120-127-130-142-156-166-172-184-190-201-205-213,"Other Streptococcal Infections Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI, including upper respiratory tract infections and scarlet fever.","5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever.",23 37,142,23,142,1,47,154,TWrex-cause,810225,"5 ,   30 ,   57  Other Streptococcal Infections  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible streptococci, including upper respiratory tract infections and scarlet fever",streptococcal infection,streptococcus
725343136,5/24/2015 13:29:12,1642625080,5/24/2015 13:27:57,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,14,72,,,22,81,SYNDROME,CLONIDINE,"Withdrawal SYNDROME patients oral clonidine) therapy therapy, oral dosages concomitant adrenergic therapy.",3-14-48-67-72-138-181-264-316-330-350-259,3-14-67-72-138-181-259-264-316-330-350,"Withdrawal syndrome oral CLONIDINE) therapy therapy, oral dosages concomitant adrenergic therapy.","b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 13:39:21,1642626959,5/24/2015 13:37:31,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,14,72,,,22,81,SYNDROME,CLONIDINE,Withdrawal SYNDROME,14-3,67-72,oral CLONIDINE),"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 13:41:38,1642627406,5/24/2015 13:41:24,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,14,72,,,22,81,SYNDROME,CLONIDINE,Withdrawal SYNDROME,3-14,67-72,oral CLONIDINE),"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 13:56:44,1642630054,5/24/2015 13:56:01,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,14,72,,,22,81,SYNDROME,CLONIDINE,Withdrawal SYNDROME,3-14,67-72,oral CLONIDINE),"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 13:59:00,1642630489,5/24/2015 13:57:53,false,clixsense,1,32362391,CAN,ON,Brampton,99.228.118.119,14,72,,,22,81,SYNDROME,CLONIDINE,SYNDROME oral clonidine) adrenergic,14-67-72-330,67-72-330,oral CLONIDINE) adrenergic,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 14:00:10,1642630653,5/24/2015 13:59:35,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,14,72,,,22,81,SYNDROME,CLONIDINE,Withdrawal SYNDROME,3-14,67-72,oral CLONIDINE),"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 14:02:11,1642630980,5/24/2015 14:01:36,false,vivatic,1,31434961,GBR,X3,Bridgend,86.150.39.244,14,72,,,22,81,SYNDROME,CLONIDINE,Withdrawal SYNDROME,14-3,3-72-14,Withdrawal syndrome CLONIDINE),"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 14:08:46,1642632177,5/24/2015 14:08:18,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,14,72,,,22,81,SYNDROME,CLONIDINE,b Withdrawal SYNDROME,0-3-14,67-72,oral CLONIDINE),"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 14:13:47,1642633041,5/24/2015 14:12:28,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,14,72,,,22,81,SYNDROME,CLONIDINE,Withdrawal SYNDROME,3-14,67-72,oral CLONIDINE),"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343136,5/24/2015 14:17:38,1642633813,5/24/2015 14:16:24,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,14,72,,,22,81,SYNDROME,CLONIDINE,Withdrawal SYNDROME,3-14,48-57-67-72-83-86-91,patients receiving oral CLONIDINE) is more pronounced,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy.",14,72,14,72,-1,22,81,TWrex-cause,800258,"b  Withdrawal syndrome (reported in about 1% of patients receiving oral clonidine) is more pronounced after abrupt cessation of long-term therapy than after short-term (1-2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β-adrenergic blocking therapy",syndrome,clonidine
725343137,5/24/2015 12:24:13,1642613091,5/24/2015 12:23:55,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"skeletal COCCIDIOIDOMYCOSIS,",18-27,90,"FLUCONAZOLE,","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 12:25:07,1642613184,5/24/2015 12:24:54,false,clixsense,1,31482589,NLD,,,31.201.11.16,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"skeletal COCCIDIOIDOMYCOSIS,",18-27,90,"FLUCONAZOLE,","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 12:42:12,1642616198,5/24/2015 12:41:41,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"However, for skeletal COCCIDIOIDOMYCOSIS, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",5-14-18-27-47-60-64-78-87-90-103-108-117-123-126-130-137-141-147-149-154-157,5-14-18-27-47-60-64-78-87-90-103-108-117-123-126-130-137-141-147-149-154-157,"However, for skeletal coccidioidomycosis, itraconazole was significantly superior to FLUCONAZOLE, with response rates of 70% versus 30% after 1 year of therapy.","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 12:59:47,1642619332,5/24/2015 12:59:28,false,clixsense,1,22984878,CAN,ON,Kingston,67.193.186.57,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"However, for skeletal COCCIDIOIDOMYCOSIS, itraconazole was significantly fluconazole,",5-14-18-27-47-60-64-90,27-47-64-78-87-90-103-108-117-18,"skeletal coccidioidomycosis, itraconazole significantly superior to FLUCONAZOLE, with response rates","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 13:16:02,1642622550,5/24/2015 13:15:52,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"skeletal COCCIDIOIDOMYCOSIS,",18-27,90,"FLUCONAZOLE,","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 13:22:46,1642623986,5/24/2015 13:22:13,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"skeletal COCCIDIOIDOMYCOSIS, itraconazole fluconazole, therapy.",18-27-47-90-157,18-27-47-90,"skeletal coccidioidomycosis, itraconazole FLUCONAZOLE,","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 13:28:58,1642625007,5/24/2015 13:27:55,false,clixsense,1,25419319,GBR,I2,Manchester,151.228.17.156,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"for skeletal COCCIDIOIDOMYCOSIS, itraconazole was significantly superior to fluconazole,",14-18-27-47-60-64-78-87-90,78-87-90-103-108-117-47,"itraconazole superior to FLUCONAZOLE, with response rates","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 13:28:59,1642625008,5/24/2015 13:28:46,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.35,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"skeletal COCCIDIOIDOMYCOSIS,",18-27,90,"FLUCONAZOLE,","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 13:33:19,1642625810,5/24/2015 13:32:39,false,clixsense,1,6340330,USA,NY,Canajoharie,67.248.115.74,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"COCCIDIOIDOMYCOSIS,",27,90,"FLUCONAZOLE,","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
725343137,5/24/2015 13:33:34,1642625848,5/24/2015 13:32:09,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,27,90,,,45,101,COCCIDIOIDOMYCOSIS,FLUCONAZOLE,"skeletal COCCIDIOIDOMYCOSIS,",18-27,90,"FLUCONAZOLE,","49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy.",27,90,27,90,-1,45,101,TWrex-cause,804655,"49   However, for skeletal coccidioidomycosis, itraconazole was significantly superior to fluconazole, with response rates of 70% versus 30% after 1 year of therapy",coccidioidomycosis,fluconazole
